IDEXX Laboratories Inc
Buy, Hold or Sell?

Let's analyse Idexx together

Penke I guess you are interested in IDEXX Laboratories Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of IDEXX Laboratories Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about IDEXX Laboratories Inc

I send you an email if I find something interesting about IDEXX Laboratories Inc.

Quick analysis of Idexx (30 sec.)

What can you expect buying and holding a share of Idexx? (30 sec.)

How much money do you get?

$5.28

When do you have the money?

1 year

How often do you get paid?

27.5%

What is your share worth?

Current worth

$17.69

Expected worth in 1 year

$28.11

How sure are you?

65.0%

+ What do you gain per year?

Total Gains per Share

$15.70

Return On Investment

3.2%

For what price can you sell your share?

Current Price per Share

$494.26

Expected price per share

$435.83 - $543.33

How sure are you?

50%

1. Valuation of Idexx (5 min.)

Live pricePrice per Share (EOD)

$494.26

Book Value per Share

$17.69

Intrinsic Value Per Share

$43.59 - $96.76

Total Value Per Share

$61.28 - $114.44

My calculation of the intrinsic value of Idexx is based how much money is coming from the company's main activities (Free Cash Flow).

The following numbers are based on moving averages and per share and per quarter.
I use a 6% discount rate for the low estimation and 3% for the high estimation.
The current Free Cash Flow Per Share is 10Y: ($1.09) 3Y: ($1.77) TTM: ($2.30)
The change per quarter (trend) of the Free Cash Flow Per Share is 10Y: ($0.05) 3Y: ($0.02) TTM: ($0.25)

Years	Total Low est.	Total High est.	Added Free Cash Flow
1	$4.38	$7.47	$4.66 - $7.92
2	$8.80	$15.52	$4.97 - $8.77
3	$13.24	$24.13	$5.28 - $9.62
4	$17.67	$33.25	$5.59 - $10.47
5	$22.09	$42.85	$5.91 - $11.32
6	$26.49	$52.88	$6.22 - $12.17
7	$30.84	$63.32	$6.53 - $13.02
8	$35.15	$74.13	$6.84 - $13.87
9	$39.40	$85.29	$7.15 - $14.71
10	$43.59	$96.76	$7.46 - $15.56

2. Growth of Idexx (5 min.)

Is Idexx growing?

	Current year	Previous year	Grow	Grow %
How rich?	$1.4b	$545.3m	$633.8m	53.8%

How much money is Idexx making?

	Current year	Previous year	Grow	Grow %
Making money	$211.2m	$169.7m	$41.4m	19.6%
Net Profit Margin	23.1%	20.2%	-	-

How much money comes from the company's main activities?

Quarterly Yearly

3. Financial Health of Idexx (5 min.)

4. Comparing to competitors in the Diagnostics & Research industry (5 min.)

Industry Rankings (Diagnostics & Research)

Richest
#22 / 145

Most Revenue
#23 / 145

Most Profit
#15 / 145

Most Efficient
#9 / 145

What can you expect buying and holding a share of Idexx? (5 min.)

Welcome investor! Idexx's management wants to use your money to grow the business. In return you get a share of Idexx.

What can you expect buying and holding a share of Idexx?

First you should know what it really means to hold a share of Idexx. And how you can make/lose money.

Speculation

The Price per Share of Idexx is $494.26. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

The fundamentals: the financial health trends of Idexx.
The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Idexx, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $17.69. Based on the TTM, the Book Value Change Per Share is $2.61 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.19 per quarter.
You may receive quarterly/yearly dividend in the form of additional shares.
You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $1.32 per quarter.

Based on historical numbers we can estimate the returns while holding a share of Idexx.

How much money are you going to get?

	MRQ		TTM		YOY		5Y		10Y
	$	% of Price per Share	$	% of Price per Share	$	% of Price per Share	$	% of Price per Share	$	% of Price per Share
Usd Eps	2.32	0.5%	2.52	0.5%	2.01	0.4%	1.91	0.4%	1.29	0.3%
Usd Book Value Change Per Share	2.24	0.5%	2.61	0.5%	-0.19	0.0%	0.89	0.2%	0.32	0.1%
Usd Dividend Per Share	0.00	0.0%	1.32	0.3%	0.08	0.0%	0.39	0.1%	0.25	0.1%
Usd Total Gains Per Share	2.24	0.5%	3.93	0.8%	-0.11	0.0%	1.27	0.3%	0.57	0.1%
Usd Price Per Share	555.05	-	498.66	-	407.89	-	426.24	-	282.14	-
Price to Earnings Ratio	59.87	-	49.80	-	51.05	-	55.77	-	55.50	-
Price-to-Total Gains Ratio	247.74	-	153.42	-	-97.81	-	-335.30	-	-213.57	-
Price to Book Ratio	31.38	-	37.04	-	63.01	-	94.78	-	-442.14	-
Price-to-Total Gains Ratio	247.74	-	153.42	-	-97.81	-	-335.30	-	-213.57	-

When do you get the money?

Usd Investment	$.00
Usd Price Per Share	494.26
Number of shares	2

Gains per Quarter	Trailing 12 Months	5 Year
Usd Dividend Per Share	1.32	0.39
Usd Book Value Change Per Share	2.61	0.89
Usd Total Gains Per Share	3.93	1.27
Gains per Quarter (2 shares)	7.85	2.55
Gains per Year (2 shares)	31.40	10.20

Years	Return on Investment (TTM)			Return on Investment (5Y)
	Dividend	Book Value gain	Total gains	Dividend	Book Value gain	Total gains
Broker costs	-	-	-10	-	-	-10
1	11	21	21	3	7	0
2	21	42	52	6	14	10
3	32	63	83	9	21	20
4	42	83	114	12	28	30
5	53	104	145	15	36	40
6	63	125	176	18	43	50
7	74	146	207	22	50	60
8	84	167	238	25	57	70
9	95	188	269	28	64	80
10	106	208	300	31	71	90

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %

	Trailing 12 Months				3Y				5 Year				10 Year				ALLTIME
				%				%				%				%				%
Earnings Per Share	4.0	0.0	0.0	100.0%	12.0	0.0	0.0	100.0%	20.0	0.0	0.0	100.0%	40.0	0.0	0.0	100.0%	126.0	4.0	0.0	96.9%
Book Value Change Per Share	4.0	0.0	0.0	100.0%	9.0	3.0	0.0	75.0%	15.0	5.0	0.0	75.0%	23.0	17.0	0.0	57.5%	78.0	52.0	0.0	60.0%
Dividend per Share	3.0	0.0	1.0	75.0%	5.0	0.0	7.0	41.7%	7.0	0.0	13.0	35.0%	11.0	0.0	29.0	27.5%	16.0	0.0	114.0	12.3%
Total Gains per Share	4.0	0.0	0.0	100.0%	9.0	3.0	0.0	75.0%	16.0	4.0	0.0	80.0%	26.0	14.0	0.0	65.0%	82.0	48.0	0.0	63.1%

Fundamentals of Idexx

About IDEXX Laboratories Inc

https://www.idexx.com
Diagnostics & Research
11000
One IDEXX Drive, Westbrook, ME, United States, 04092
Google Maps Bing Maps

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Fundamental data was last updated by Penke on 2024-04-11 11:29:03.

Financial Health

Profitability Details

	Compared to previous year	Compared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.

Operating Efficiency Details

	Compared to previous year	Compared to industry
The company is operating very efficient.
The company is efficient in keeping operating costs low.

Liquidity Details

	Compared to previous year	Compared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.

Solvency Details

	Compared to previous year	Compared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details

	Compared to previous year	Compared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is overpriced.

1.1. Profitability of IDEXX Laboratories Inc.

1.1. Profitability

1.1.1. Net Profit Margin

Measures how much net profit Idexx earns for each $1 of revenue.

Above 10% is considered healthy but always compare Idexx to the Diagnostics & Research industry mean.
A Net Profit Margin of 21.6% means that $0.22 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of IDEXX Laboratories Inc:

The MRQ is 21.6%. The company is making a huge profit. +2
The TTM is 23.1%. The company is making a huge profit. +2

Trends

Current period		Compared to		+/-
MRQ	21.6%	TTM	23.1%	-1.5%
TTM	23.1%	YOY	20.2%	+2.9%
TTM	23.1%	5Y	21.1%	+1.9%
5Y	21.1%	10Y	17.3%	+3.9%

Compared to industry (Diagnostics & Research)

Period	Company	Industry (mean)	+/-
MRQ	21.6%	-7.7%	+29.3%
TTM	23.1%	-6.7%	+29.8%
YOY	20.2%	2.4%	+17.8%
5Y	21.1%	-1.5%	+22.6%
10Y	17.3%	-3.4%	+20.7%

Measures how much net profit Idexx earns for each $1 of revenue.

Revenue is the amount of profit Idexx generates before taxes and all other costs. For example, when you buy a cup of coffee it will cost you $3. The company does not earn $3 in profit but also has to pay various costs and taxes to create that cup of coffee. Let's assume the cost of creating a cup of coffee is $1.5.

The $3 you pay for a cup of coffee is called revenue.
The $1.5 that’s left over when all costs to create that cup of coffee (including taxes) are deduced from the revenue is called net profit.

The net profit margin looks at how much net profit Idexx earns for each $1 in revenue.

How to use net profit margin

Higher profit margin is better (more profit).
Above 10% is considered healthy but always compare Idexx to the Diagnostics & Research industry mean.
Can be used to compare companies within the Diagnostics & Research industry.

You typically want a high profit margin. This means that for each $1 in sales, Idexx makes more profit. This shows the investor how efficiently Idexx is operating in general and compared to other companies in the same industry. Idexx operates in the Diagnostics & Research industry.

Why do investors use net profit margin in their analysis

It helps investors to determine the efficiency of Idexx. If profit margins remain low (compared to the Diagnostics & Research industry mean) and there are no improvements to make in production costs or other areas that might be a warning sign. If profit margins are high that means the company has low overhead costs and is efficiently using its resources to generate profit.

The three steps every investor should look at:

What is the current net profit margin?
The current most recent quarter (MRQ) Net Profit Margin of Idexx is 0.22. This means that Idexx earned $0.22 for each $1 in revenue in the most recent quarter.
How does it compare to the industry?
The mean MRQ Net Profit Margin of the Diagnostics & Research industry is -7.7%.
What is the trend?
The trend is important because it shows you how Idexx is performing over time. The most recent quarter might be important if Idexx released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Idexx up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare Idexx with other companies in the same industry (Diagnostics & Research).
Net profit margin should rise over the years.
Can be influenced when Idexx sells assets (profit will increase while costs remain the same).
It won’t show what part of Idexx is doing great or needs improvement (it only looks at total revenue and total net income).

How to calculate net profit margin

Net profit margin = net income / total revenue * 100%

Real example of Idexx

You need the following data to determine net profit margin:

Income statement from the period you want to calculate (for example, MRQ or TTM).

Net income MRQ Idexx = 194,521
Total revenue MRQ Idexx = 901,601
$194,521 / $901,601 = 0.22 or 21.6%

Higher is better

The higher the net profit margin, the more efficient the company is generating income. This helps investors to determine how the company is managing money. The net profit margin is an important indicator when diving into the financial health of a company. Overall, you want to see the net profit margin rising over the years. That means the company improved their production and made it more efficient (if possible).

You can use the net profit margin to compare companies within the same industry. If there are two companies where one is much bigger but the smaller one has a higher net profit margin, that means the smaller company is more efficiently using operational costs.

Important: Profit margins can be very different between industries. Companies with assembly lines or transports are much more prone to see shifting in prices for fuel, ingredients and maintenance compared to companies that only provide services. You should never compare net profit margin between different industries.

1.1.2. Return on Assets

Shows how efficient Idexx is using its assets to generate profit.

Above 5% is considered healthy but always compare Idexx to the Diagnostics & Research industry mean.
6.0% Return on Assets means that Idexx generated $0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of IDEXX Laboratories Inc:

The MRQ is 6.0%. Using its assets, the company is efficient in making profit. +1
The TTM is 7.1%. Using its assets, the company is efficient in making profit. +1

Trends

Current period		Compared to		+/-
MRQ	6.0%	TTM	7.1%	-1.1%
TTM	7.1%	YOY	6.4%	+0.7%
TTM	7.1%	5Y	6.9%	+0.2%
5Y	6.9%	10Y	5.5%	+1.4%

Compared to industry (Diagnostics & Research)

Period	Company	Industry (mean)	+/-
MRQ	6.0%	-1.7%	+7.7%
TTM	7.1%	-1.3%	+8.4%
YOY	6.4%	-0.9%	+7.3%
5Y	6.9%	-0.5%	+7.4%
10Y	5.5%	-0.9%	+6.4%

Shows how efficient Idexx is using its assets to generate profit.

For a farm, a tractor is considered an asset. The tractor helps ploughing the land making it possible to plant and harvest crops. But the tractor might be old and needing maintenance all the time reducing its efficiency. Return on assets indicates how effectively the farm is using the tractor (and other assets that help the core business) to plough the land.

How to use return on assets

Higher is better.
Above 5% is considered healthy but always compare Idexx to the Diagnostics & Research industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use return on assets in their analysis

Shows the investor how effectively Idexx is using its resources to generate profit. If the return on assets (6.0%) from Idexx are higher than the Diagnostics & Research mean (-1.7%) that means Idexx is using its resources better than their competitors. If not, that means their competitors are more efficient in using their resources to generate profit.

An investor should always look at:

What is the current return on assets?
The current most recent quarter (MRQ) Return on Assets of Idexx is 6.0%. This means the company generated $0.06 for each $1 in assets.
How does it compare to the industry?
The mean MRQ Return on Assets of the Diagnostics & Research industry is -1.7%.
What is the trend?
The trend is important because it shows you how Idexx is performing over time. The most recent quarter might be important if Idexx released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Idexx up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
If a company has many assets changing over time, it’s better to calculate the average assets instead of the total assets.

How to calculate return on assets

Return on assets = net income / total assets * 100%

Real example Idexx

You need the following data to determine return on assets (ROA):

Income statement
Balance sheet

Net income MRQ (income statement) from Idexx = 194,521
Total assets MRQ (balance sheet) from Idexx = 3,259,925
194,521 / 3,259,925 = 0.06 or 6.0%

ROA is an important ratio as it will tell you how effectively Idexx is using its resources to generate profits. Example:

Bob and Kristin both sell ice cream in the summer. They both have an ice cream truck. The truck Bob owes cost him $20.000 and the truck Kristin owes cost her $1500. Over the summer, Bob earned $2000 and Kristin earned $200. To calculate the return on assets:

Bob: $2000 / $20.000 * 100% = 10%
Kristin: $200 / $1500 * 100% = 13.3%

This tells you Bob’s company is more valuable but Kristin's company is more efficient. Be aware that total assets can change over time. A transportation business will buy and sell trucks or planes all the time. Before using return on assets as a guideline, you have to know what the exact assets are. For a company that has many assets changing over time, it’s better to calculate the average assets instead of the total assets.

1.1.3. Return on Equity

Shows how efficient Idexx is using its investors money to generate profit.

Above 15%-20% is considered healthy but always compare Idexx to the Diagnostics & Research industry mean.
13.1% Return on Equity means Idexx generated $0.13 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of IDEXX Laboratories Inc:

The MRQ is 13.1%. Using its investors money, the company is less efficient in making profit.
The TTM is 18.9%. Using its investors money, the company is efficient in making profit. +1

Trends

Current period		Compared to		+/-
MRQ	13.1%	TTM	18.9%	-5.7%
TTM	18.9%	YOY	31.4%	-12.5%
TTM	18.9%	5Y	45.0%	-26.2%
5Y	45.0%	10Y	47.0%	-2.0%

Compared to industry (Diagnostics & Research)

Period	Company	Industry (mean)	+/-
MRQ	13.1%	-0.7%	+13.8%
TTM	18.9%	-0.1%	+19.0%
YOY	31.4%	0.3%	+31.1%
5Y	45.0%	-1.4%	+46.4%
10Y	47.0%	-2.3%	+49.3%

Shows how efficient Idexx is using its investors money to generate profit.

A publicly traded company (any company that issues shares to the public) is owned by its shareholders. Return on equity calculates the amount of profit for every $1 the shareholders invested.

How to use return on equity

Higher is better.
Above 15%-20% is considered healthy but always compare Idexx to the Diagnostics & Research industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use return on equity in their analysis

To find out the owners/management's attitude toward their company. You typically want the owners/management to invest in the company and focus on generating profit. If not enough profit is generated (compared to the Diagnostics & Research industry mean), the company might not be investing their money efficiently.

The three steps every investor should look at:

What is the current return on equity?
The current most recent quarter (MRQ) Return on Equity of Idexx is 13.1%. This means Idexx generated $0.13 for each $1 the owners (shareholders) invested.
How does it compare to the industry?
The mean MRQ Return on Equity of the Diagnostics & Research industry is -0.7%.
What is the trend?
The trend is important because it shows you how Idexx is performing over time. The most recent quarter might be important if Idexx released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Idexx up to 10 years back (depending if Idexx existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Does not include intangible assets (non physical assets like licences, computer software, etc.).
Stockholders equity and shareholders equity refer to the same thing.
Liabilities should not be more than three times return on equity.

How to calculate return on equity

Return on equity = net profit / shareholders equity * 100%

Real example of Idexx

You need the following data to determine ROE:

Income statement
Balance sheet
Net profit MRQ (income statement) Idexx = 194,521
Shareholders equity (balance sheet) MRQ Idexx = 1,484,530
194,521 / 1,484,530 = 0.13 or 13.1%

A negative shareholder equity is a warning sign. It means the company has more liabilities than assets. It might also mean that the owners did not invest enough money or they are taking money out of the business.

1.2. Operating Efficiency of IDEXX Laboratories Inc.

1.2. Operating Efficiency

1.2.1. Operating Margin

Measures how efficient Idexx is operating .

Measures how much profit Idexx makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
Above 15% is considered healthy but always compare Idexx to the Diagnostics & Research industry mean.
An Operating Margin of 23.9% means the company generated $0.24 for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of IDEXX Laboratories Inc:

The MRQ is 23.9%. The company is operating efficient. +1
The TTM is 26.8%. The company is operating very efficient. +2

Trends

Current period		Compared to		+/-
MRQ	23.9%	TTM	26.8%	-2.9%
TTM	26.8%	YOY	25.0%	+1.8%
TTM	26.8%	5Y	25.2%	+1.6%
5Y	25.2%	10Y	22.0%	+3.3%

Compared to industry (Diagnostics & Research)

Period	Company	Industry (mean)	+/-
MRQ	23.9%	-6.2%	+30.1%
TTM	26.8%	0.5%	+26.3%
YOY	25.0%	4.3%	+20.7%
5Y	25.2%	3.7%	+21.5%
10Y	22.0%	-1.3%	+23.3%

Measures how efficient Idexx is operating .

The more effecient a company creates products or provides services, the more profit it generates.

How to use operating margin

Higher is better
Above 15% is considered healthy but always compare Idexx to the Diagnostics & Research industry mean.
Can be very different between industries
Can be used to compare companies

Why do investors use operating margin in their analysis

To determine how much profit Idexx is making from it’s core business.

The three steps every investor should look at:

What is the current net profit margin?
The current most recent quarter (MRQ) Operating Margin of Idexx is 23.9%. This means that Idexx earned $0.24 for each $1 in revenue in the most recent quarter.
How does it compare to the industry?
The mean MRQ Operating Margin of the Diagnostics & Research industry is -6.2%.
What is the trend?
The trend is important because it shows you how Idexx is performing over time. The most recent quarter might be important if Idexx released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Idexx up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry
Can be calculated in different ways

How to calculate operating margin

Operating margin = operating earnings / total revenue

Real example of Idexx

You need the following data to determine operating margin:

Income statement
Operating earnings MRQ Idexx = 245,302
Total revenue MRQ Idexx = 901,601
$245,302 / $901,601 = 0.24 or 23.9%

Operating margin is used to calculate how much profit a company makes after variable costs of production but before paying interest and taxes. Some variable costs examples are wages, raw materials, packaging, and transaction fees. The amount of variable costs is different for each company and industry. In general, a higher operating margin is better as this implicates that a company is running efficiently.

For investors, a higher operating margin is a good sign. Although you should always look at operating margin in the long term. If operating margin is fluctuating over the years this might be a sign that things are not running efficiently enough. It’s a way to check how much profit a company is making from its core business.

Operation earnings can be calculated in multiple ways:

Operation earnings = EBIT - non operating income + non operating expense
Operation earnings = Gross profit - operating expense - depreciation and amortisation
Operation earnings = Total revenue - COGS (costs of goods sold) - indirect costs

1.2.2. Operating Ratio

Measures how efficient Idexx is keeping operating costs low.

Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
An Operation Ratio of 0.73 means that the operating costs are $0.73 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of IDEXX Laboratories Inc:

The MRQ is 0.728. The company is efficient in keeping operating costs low. +1
The TTM is 0.700. The company is efficient in keeping operating costs low. +1

Trends

Current period		Compared to		+/-
MRQ	0.728	TTM	0.700	+0.027
TTM	0.700	YOY	0.733	-0.032
TTM	0.700	5Y	0.731	-0.031
5Y	0.731	10Y	0.766	-0.035

Compared to industry (Diagnostics & Research)

Period	Company	Industry (mean)	+/-
MRQ	0.728	1.296	-0.568
TTM	0.700	1.301	-0.601
YOY	0.733	1.238	-0.505
5Y	0.731	1.268	-0.537
10Y	0.766	1.217	-0.451

Measures how efficient Idexx is keeping operating costs low.

If the operating ratio is below 1 that means the company is making money. The lower the operating ratio, the more efficient the company.

How to use operating ratio

Lower is better.
Below 1 is considered healthy but always compare Idexx to the Diagnostics & Research industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use operating ratio in their analysis

Shows if costs of creating products and or services is increasing or decreasing. The lower the operating ratio, the more efficient the company is creating products and services.

The three steps every investor should look at:

What is the current Operatin ratio?
The current most recent quarter (MRQ) Operating Ratio of Idexx is 72.8%. This means that Idexx earned $0.73 for each $1 in net sales in the most recent quarter.
How does it compare to the industry?
The mean MRQ Operating Ratio of the Diagnostics & Research industry is 1.30.
What is the trend?
The trend is important because it shows you how Idexx is performing over time. The most recent quarter might be important if Idexx released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Idexx up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
You need COGS to calculate operating ratio which is not always shown in the income statement.
Does not consider debt.

How to calculate operating ratio

Operating ratio = Operating expenses + COGS \ Net sales

Real life example Idexx

You need the following data to determine operating ratio:

Income statement

COGS is not always specified on the income statement. If so you can use the following calculation:

(cost of revenue + total operating expenses) \ total revenue
(375,434 +280,865) \ 901,601 = 0.73

The operating ratio measures the efficiency of a company at keeping low costs while generating profits from sales. It compares the total operating expenses to the net amount of sales. The total operating expenses exists of:

COGS (materials, labour, rent of facility, repairs)
Operating expenses (legal fees, marketing, wages, rent, maintenance/repairs)

Operating expenses are all the costs the company makes that are not directly tied to the production of the service or product. Where COGS are costs that are directly tied to the production of a product or service.

Do note that COGS is not always available in the income statement. Some companies include COGS in the operating expenses while others list COGS separately. To make it even more confusing, COGS is also known as “costs of sales” and costs of sales is the same as costs of revenue.

The operating ratio tells you how efficient the company is creating its products or services while keeping prices low. In this case, a lower ratio is better. Higher or rising operating ratios might tell you that costs are rising while sales are not improving or staying the same.

1.3. Liquidity of IDEXX Laboratories Inc.

1.3. Liquidity

1.3.1. Current Ratio

Measures if Idexx is able to pay off Short-term Debt.

Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
A Current Ratio of 1.57 means the company has $1.57 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of IDEXX Laboratories Inc:

The MRQ is 1.571. The company is able to pay all its short-term debts. +1
The TTM is 1.353. The company is just able to pay all its short-term debts.

Trends

Current period		Compared to		+/-
MRQ	1.571	TTM	1.353	+0.219
TTM	1.353	YOY	0.949	+0.403
TTM	1.353	5Y	1.262	+0.091
5Y	1.262	10Y	1.130	+0.132

Compared to industry (Diagnostics & Research)

Period	Company	Industry (mean)	+/-
MRQ	1.571	2.111	-0.540
TTM	1.353	2.298	-0.945
YOY	0.949	2.581	-1.632
5Y	1.262	3.012	-1.750
10Y	1.130	3.081	-1.951

Measures if Idexx is able to pay off Short-term Debt.

How to use current ratio

Higher is better
Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
Can be very different between industries
Can be used to compare companies

Why do investors use current ratio in their analysis

Shows if the company can pay of short term debts if needed. A company that can't pay off it's short term debts might get in trouble if they have to pay off their short term debts for whatever reason. For example, markets can change due to global events like covid-19 or the war in Ukraine versus Russia. Because debts are always taken based on future income, it might become troublesome for Idexx if something happens in the market that will cause sales to plummet.

The three steps every investor should look at:

What is the current current Ratio?
The current most recent quarter (MRQ) Current Ratio of Idexx is 1.57. This means Idexx has $1.57 in assets for each $1 in short-term debts.
How does it compare to the industry?
The mean MRQ Current Ratio of the Diagnostics & Research industry is 2.11.
What is the trend?
The trend is important because it shows you how Idexx is performing over time. The most recent quarter might be important if Idexx released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Idexx up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Might be deluded.
Not all assets can always be quickly sold.
Can be manipulated by increasing or decreasing the assets and/or liabilities.

How to calculate current ratio

Current ratio = current assets \ current liabilities

Real life example Idexx

You need the following data to determine operating ratio:

Balance sheet
Current ratio = current assets \ current liabilities
1,495,254 \ 951,547) = 1.57

The current ratio measures if Idexx is able to pay short-term debts (obligations). Short term in this context means all debt obligations that are about to expire within one year. The current ratio incorporates current liabilities and current assets. Current assets are all the assets a company has that are expected to be consumed or sold within standard business operations. You can find the current assets in the balance sheet. They consist of:

Inventory
Accounts receivable
Marketable securities
Prepaid expenses
Cash
Cash equivalents
liquid assets

The current liabilities are short term obligations that are due within one year. These consist of:

Short term debts
Dividends
Income taxes
Short-term debts
Accounts payable
Interest payments

The result shows an investor if Idexx is able to pay all its short-term debts if they were due all at once. When the result of the above formula is below 1, then Idexx does not have enough capital after selling all its assets to pay all short-term debts. If the ratio drops far below 1 that might indicate Idexx is or will be in financial trouble anytime soon.

Although this gives an investor some clues, the current ratio may also be deluded. Because owning assets does not mean the company can easily sell them. Also, Accounts receivable may be quite old (they will probably never pay) which deludes the current ratio. As with all ratios, you should only compare them between the same industries and companies.

1.3.2. Quick Ratio

Measures if Idexx is able to pay off Short-term Debt but only using the most liquid assets.

Above 1 is considered healthy but always compare Idexx to the Diagnostics & Research industry mean.
A Quick Ratio of 0.96 means the company can pay off $0.96 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of IDEXX Laboratories Inc:

The MRQ is 0.958. The company is just not able to pay all its short-term debts with the most liquid assets. -1
The TTM is 0.741. The company is just not able to pay all its short-term debts with the most liquid assets. -1

Trends

Current period		Compared to		+/-
MRQ	0.958	TTM	0.741	+0.217
TTM	0.741	YOY	0.510	+0.231
TTM	0.741	5Y	0.743	-0.002
5Y	0.743	10Y	0.787	-0.045

Compared to industry (Diagnostics & Research)

Period	Company	Industry (mean)	+/-
MRQ	0.958	1.204	-0.246
TTM	0.741	1.285	-0.544
YOY	0.510	1.565	-1.055
5Y	0.743	1.925	-1.182
10Y	0.787	2.128	-1.341

1.4. Solvency of IDEXX Laboratories Inc.

1.3. Liquidity

1.4.1. Debt to Asset Ratio

Measures how much % of Idexx assets are financed with debt.

Below 1 (100%) is considered healthy but always compare Idexx to Diagnostics & Research industry mean.
A Debt to Asset Ratio of 0.54 means that Idexx assets are financed with 54.5% credit (debt) and the remaining percentage (100% - 54.5%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of IDEXX Laboratories Inc:

The MRQ is 0.545. The company is able to pay all its debts by selling its assets. +1
The TTM is 0.611. The company is able to pay all its debts by selling its assets. +1

Trends

Current period		Compared to		+/-
MRQ	0.545	TTM	0.611	-0.066
TTM	0.611	YOY	0.794	-0.183
TTM	0.611	5Y	0.769	-0.158
5Y	0.769	10Y	0.868	-0.099

Compared to industry (Diagnostics & Research)

Period	Company	Industry (mean)	+/-
MRQ	0.545	0.421	+0.124
TTM	0.611	0.407	+0.204
YOY	0.794	0.394	+0.400
5Y	0.769	0.448	+0.321
10Y	0.868	0.446	+0.422

Measures how much % of Idexx assets are financed with debt.

When there are more debts than assets, that means creditors have a larger stake Idexx than its shareholders.

How to use debt to asset ratio

Lower is better.
below 1 (100%) is considered healthy but always compare Idexx to Diagnostics & Research industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use the debt to asset ratio in their analysis

It shows how much debt the company used to finance its assets. If a company is almost entirely financed with debt that means the company might get into serious trouble when emergencies arise like a raise in interest.

The three steps every investor should look at:

What is the current debt to asset ratio?
The current most recent quarter (MRQ) Debt to Asset Ratio of Idexx is 0.54. This means means that Idexx is financed with 54.5% credit and the remaining percentage is financed by it's owners (shareholders).
How does it compare to the industry?
The mean MRQ Current Ratio of the Diagnostics & Research industry is 211.1%.
What is the trend?
The trend is important because it shows you how Idexx is performing over time. The most recent quarter might be important if Idexx released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Idexx up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry
Some companies can have higher debt to assets ratio's (for example, banks).
Debt to asset ratio should improve over the years.
If the debt to asset ratio is above 1, look at the industry mean and find out why Idexx has so much debt.

How to calculate debt to asset ratio

Debt to asset ratio = total debt \ total assets

Real life example Idexx

You need the following data to determine debt to asset ratio:

Balance sheet
Debt to asset ratio = total debt \ total assets
1,775,395 \ 3,259,925 = 54.5% or 0.54.

The debt to total assets ratio shows if the company is owned by creditors or shareholders. Or in other words, the total debt in relation to the total amount of assets. It shows how much debt the company used to finance its assets.

1.4.2. Debt to Equity Ratio

Measures if Idexx is able to pay off its debts by using shareholders equity.

Below 2 is considered healthy but always compare Idexx to the Diagnostics & Research industry mean.
A Debt to Equity ratio of 119.6% means that company has $1.20 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of IDEXX Laboratories Inc:

The MRQ is 1.196. The company is able to pay all its debts with equity. +1
The TTM is 1.635. The company is just able to pay all its debts with equity.

Trends

Current period		Compared to		+/-
MRQ	1.196	TTM	1.635	-0.439
TTM	1.635	YOY	3.954	-2.319
TTM	1.635	5Y	5.910	-4.275
5Y	5.910	10Y	9.444	-3.534

Compared to industry (Diagnostics & Research)

Period	Company	Industry (mean)	+/-
MRQ	1.196	0.606	+0.590
TTM	1.635	0.567	+1.068
YOY	3.954	0.631	+3.323
5Y	5.910	0.658	+5.252
10Y	9.444	0.742	+8.702

Measures if Idexx is able to pay off its debts by using shareholders equity.

How to use debt to equity ratio

Lower is better.
Below 2 is considered healthy (always use industry average).
Can be very different between industries.
Can be used to compare companies.

Why do investors use the debt to shareholders equity ratio in their analysis

It shows how much debt the company uses to finance their operations. Shareholders equity is whats left over when you subtract total liabilities from total assets. It's another way to meassure how much of Idexx is financed with debt or own resources.

The three steps every investor should look at:

What is the current debt to equity ratio?
The current most recent quarter (MRQ) quickRatio of Idexx is 1.20. This means that Idexx can pay off $1.20 for each $1 in debt.
How does it compare to the industry?
The mean MRQ Quick Ratio of the Diagnostics & Research industry is 0.61.
What is the trend?
The trend is important because it shows you how Idexx is performing over time. The most recent quarter might be important if Idexx released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Idexx up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Not all debt is equally risky (for example, short term risk is less risky).

How to calculate debt to equity ratio

Debt to equity ratio = total debt \ shareholders equity.

Real life example Idexx

You need the following data to determine equity ratio:

Balance sheet
Debt to equity ratio = total debt \ shareholders equity
1,775,395 \ 1,484,530 = 1.20 or 119.6%

Debt to equity measures the total debt versus the total shareholders equity. While the total debts to total assets ratio uses total assets, the debt to equity ratio looks at the total equity of shareholders. Where equity of shareholders are:

Common shares.
Preferred shares.
Retained earnings.

You can find the shareholders' equity in the balance sheet. A ratio between 0,5 and 1,5 is preferred. If the ratio is above 1.5, that would indicate creditors have significantly more stake (debt) in the company than the shareholders. In other words, the company is using a lot of debt to finance their operations.

Not all debt is equally risky. Meaning you can adjust the ratio by including or excluding certain amounts of debt. Short term debts are less risky because they have to be paid back within one year anyway. It’s much easier to plan one year ahead versus five or ten years.

2. Market Valuation of IDEXX Laboratories Inc

2.1. Earnings Per Share

2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Idexx generates.

Above 15 is considered overpriced but always compare Idexx to the Diagnostics & Research industry mean.
A PE ratio of 59.87 means the investor is paying $59.87 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of IDEXX Laboratories Inc:

The EOD is 53.317. Based on the earnings, the company is expensive. -2
The MRQ is 59.874. Based on the earnings, the company is expensive. -2
The TTM is 49.800. Based on the earnings, the company is overpriced. -1

Trends

Current period		Compared to		+/-
EOD	53.317	MRQ	59.874	-6.558
MRQ	59.874	TTM	49.800	+10.074
TTM	49.800	YOY	51.053	-1.253
TTM	49.800	5Y	55.771	-5.971
5Y	55.771	10Y	55.500	+0.271

Compared to industry (Diagnostics & Research)

Period	Company	Industry (mean)	+/-
EOD	53.317	-0.261	+53.578
MRQ	59.874	-0.409	+60.283
TTM	49.800	-0.341	+50.141
YOY	51.053	0.002	+51.051
5Y	55.771	4.832	+50.939
10Y	55.500	5.198	+50.302

Measures how much money you pay for each share for every $1 in earnings Idexx generates.

Indicates if the company’s shares are under or overvalued.

How to use PE ratio

Above 15 is considered overpriced but is hard to determine. Always compare Idexx to the Diagnostics & Research industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use PE ratio in their analysis

The PE ratio tells investors the current sentiment in the market for that company. As with every stock, the stock price never shows the real valuation of a company but rather how the market thinks how much the stock is worth.

In other words, the current stock price also incorporates any future earnings or business opportunities in the future. The best example is the stock market crash in 2000. The PE ratio for any internet based company was going through the roof. Only based on the general assumption the internet and all associated businesses would thrive in the future. But this was based on nothing. A business still needs a good product or service to be able to survive. Instead, every investor bought any stock which did something related to the internet. Result: huge market crash.

Many investors were willing to pay premium prices and that was causing the PE ratio to rise. A high PE ratio is a warning sign that investors might be overvaluing a stock based on future earnings.

The three steps every investor should look at:

What is the current PE Ratio?
The current most recent quarter (MRQ) PE Ratio of Idexx is 59.87. This means the investor is paying $59.87 for every $1 in earnings.
How does it compare to the industry?
The mean MRQ Quick Ratio of the Diagnostics & Research industry is -0.41.
What is the trend?
The trend is important because it shows you how Idexx is performing over time. The most recent quarter might be important if Idexx released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Idexx up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Some industries might have very high or very low PE ratios in general.
PE ratios can be high for several years, it does not mean a sudden collapse is imminent.
Earnings growth is not included in the PE ratio.

How to calculate PE ratio

PE ratio = market value per share \ earnings per share

Real life example Idexx

You need the following data to determine the PE ratio:

Balance sheet
Income statement

The PE ratio is a very commonly used ratio to determine the value of a company by comparing the current stock price relative to its earnings per share (EPS). Before we can calculate the PE ratio we need to know the EPS. EPS is calculated as follows:

EPS = (net profit - preferred dividends) \ end of period outstanding shares*
Net profit = revenue - expenses
0 \ 83,933 = EPS
PE ratio MRQ = 59.87

* The net profit minus preferred dividends can be found in the incomestatement as netIncomeApplicableToCommonShares.

The PE value helps investors to determine if the current stock price is under or overvalued. It also projects future growth.

In general, a higher PE ratio means that investors predict higher future growth. If the PE ratio is too high, then investors expect way too much future growth the company can never fulfil. This is most likely to happen in faster moving companies like tech companies or automobile companies like Tesla. These are hot and booming markets where investors expect much future growth driven by new technology (electric cars). When looking at the current MRQ (most recent quarter) PE ratio of Tesla ( jan. 2021) it's about 247 while the average in the industry is only 6. That might be a clue that Tesla is trading for way too high prices compared to their current assets and is more based on future growth.

2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of IDEXX Laboratories Inc:

The EOD is 47.729. Based on how much money comes from the company's main activities, the company is fair priced.
The MRQ is 53.599. Based on how much money comes from the company's main activities, the company is overpriced. -1
The TTM is 56.455. Based on how much money comes from the company's main activities, the company is overpriced. -1

Trends

Current period		Compared to		+/-
EOD	47.729	MRQ	53.599	-5.870
MRQ	53.599	TTM	56.455	-2.856
TTM	56.455	YOY	119.404	-62.949
TTM	56.455	5Y	-8.050	+64.506
5Y	-8.050	10Y	74.758	-82.809

Compared to industry (Diagnostics & Research)

Period	Company	Industry (mean)	+/-
EOD	47.729	-0.291	+48.020
MRQ	53.599	-0.441	+54.040
TTM	56.455	-1.388	+57.843
YOY	119.404	-2.079	+121.483
5Y	-8.050	-1.446	-6.604
10Y	74.758	-1.971	+76.729

2. Book Value per Share

2.3. Price to Book Ratio

Measures if the stock price of Idexx is to cheap or to expensive compared to its book value.

At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
A PB ratio of 31.38 means the investor is paying $31.38 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of IDEXX Laboratories Inc:

The EOD is 27.945. Based on the equity, the company is expensive. -2
The MRQ is 31.382. Based on the equity, the company is expensive. -2
The TTM is 37.042. Based on the equity, the company is expensive. -2

Trends

Current period		Compared to		+/-
EOD	27.945	MRQ	31.382	-3.437
MRQ	31.382	TTM	37.042	-5.660
TTM	37.042	YOY	63.007	-25.965
TTM	37.042	5Y	94.776	-57.734
5Y	94.776	10Y	-442.144	+536.920

Compared to industry (Diagnostics & Research)

Period	Company	Industry (mean)	+/-
EOD	27.945	1.857	+26.088
MRQ	31.382	2.228	+29.154
TTM	37.042	2.222	+34.820
YOY	63.007	3.104	+59.903
5Y	94.776	3.447	+91.329
10Y	-442.144	4.036	-446.180

2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of IDEXX Laboratories Inc.

3.1. Institutions holding IDEXX Laboratories Inc

Institutions are holding 92.703% of the shares of IDEXX Laboratories Inc.

Date	Name	Total Shares	Total Assets	Current Shares	Change	%
2023-12-31	BlackRock Inc	10.9017	0.1281	9054307	420016	4.8645
2023-12-31	Vanguard Group Inc	10.087	0.1016	8377667	117207	1.4189
2023-12-31	State Street Corporation	4.5476	0.102	3776949	14879	0.3955
2023-12-31	AllianceBernstein L.P.	3.5372	0.6275	2937760	-388256	-11.6733
2023-12-31	Fundsmith LLP	3.2857	6.3407	2728917	-235637	-7.9485
2023-12-31	BAMCO Inc	2.7693	3.3999	2300017	-36313	-1.5543
2023-12-31	Geode Capital Management, LLC	2.5336	0.1219	2104258	40119	1.9436
2023-12-31	Franklin Resources Inc	1.6927	0.3649	1405824	28475	2.0674
2023-12-31	Amvescap Plc.	1.5973	0.1752	1326593	109615	9.0071
2023-12-31	Goldman Sachs Group Inc	1.4798	0.0612	1229074	686838	126.6677
2023-12-31	Blair William & Co	1.4463	2.272	1201251	1306	0.1088
2023-12-31	Brown Advisory Holdings Inc	1.3931	0.9028	1157059	-4065	-0.3501
2023-12-31	Morgan Stanley - Brokerage Accounts	1.3184	0.0536	1094980	30466	2.862
2023-12-31	Capital World Investors	1.2313	0.101	1022678	11351	1.1224
2023-12-31	NORGES BANK	1.1111	0.0895	922781	98152	11.9026
2023-12-31	Northern Trust Corp	1.0386	0.0867	862595	-56596	-6.1572
2023-12-31	JPMorgan Chase & Co	1.036	0.0459	860479	59205	7.3889
2023-12-31	FUNDSMITH INVESTMENT SERVICES LTD.	0.9856	6.5624	818619	-170973	-17.2771
2023-12-31	Legal & General Group PLC	0.9478	0.1121	787198	115159	17.1358
2023-12-31	Principal Financial Group Inc	0.9408	0.2765	781368	-34495	-4.228
Total		53.8809	21.9255	44750374	+806453	+1.8%

3.2. Funds holding IDEXX Laboratories Inc

Date	Name	Total Shares	Total Assets	Current Shares	Change	%
2024-02-29	Vanguard Total Stock Mkt Idx Inv	3.1383	0.0967	2606450	-5676	-0.2173
2024-02-29	Vanguard Institutional 500 Index Trust	2.4986	0.1116	2075184	21729	1.0582
2024-03-28	Invesco QQQ Trust	1.8752	0.3239	1557449	1862	0.1197
2024-03-28	SPDR® S&P 500 ETF Trust	1.2167	0.1015	1010504	5880	0.5853
2024-02-29	Fidelity 500 Index	1.2	0.1113	996620	10029	1.0165
2023-09-30	Fundsmith Equity I Acc	1.1492	4.8131	954446	-30186	-3.0657
2024-02-29	Vanguard Mid Cap Index Institutional	1.1173	0.3333	927940	-2463	-0.2647
2023-12-31	Capital Group New Perspective Comp	1.0471	0.381	869643	0	0
2023-12-31	American Funds New Perspective A	1.0471	0.381	869643	0	0
2024-01-31	AllianceBernstein US L/C Growth Eqty MF	1.0366	1.7732	860957	-2487	-0.288
2024-03-28	iShares Core S&P 500 ETF	1.0362	0.1015	860640	6272	0.7341
2024-02-29	AB Large Cap Growth A	1.014	1.8351	842169	38191	4.7503
2024-02-29	Vanguard Growth Index Investor	0.9294	0.1998	771905	6666	0.8711
2023-12-31	Franklin Innovation Composite	0.8428	1.767	700000	-25000	-3.4483
2024-03-31	Baron Partners Retail	0.8428	6.2471	700000	-100000	-12.5
2024-02-29	Franklin DynaTech Fund A	0.7826	1.533	650000	-17373	-2.6032
2024-03-28	Health Care Select Sector SPDR® ETF	0.754	0.8189	626219	-1008	-0.1607
2024-02-29	BlackRock Mid-Cap Growth Equity Instl	0.7512	2.8333	623868	0	0
2023-12-31	Baron Mid Cap Growth Strategy	0.7412	7.0847	615630	-33000	-5.0876
2023-12-31	Baron Asset Retail	0.7412	7.108	615630	-33000	-5.0876
Total		23.7615	37.955	19734897	-159564	-0.8%

3.3. Insider Transactions

Insiders are holding 1.107% of the shares of IDEXX Laboratories Inc.

Date	Owner	Type	Amount	Price
2024-02-08	George Fennell	SELL	8198	573.87
2024-02-07	Brian P Mckeon	SELL	23326	570.01
2024-02-07	Jonathan Jay Mazelsky	SELL	12000	572.61
2023-12-07	James F Polewaczyk	SELL	11636	521.79
2023-12-04	Jonathan Jay Mazelsky	SELL	7128	513.05
2023-08-31	Jonathan Jay Mazelsky	SELL	13424	512.01
2023-08-29	James F Polewaczyk	SELL	22909	510.56
2023-08-03	Michael Lane	SELL	16027	510
2023-05-18	Jonathan W Ayers	SELL	10000	489.23
2023-05-05	Michael Lane	SELL	1000	484
2023-05-04	Sophie V Vandebroek	SELL	2187	469.02

4. Summary

4.1. Key Performance Indicators

The key performance indicators of IDEXX Laboratories Inc compared to the Most Recent Quarter (MRQ).

	End of day	+/-	Most Recent Quarter	Trailing 12 Months	+/-	Year-Over-Year	+/-	5 Year	+/-	10 Year	+/-
Book Value Change Per Share	-	-	2.240	2.606	-14%	-0.187	+108%	0.890	+152%	0.319	+602%
Book Value Per Share	-	-	17.687	14.044	+26%	6.446	+174%	6.956	+154%	3.636	+386%
Current Ratio	-	-	1.571	1.353	+16%	0.949	+66%	1.262	+25%	1.130	+39%
Debt To Asset Ratio	-	-	0.545	0.611	-11%	0.794	-31%	0.769	-29%	0.868	-37%
Debt To Equity Ratio	-	-	1.196	1.635	-27%	3.954	-70%	5.910	-80%	9.444	-87%
Dividend Per Share	-	-	-	1.319	-100%	0.080	-100%	0.385	-100%	0.248	-100%
Eps	-	-	2.318	2.516	-8%	2.007	+15%	1.915	+21%	1.294	+79%
Free Cash Flow Per Share	-	-	2.589	2.301	+13%	1.168	+122%	1.547	+67%	1.088	+138%
Free Cash Flow To Equity Per Share	-	-	1.376	0.985	+40%	0.068	+1934%	0.353	+289%	0.154	+794%
Gross Profit Margin	-	-	0.270	0.328	-18%	0.212	+28%	0.223	+21%	-0.118	+144%
Intrinsic Value_10Y_max	-	-	96.756	-	-	-	-	-	-	-	-
Intrinsic Value_10Y_min	-	-	43.595	-	-	-	-	-	-	-	-
Intrinsic Value_1Y_max	-	-	7.466	-	-	-	-	-	-	-	-
Intrinsic Value_1Y_min	-	-	4.383	-	-	-	-	-	-	-	-
Intrinsic Value_3Y_max	-	-	24.131	-	-	-	-	-	-	-	-
Intrinsic Value_3Y_min	-	-	13.235	-	-	-	-	-	-	-	-
Intrinsic Value_5Y_max	-	-	42.845	-	-	-	-	-	-	-	-
Intrinsic Value_5Y_min	-	-	22.091	-	-	-	-	-	-	-	-
Market Cap	41067766844.000	-13%	46587011650.000	41869907392.500	+11%	34542017745.000	+35%	36539345343.000	+27%	24634585307.500	+89%
Net Profit Margin	-	-	0.216	0.231	-6%	0.202	+7%	0.211	+2%	0.173	+25%
Operating Margin	-	-	0.239	0.268	-11%	0.250	-5%	0.252	-5%	0.220	+9%
Operating Ratio	-	-	0.728	0.700	+4%	0.733	-1%	0.731	0%	0.766	-5%
Pb Ratio	27.945	-12%	31.382	37.042	-15%	63.007	-50%	94.776	-67%	-442.144	+1509%
Pe Ratio	53.317	-12%	59.874	49.800	+20%	51.053	+17%	55.771	+7%	55.500	+8%
Price Per Share	494.260	-12%	555.050	498.658	+11%	407.888	+36%	426.239	+30%	282.143	+97%
Price To Free Cash Flow Ratio	47.729	-12%	53.599	56.455	-5%	119.404	-55%	-8.050	+115%	74.758	-28%
Price To Total Gains Ratio	220.605	-12%	247.738	153.420	+61%	-97.806	+139%	-335.301	+235%	-213.566	+186%
Quick Ratio	-	-	0.958	0.741	+29%	0.510	+88%	0.743	+29%	0.787	+22%
Return On Assets	-	-	0.060	0.071	-16%	0.064	-7%	0.069	-14%	0.055	+8%
Return On Equity	-	-	0.131	0.189	-30%	0.314	-58%	0.450	-71%	0.470	-72%
Total Gains Per Share	-	-	2.240	3.925	-43%	-0.107	+105%	1.275	+76%	0.567	+295%
Usd Book Value	-	-	1484530000.000	1179224750.000	+26%	545385500.000	+172%	592744100.000	+150%	314719125.000	+372%
Usd Book Value Change Per Share	-	-	2.240	2.606	-14%	-0.187	+108%	0.890	+152%	0.319	+602%
Usd Book Value Per Share	-	-	17.687	14.044	+26%	6.446	+174%	6.956	+154%	3.636	+386%
Usd Dividend Per Share	-	-	-	1.319	-100%	0.080	-100%	0.385	-100%	0.248	-100%
Usd Eps	-	-	2.318	2.516	-8%	2.007	+15%	1.915	+21%	1.294	+79%
Usd Free Cash Flow	-	-	217295001.000	193219750.250	+12%	98536500.000	+121%	132369650.050	+64%	94987200.025	+129%
Usd Free Cash Flow Per Share	-	-	2.589	2.301	+13%	1.168	+122%	1.547	+67%	1.088	+138%
Usd Free Cash Flow To Equity Per Share	-	-	1.376	0.985	+40%	0.068	+1934%	0.353	+289%	0.154	+794%
Usd Market Cap	41067766844.000	-13%	46587011650.000	41869907392.500	+11%	34542017745.000	+35%	36539345343.000	+27%	24634585307.500	+89%
Usd Price Per Share	494.260	-12%	555.050	498.658	+11%	407.888	+36%	426.239	+30%	282.143	+97%
Usd Profit	-	-	194521000.000	211260500.000	-8%	169772250.000	+15%	163923600.000	+19%	112866900.000	+72%
Usd Revenue	-	-	901601000.000	915238250.000	-1%	841831000.000	+7%	767860000.000	+17%	610065550.000	+48%
Usd Total Gains Per Share	-	-	2.240	3.925	-43%	-0.107	+105%	1.275	+76%	0.567	+295%
	EOD	+4 -4	MRQ	TTM	+18 -18	YOY	+29 -7	5Y	+28 -8	10Y	+30 -6

4.2. Fundamental Score

Let's check the fundamental score of IDEXX Laboratories Inc based on Penke's default stock scanner.

Penke's Stock Scanner

Indicator	Condition		Value
Price to Earnings Ratio (EOD)	Between	0-15	53.317
Price to Book Ratio (EOD)	Between	0-1	27.945
Net Profit Margin (MRQ)	Greater than	0	0.216
Operating Margin (MRQ)	Greater than	0	0.239
Quick Ratio (MRQ)	Greater than	1	0.958
Current Ratio (MRQ)	Greater than	1	1.571
Debt to Asset Ratio (MRQ)	Less than	1	0.545
Debt to Equity Ratio (MRQ)	Less than	1	1.196
Return on Equity (MRQ)	Greater than	0.15	0.131
Return on Assets (MRQ)	Greater than	0.05	0.060
Total			5/10 (50.0%)

Create your own Stock Scanner

Investing is personal. The best investors buy stocks based on their own analysis. Create your personal Stock Scanner with the key performance indicators that are important to you.
Create your own Stock Scanner

4.3. Technical Score

Let's check the technical score of IDEXX Laboratories Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

Indicator	Condition		Value
Rsi	Greater than	50	38.979
Ma 20	Greater than	Ma 50	505.784
Ma 50	Greater than	Ma 100	534.156
Ma 100	Greater than	Ma 200	536.235
Open	Greater than	Close	489.240
Total			1/5 (20.0%)

Create your own Symbol Scanner

Trading is personal. The best traders buy and sell based on their own technical analysis. Create your personal Symbol Scanner with the technical indicators that are important to you.
Create your own Symbol Scanner

Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary

Total Assets	3,259,925
Total Liabilities	1,775,395
Total Stockholder Equity	1,484,530

	As reported
Total Liabilities	1,775,395
Total Stockholder Equity	+ 1,484,530
Total Assets	= 3,259,925

Assets

Total Assets	3,259,925
Total Current Assets	1,495,254
Long-term Assets	1,764,671

Total Current Assets

Total Current Assets (as reported)	1,495,254
Cash And Cash Equivalents	453,932
Net Receivables	457,445
Inventory	380,282
Other Current Assets	203,595
Total Current Assets (calculated)	1,495,254
+/-	0

Long-term Assets

Long-term Assets (as reported)	1,764,671
Property Plant Equipment	702,177
Goodwill	365,961
Long Term Investments	56,193
Intangible Assets	84,500
Long-term Assets Other	448,476
Long-term Assets (calculated)	1,657,307
+/-	107,364

Liabilities & Shareholders' Equity

Total Current Liabilities	951,547
Long-term Liabilities	823,848
Total Stockholder Equity	1,484,530

Total Current Liabilities

Total Current Liabilities (as reported)	951,547
Short-term Debt	324,997
Short Long Term Debt	324,997
Accounts payable	110,643
Other Current Liabilities	478,712
Total Current Liabilities (calculated)	1,239,349
+/-	287,802

Long-term Liabilities

Long-term Liabilities (as reported)	823,848
Long term Debt	622,883
Capital Lease Obligations	119,473
Long-term Liabilities (calculated)	742,356
+/-	81,492

Total Stockholder Equity

Total Stockholder Equity (as reported)	1,484,530
Common Stock	10,751
Retained Earnings	4,444,571
Accumulated Other Comprehensive Income	-71,206
Other Stockholders Equity	-2,899,586
Total Stockholder Equity (calculated)	1,484,530
+/-	0

Other

Capital Stock	10,751
Cash and Short Term Investments	453,932
Common Stock Shares Outstanding	83,933
Current Deferred Revenue	37,195
Liabilities and Stockholders Equity	3,259,925
Net Debt	493,948
Net Invested Capital	2,432,410
Net Working Capital	543,707
Property Plant and Equipment Gross	1,602,493
Short Long Term Debt Total	947,880

Balance Sheet

Currency in USD. All numbers in thousands.

Trend

2023-12-31

2023-09-30

2023-06-30

2023-03-31

2022-12-31

2022-09-30

2022-06-30

2022-03-31

2021-12-31

2021-09-30

2021-06-30

2021-03-31

2020-12-31

2020-09-30

2020-06-30

2020-03-31

2019-12-31

2019-09-30

2019-06-30

2019-03-31

2018-12-31

2018-09-30

2018-06-30

2018-03-31

2017-12-31

2017-09-30

2017-06-30

2017-03-31

2016-12-31

2016-09-30

2016-06-30

2016-03-31

2015-12-31

2015-09-30

2015-06-30

2015-03-31

2014-12-31

2014-09-30

2014-06-30

2014-03-31

2013-12-31

2013-09-30

2013-06-30

2013-03-31

2012-12-31

2012-09-30

2012-06-30

2012-03-31

2011-12-31

2011-09-30

2011-06-30

2011-03-31

2010-12-31

2010-09-30

2010-06-30

2010-03-31

2009-12-31

2009-09-30

2009-06-30

2009-03-31

2008-12-31

2008-09-30

2008-06-30

2008-03-31

2007-12-31

2007-09-30

2007-06-30

2007-03-31

2006-12-31

2006-09-30

2006-06-30

2006-03-31

2005-12-31

2005-09-30

2005-06-30

2005-03-31

2004-12-31

2004-09-30

2004-06-30

2004-03-31

2003-12-31

2003-09-30

2003-06-30

2003-03-31

2002-12-31

2002-09-30

2002-06-30

2002-03-31

2001-12-31

2001-09-30

2001-06-30

2001-03-31

2000-12-31

2000-09-30

2000-06-30

2000-03-31

1999-12-31

1999-09-30

1999-06-30

1999-03-31

1998-12-31

1998-09-30

1998-06-30

1998-03-31

1997-12-31

1997-09-30

1997-06-30

1997-03-31

1996-12-31

1996-09-30

1996-06-30

1996-03-31

1995-12-31

1995-09-30

1995-06-30

1995-03-31

1994-12-31

1994-09-30

1994-06-30

1994-03-31

1993-12-31

1993-09-30

1993-06-30

1993-03-31

1992-12-31

1992-09-30

1992-06-30

1992-03-31

1991-12-31

1991-09-30

1991-06-30

1991-03-31

> Total Assets

0
35,500
36,200
38,100
46,500
77,100
77,900
79,700
85,100
88,300
93,000
98,000
106,200
113,000
116,700
121,700
135,900
145,100
302,800
312,500
324,500
348,800
356,600
373,900
372,700
377,900
375,000
377,000
375,500
385,600
380,400
390,500
387,600
409,200
383,100
360,200
361,802
376,089
354,360
335,796
322,588
342,612
362,884
373,107
395,364
375,549
410,814
416,652
436,918
465,908
497,219
521,875
523,085
523,201
512,404
514,237
487,918
500,250
492,630
490,676
475,242
501,378
524,972
559,560
646,494
646,169
674,233
702,179
736,857
764,889
778,693
765,437
770,504
798,510
814,889
808,527
824,284
833,735
862,297
897,144
909,478
950,575
969,199
1,030,814
1,061,105
1,067,317
1,093,351
1,103,602
1,132,638
1,164,071
1,195,238
1,230,516
1,262,324
1,283,193
1,290,632
1,384,211
1,431,014
1,477,370
1,477,210
1,474,993
1,478,647
1,489,241
1,500,370
1,530,704
1,572,091
1,637,137
1,669,334
1,713,416
1,469,492
1,520,685
1,544,530
1,537,349
1,680,968
1,724,237
1,751,481
1,832,475
1,886,245
1,960,713
2,047,407
2,294,561
2,327,385
2,412,149
2,385,744
2,437,203
2,592,689
2,607,185
2,640,067
2,746,765
2,808,398
2,870,806
3,086,404
3,259,925

3,259,925

3,086,404

2,870,806

2,808,398

2,746,765

2,640,067

2,607,185

2,592,689

2,437,203

2,385,744

2,412,149

2,327,385

2,294,561

2,047,407

1,960,713

1,886,245

1,832,475

1,751,481

1,724,237

1,680,968

1,537,349

1,544,530

1,520,685

1,469,492

1,713,416

1,669,334

1,637,137

1,572,091

1,530,704

1,500,370

1,489,241

1,478,647

1,474,993

1,477,210

1,477,370

1,431,014

1,384,211

1,290,632

1,283,193

1,262,324

1,230,516

1,195,238

1,164,071

1,132,638

1,103,602

1,093,351

1,067,317

1,061,105

1,030,814

969,199

950,575

909,478

897,144

862,297

833,735

824,284

808,527

814,889

798,510

770,504

765,437

778,693

764,889

736,857

702,179

674,233

646,169

646,494

559,560

524,972

501,378

475,242

490,676

492,630

500,250

487,918

514,237

512,404

523,201

523,085

521,875

497,219

465,908

436,918

416,652

410,814

375,549

395,364

373,107

362,884

342,612

322,588

335,796

354,360

376,089

361,802

360,200

383,100

409,200

387,600

390,500

380,400

385,600

375,500

377,000

375,000

377,900

372,700

373,900

356,600

348,800

324,500

312,500

302,800

145,100

135,900

121,700

116,700

113,000

106,200

98,000

93,000

88,300

85,100

79,700

77,900

77,100

46,500

38,100

36,200

35,500

> Total Current Assets

0
31,000
28,800
26,400
24,100
54,900
55,800
57,400
62,700
66,200
71,400
76,800
85,500
91,400
93,700
98,500
110,000
112,500
267,000
262,000
276,200
295,800
285,800
301,700
274,900
285,200
271,100
274,200
265,200
285,100
277,700
263,300
249,500
271,000
244,200
232,400
241,845
265,748
234,167
215,830
206,562
223,285
235,932
235,576
253,151
233,733
270,220
289,120
317,701
332,144
357,358
370,589
366,878
371,241
360,420
301,592
286,344
307,331
299,676
299,245
280,959
271,794
291,894
302,263
296,756
282,468
293,749
305,663
322,366
339,064
353,377
355,890
367,783
384,337
385,727
376,338
398,369
410,552
429,911
460,591
465,441
493,571
510,752
524,227
544,866
555,307
570,774
569,537
594,395
614,902
625,223
652,706
683,166
701,707
702,621
759,398
808,909
833,034
833,396
821,634
809,006
821,110
828,100
845,584
878,588
918,658
942,722
971,985
701,707
739,832
704,197
654,172
697,646
712,298
703,382
679,639
721,351
779,612
868,679
1,062,738
1,097,798
1,001,226
938,037
955,655
1,089,772
1,042,825
1,058,859
1,101,477
1,149,446
1,179,025
1,384,230
1,495,254

1,495,254

1,384,230

1,179,025

1,149,446

1,101,477

1,058,859

1,042,825

1,089,772

955,655

938,037

1,001,226

1,097,798

1,062,738

868,679

779,612

721,351

679,639

703,382

712,298

697,646

654,172

704,197

739,832

701,707

971,985

942,722

918,658

878,588

845,584

828,100

821,110

809,006

821,634

833,396

833,034

808,909

759,398

702,621

701,707

683,166

652,706

625,223

614,902

594,395

569,537

570,774

555,307

544,866

524,227

510,752

493,571

465,441

460,591

429,911

410,552

398,369

376,338

385,727

384,337

367,783

355,890

353,377

339,064

322,366

305,663

293,749

282,468

296,756

302,263

291,894

271,794

280,959

299,245

299,676

307,331

286,344

301,592

360,420

371,241

366,878

370,589

357,358

332,144

317,701

289,120

270,220

233,733

253,151

235,576

235,932

223,285

206,562

215,830

234,167

265,748

241,845

232,400

244,200

271,000

249,500

263,300

277,700

285,100

265,200

274,200

271,100

285,200

274,900

301,700

285,800

295,800

276,200

262,000

267,000

112,500

110,000

98,500

93,700

91,400

85,500

76,800

71,400

66,200

62,700

57,400

55,800

54,900

24,100

26,400

28,800

31,000

Cash And Cash Equivalents

0
20,800
10,300
9,300
2,200
11,500
13,200
17,200
20,000
21,500
21,600
18,900
22,100
22,400
20,600
25,200
34,700
31,500
185,800
149,300
128,700
139,400
125,500
127,700
109,800
119,200
105,500
107,000
108,900
129,600
138,700
109,100
91,300
107,100
74,700
58,600
68,369
73,654
38,726
46,007
27,870
49,495
69,037
66,666
81,478
68,570
105,197
113,788
133,451
151,434
176,857
186,717
180,510
164,659
146,534
47,156
44,579
52,354
57,768
67,151
35,339
50,023
50,950
61,666
53,937
49,588
58,507
60,360
60,220
75,265
84,586
78,868
86,295
103,744
106,728
106,728
106,354
117,975
133,512
156,915
153,459
159,398
181,499
183,895
185,491
201,813
221,441
223,986
228,364
251,013
264,811
279,058
286,203
305,048
292,735
322,536
182,160
163,152
141,150
128,994
132,953
141,139
150,072
154,901
160,408
165,975
169,019
187,675
159,229
174,559
146,877
123,794
116,616
110,845
103,996
90,326
81,395
105,293
175,587
383,928
351,163
232,134
145,203
144,454
204,618
114,362
99,176
112,546
111,367
132,838
331,696
453,932

453,932

331,696

132,838

111,367

112,546

99,176

114,362

204,618

144,454

145,203

232,134

351,163

383,928

175,587

105,293

81,395

90,326

103,996

110,845

116,616

123,794

146,877

174,559

159,229

187,675

169,019

165,975

160,408

154,901

150,072

141,139

132,953

128,994

141,150

163,152

182,160

322,536

292,735

305,048

286,203

279,058

264,811

251,013

228,364

223,986

221,441

201,813

185,491

183,895

181,499

159,398

153,459

156,915

133,512

117,975

106,354

106,728

103,744

86,295

78,868

84,586

75,265

60,220

60,360

58,507

49,588

53,937

61,666

50,950

50,023

35,339

67,151

57,768

52,354

44,579

47,156

146,534

164,659

180,510

186,717

176,857

151,434

133,451

113,788

105,197

68,570

81,478

66,666

69,037

49,495

27,870

46,007

38,726

73,654

68,369

58,600

74,700

107,100

91,300

109,100

138,700

129,600

108,900

107,000

105,500

119,200

109,800

127,700

125,500

139,400

128,700

149,300

185,800

31,500

34,700

25,200

20,600

22,400

22,100

18,900

21,600

21,500

20,000

17,200

13,200

11,500

2,200

9,300

10,300

20,800

Short-term Investments

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
46,200
0
41,981
50,763
47,278
29,196
17,682
18,721
10,328
12,893
15,373
21,585
22,329
33,403
41,980
38,691
39,323
33,988
28,911
48,057
50,040
90,116
65,622
78,603
71,688
65,580
57,658
27,034
43,641
35,000
35,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
139,215
180,870
208,399
213,591
217,617
229,063
241,402
236,949
239,933
256,923
285,085
284,255
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

284,255

285,085

256,923

239,933

236,949

241,402

229,063

217,617

213,591

208,399

180,870

139,215

35,000

43,641

27,034

57,658

65,580

71,688

78,603

65,622

90,116

50,040

48,057

28,911

33,988

39,323

38,691

41,980

33,403

22,329

21,585

15,373

12,893

10,328

18,721

17,682

29,196

47,278

50,763

41,981

46,200

Net Receivables

0
4,600
4,500
10,500
7,700
30,200
10,500
11,900
14,000
16,100
18,200
21,400
24,400
23,600
23,100
25,800
29,600
34,200
37,100
47,300
55,800
59,500
63,200
66,600
62,300
46,500
48,700
47,300
51,700
49,200
43,900
47,900
58,000
57,900
55,900
58,400
62,686
63,294
62,361
57,266
56,839
56,482
53,993
50,772
51,683
48,004
47,611
45,689
51,582
50,783
50,672
53,976
61,466
59,288
57,950
65,639
75,617
73,139
68,098
71,688
81,916
84,473
79,301
81,389
104,791
106,684
103,407
108,384
125,245
120,565
112,053
111,498
115,253
118,782
115,141
115,107
130,519
127,138
120,454
120,080
137,551
149,314
134,923
141,275
160,981
147,159
141,374
138,324
158,988
159,119
151,568
158,038
179,919
168,641
160,467
152,380
196,231
212,350
201,829
188,318
225,291
225,424
217,560
204,494
245,570
265,843
248,597
234,597
291,157
312,885
295,689
248,855
306,641
321,906
304,072
269,312
333,803
354,949
382,005
331,429
423,101
382,308
425,029
368,348
465,618
412,898
475,228
400,619
446,025
461,858
452,699
457,445

457,445

452,699

461,858

446,025

400,619

475,228

412,898

465,618

368,348

425,029

382,308

423,101

331,429

382,005

354,949

333,803

269,312

304,072

321,906

306,641

248,855

295,689

312,885

291,157

234,597

248,597

265,843

245,570

204,494

217,560

225,424

225,291

188,318

201,829

212,350

196,231

152,380

160,467

168,641

179,919

158,038

151,568

159,119

158,988

138,324

141,374

147,159

160,981

141,275

134,923

149,314

137,551

120,080

120,454

127,138

130,519

115,107

115,141

118,782

115,253

111,498

112,053

120,565

125,245

108,384

103,407

106,684

104,791

81,389

79,301

84,473

81,916

71,688

68,098

73,139

75,617

65,639

57,950

59,288

61,466

53,976

50,672

50,783

51,582

45,689

47,611

48,004

51,683

50,772

53,993

56,482

56,839

57,266

62,361

63,294

62,686

58,400

55,900

57,900

58,000

47,900

43,900

49,200

51,700

47,300

48,700

46,500

62,300

66,600

63,200

59,500

55,800

47,300

37,100

34,200

29,600

25,800

23,100

23,600

24,400

21,400

18,200

16,100

14,000

11,900

10,500

30,200

7,700

10,500

4,500

4,600

Other Current Assets

0
900
9,400
1,500
3,900
1,600
19,700
15,500
15,500
15,900
17,700
21,900
20,700
25,400
29,200
26,700
21,000
19,400
18,700
37,200
58,300
56,700
56,100
59,000
41,900
48,200
53,900
59,700
48,800
55,300
52,100
50,900
53,400
58,500
19,000
67,900
21,622
21,290
22,932
17,426
5,901
5,753
5,877
4,812
5,337
5,998
5,950
6,267
5,801
5,819
5,882
6,800
20,128
5,788
6,038
8,797
9,572
9,689
10,047
11,679
10,524
9,544
10,793
11,328
10,530
11,793
11,259
14,509
12,130
13,019
19,624
28,121
21,745
38,887
15,993
18,890
16,240
19,974
19,488
29,508
21,387
24,034
29,934
40,321
57,290
62,632
35,055
66,281
33,082
63,832
35,553
82,183
43,905
48,829
60,154
124,140
117,933
10,045
6,552
101,898
8,843
6,815
10,034
91,206
15,800
13,031
12,881
101,140
8,839
11,908
12,754
108,220
13,169
12,561
14,966
124,982
17,085
11,308
9,108
137,508
12,043
145,392
17,393
173,823
21,817
183,000
33,512
220,489
201,043
189,188
205,861
203,595

203,595

205,861

189,188

201,043

220,489

33,512

183,000

21,817

173,823

17,393

145,392

12,043

137,508

9,108

11,308

17,085

124,982

14,966

12,561

13,169

108,220

12,754

11,908

8,839

101,140

12,881

13,031

15,800

91,206

10,034

6,815

8,843

101,898

6,552

10,045

117,933

124,140

60,154

48,829

43,905

82,183

35,553

63,832

33,082

66,281

35,055

62,632

57,290

40,321

29,934

24,034

21,387

29,508

19,488

19,974

16,240

18,890

15,993

38,887

21,745

28,121

19,624

13,019

12,130

14,509

11,259

11,793

10,530

11,328

10,793

9,544

10,524

11,679

10,047

9,689

9,572

8,797

6,038

5,788

20,128

6,800

5,882

5,819

5,801

6,267

5,950

5,998

5,337

4,812

5,877

5,753

5,901

17,426

22,932

21,290

21,622

67,900

19,000

58,500

53,400

50,900

52,100

55,300

48,800

59,700

53,900

48,200

41,900

59,000

56,100

56,700

58,300

37,200

18,700

19,400

21,000

26,700

29,200

25,400

20,700

21,900

17,700

15,900

15,500

19,700

1,600

3,900

1,500

9,400

900

> Long-term Assets

0
4,500
7,400
11,700
22,400
22,200
22,100
22,300
22,400
22,100
21,600
21,200
20,700
21,600
23,000
23,200
25,900
32,600
35,800
50,500
48,300
53,000
70,800
72,200
97,800
92,700
103,900
102,800
110,300
100,500
102,700
127,200
138,100
138,200
138,900
127,800
119,957
110,341
120,193
119,966
116,026
119,327
126,952
137,531
142,213
141,816
140,594
127,532
119,217
133,764
139,861
151,286
156,207
151,960
151,984
212,645
201,574
192,919
192,954
191,431
194,283
229,584
233,078
257,297
349,738
363,701
380,484
396,516
414,491
425,825
425,316
409,547
402,721
414,173
429,162
432,189
425,915
423,183
432,386
436,553
444,037
457,004
458,447
506,587
516,239
512,010
522,577
534,065
538,243
549,169
570,015
577,810
579,158
581,486
588,011
624,813
622,105
644,336
643,814
653,359
669,641
668,131
672,270
685,120
693,503
718,479
726,612
741,431
767,785
780,853
840,333
883,177
983,322
1,011,939
1,048,099
1,152,836
1,164,894
1,181,101
1,178,728
1,231,823
1,229,587
1,410,923
1,447,707
1,481,548
1,502,917
1,564,360
1,581,208
1,645,288
1,658,952
1,691,781
1,702,174
1,764,671

1,764,671

1,702,174

1,691,781

1,658,952

1,645,288

1,581,208

1,564,360

1,502,917

1,481,548

1,447,707

1,410,923

1,229,587

1,231,823

1,178,728

1,181,101

1,164,894

1,152,836

1,048,099

1,011,939

983,322

883,177

840,333

780,853

767,785

741,431

726,612

718,479

693,503

685,120

672,270

668,131

669,641

653,359

643,814

644,336

622,105

624,813

588,011

581,486

579,158

577,810

570,015

549,169

538,243

534,065

522,577

512,010

516,239

506,587

458,447

457,004

444,037

436,553

432,386

423,183

425,915

432,189

429,162

414,173

402,721

409,547

425,316

425,825

414,491

396,516

380,484

363,701

349,738

257,297

233,078

229,584

194,283

191,431

192,954

192,919

201,574

212,645

151,984

151,960

156,207

151,286

139,861

133,764

119,217

127,532

140,594

141,816

142,213

137,531

126,952

119,327

116,026

119,966

120,193

110,341

119,957

127,800

138,900

138,200

138,100

127,200

102,700

100,500

110,300

102,800

103,900

92,700

97,800

72,200

70,800

53,000

48,300

50,500

35,800

32,600

25,900

23,200

23,000

21,600

20,700

21,200

21,600

22,100

22,400

22,300

22,100

22,200

22,400

11,700

7,400

4,500

Property Plant Equipment

0
4,000
6,800
11,000
11,400
11,400
11,400
11,700
12,000
12,200
12,000
12,000
12,000
12,600
13,000
13,400
16,200
20,100
23,900
25,500
25,900
30,000
35,600
36,400
38,900
41,100
42,500
41,000
41,500
40,400
40,100
41,500
41,700
41,300
40,100
39,600
39,322
39,504
41,753
45,661
45,529
48,126
49,029
49,215
49,437
49,512
49,631
49,455
48,763
50,872
51,832
45,224
48,393
56,509
58,329
62,630
62,744
63,721
64,936
65,697
67,273
88,795
91,165
99,628
108,796
117,806
126,865
141,852
151,094
166,604
178,655
189,646
186,708
189,660
196,542
199,946
197,063
196,714
200,610
201,725
202,748
210,163
213,868
216,777
216,927
220,580
231,639
245,177
253,742
266,494
274,158
281,214
282,226
286,712
291,701
303,587
309,827
326,041
320,337
333,026
343,010
347,161
349,664
357,422
361,233
364,779
367,513
379,096
384,246
394,021
409,980
437,270
529,697
551,537
575,561
533,845
624,770
633,302
632,359
555,167
637,528
550,255
680,347
587,667
701,193
594,224
722,508
649,474
665,439
683,270
687,101
702,177

702,177

687,101

683,270

665,439

649,474

722,508

594,224

701,193

587,667

680,347

550,255

637,528

555,167

632,359

633,302

624,770

533,845

575,561

551,537

529,697

437,270

409,980

394,021

384,246

379,096

367,513

364,779

361,233

357,422

349,664

347,161

343,010

333,026

320,337

326,041

309,827

303,587

291,701

286,712

282,226

281,214

274,158

266,494

253,742

245,177

231,639

220,580

216,927

216,777

213,868

210,163

202,748

201,725

200,610

196,714

197,063

199,946

196,542

189,660

186,708

189,646

178,655

166,604

151,094

141,852

126,865

117,806

108,796

99,628

91,165

88,795

67,273

65,697

64,936

63,721

62,744

62,630

58,329

56,509

48,393

45,224

51,832

50,872

48,763

49,455

49,631

49,512

49,437

49,215

49,029

48,126

45,529

45,661

41,753

39,504

39,322

39,600

40,100

41,300

41,700

41,500

40,100

40,400

41,500

41,000

42,500

41,100

38,900

36,400

35,600

30,000

25,900

25,500

23,900

20,100

16,200

13,400

13,000

12,600

12,000

12,200

12,000

11,700

11,400

11,000

6,800

4,000

Goodwill

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
51,781
52,321
52,280
53,438
53,499
54,994
0
0
0
92,937
91,092
87,815
88,397
88,127
119,255
133,033
132,723
104,826
227,369
230,562
235,881
236,414
244,781
242,137
231,379
138,768
136,158
142,930
148,137
148,705
146,534
143,252
148,597
149,112
152,498
154,191
150,018
172,610
175,105
170,929
174,614
174,994
172,459
171,403
180,988
180,521
180,466
181,619
176,537
184,450
176,932
179,705
180,392
178,934
181,941
180,657
180,952
178,228
180,601
196,670
199,521
199,873
201,022
195,974
216,046
214,489
214,517
215,157
212,171
239,724
233,211
235,426
238,100
243,347
242,586
353,842
355,240
359,345
360,968
355,528
355,292
361,795
362,942
364,206
361,766
365,961

365,961

361,766

364,206

362,942

361,795

355,292

355,528

360,968

359,345

355,240

353,842

242,586

243,347

238,100

235,426

233,211

239,724

212,171

215,157

214,517

214,489

216,046

195,974

201,022

199,873

199,521

196,670

180,601

178,228

180,952

180,657

181,941

178,934

180,392

179,705

176,932

184,450

176,537

181,619

180,466

180,521

180,988

171,403

172,459

174,994

174,614

170,929

175,105

172,610

150,018

154,191

152,498

149,112

148,597

143,252

146,534

148,705

148,137

142,930

136,158

138,768

231,379

242,137

244,781

236,414

235,881

230,562

227,369

104,826

132,723

133,033

119,255

88,127

88,397

87,815

91,092

92,937

54,994

53,499

53,438

52,280

52,321

51,781

Long Term Investments

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,621
12,386
13,082
13,657
13,785
104,406
12,599
12,065
11,185
10,489
9,790
13,348
12,014
52,892
51,760
55,500
54,271
55,391
54,333
56,193

56,193

54,333

55,391

54,271

55,500

51,760

52,892

12,014

13,348

9,790

10,489

11,185

12,065

12,599

104,406

13,785

13,657

13,082

12,386

11,621

Intangible Assets

0
0
0
0
10,800
10,700
10,300
10,300
10,000
9,500
9,200
8,900
8,300
8,100
8,600
8,200
8,100
10,800
10,300
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
51,781
56,157
56,098
57,264
57,938
61,766
67,755
68,057
69,663
124,494
120,810
115,373
119,904
118,746
118,746
133,033
132,723
43,353
43,353
230,562
235,881
236,414
244,781
242,137
231,379
68,327
200,748
207,682
214,974
63,907
61,304
57,873
57,554
55,752
54,715
53,044
50,607
69,209
68,426
64,627
63,363
62,833
61,036
58,103
61,387
58,844
57,281
55,550
59,210
65,122
59,911
57,517
58,650
55,909
53,257
49,729
47,566
46,155
45,686
46,089
45,251
43,846
41,893
39,036
42,420
41,825
39,499
37,989
35,662
58,468
57,948
55,619
53,467
52,543
53,969
96,757
94,976
99,035
105,188
100,594
99,968
97,672
94,361
90,932
87,129
84,500

84,500

87,129

90,932

94,361

97,672

99,968

100,594

105,188

99,035

94,976

96,757

53,969

52,543

53,467

55,619

57,948

58,468

35,662

37,989

39,499

41,825

42,420

39,036

41,893

43,846

45,251

46,089

45,686

46,155

47,566

49,729

53,257

55,909

58,650

57,517

59,911

65,122

59,210

55,550

57,281

58,844

61,387

58,103

61,036

62,833

63,363

64,627

68,426

69,209

50,607

53,044

54,715

55,752

57,554

57,873

61,304

63,907

214,974

207,682

200,748

68,327

231,379

242,137

244,781

236,414

235,881

230,562

43,353

132,723

133,033

118,746

119,904

115,373

120,810

124,494

69,663

68,057

67,755

61,766

57,938

57,264

56,098

56,157

51,781

10,300

10,800

8,100

8,200

8,600

8,100

8,300

8,900

9,200

9,500

10,000

10,300

10,700

10,800

Other Assets

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
80,635
70,837
78,440
74,305
70,497
71,201
77,923
88,316
92,776
92,304
90,963
78,077
70,454
82,892
88,029
106,062
107,814
95,451
93,655
150,015
138,830
129,198
128,018
125,734
127,010
140,789
141,913
157,669
240,942
245,895
253,619
254,664
263,397
259,221
246,661
219,901
216,013
224,513
232,620
232,243
228,852
226,469
231,776
234,828
241,289
246,841
244,579
289,810
299,312
291,430
290,938
288,888
284,501
282,675
295,857
296,596
296,932
294,774
296,310
321,226
312,278
318,295
323,477
320,333
326,631
320,970
322,606
327,698
332,270
353,700
359,099
362,335
140,624
151,822
171,887
189,593
150,149
207,256
224,705
240,192
248,965
256,754
254,802
676,656
685,624
860,668
874,322
893,881
335,568
398,553
373,190
387,479
390,900
0
0
0

390,900

387,479

373,190

398,553

335,568

893,881

874,322

860,668

685,624

676,656

254,802

256,754

248,965

240,192

224,705

207,256

150,149

189,593

171,887

151,822

140,624

362,335

359,099

353,700

332,270

327,698

322,606

320,970

326,631

320,333

323,477

318,295

312,278

321,226

296,310

294,774

296,932

296,596

295,857

282,675

284,501

288,888

290,938

291,430

299,312

289,810

244,579

246,841

241,289

234,828

231,776

226,469

228,852

232,243

232,620

224,513

216,013

219,901

246,661

259,221

263,397

254,664

253,619

245,895

240,942

157,669

141,913

140,789

127,010

125,734

128,018

129,198

138,830

150,015

93,655

95,451

107,814

106,062

88,029

82,892

70,454

78,077

90,963

92,304

92,776

88,316

77,923

71,201

70,497

74,305

78,440

70,837

80,635

> Total Liabilities

0
6,800
6,600
6,600
9,400
9,800
9,100
9,300
11,300
12,400
14,000
14,400
19,100
22,600
22,500
21,900
30,400
33,100
31,900
33,400
35,800
50,000
47,500
51,200
49,300
55,800
70,000
74,300
69,000
71,600
58,400
82,700
69,800
79,700
74,400
75,900
72,989
87,039
87,956
74,049
65,443
66,621
74,017
71,377
81,102
70,250
91,116
75,679
83,567
93,814
94,160
108,583
96,140
99,144
103,204
116,577
100,473
107,789
111,504
121,366
111,995
144,344
137,387
149,699
234,410
261,617
254,093
263,856
303,221
336,428
341,366
327,243
324,676
327,936
315,255
293,948
327,152
309,458
315,645
322,863
312,570
341,764
383,231
491,221
494,224
477,376
475,816
467,345
501,343
614,480
660,343
712,302
750,072
830,263
1,061,161
1,266,622
1,396,935
1,468,819
1,516,013
1,558,988
1,552,434
1,497,739
1,445,384
1,638,917
1,646,003
1,723,244
1,717,725
1,767,258
1,518,474
1,561,534
1,545,893
1,546,582
1,629,098
1,552,688
1,548,759
1,654,650
1,778,190
1,687,313
1,606,292
1,661,766
1,623,950
1,663,926
1,630,284
1,747,211
1,952,891
2,150,177
2,164,068
2,138,028
1,967,297
1,776,945
1,788,997
1,775,395

1,775,395

1,788,997

1,776,945

1,967,297

2,138,028

2,164,068

2,150,177

1,952,891

1,747,211

1,630,284

1,663,926

1,623,950

1,661,766

1,606,292

1,687,313

1,778,190

1,654,650

1,548,759

1,552,688

1,629,098

1,546,582

1,545,893

1,561,534

1,518,474

1,767,258

1,717,725

1,723,244

1,646,003

1,638,917

1,445,384

1,497,739

1,552,434

1,558,988

1,516,013

1,468,819

1,396,935

1,266,622

1,061,161

830,263

750,072

712,302

660,343

614,480

501,343

467,345

475,816

477,376

494,224

491,221

383,231

341,764

312,570

322,863

315,645

309,458

327,152

293,948

315,255

327,936

324,676

327,243

341,366

336,428

303,221

263,856

254,093

261,617

234,410

149,699

137,387

144,344

111,995

121,366

111,504

107,789

100,473

116,577

103,204

99,144

96,140

108,583

94,160

93,814

83,567

75,679

91,116

70,250

81,102

71,377

74,017

66,621

65,443

74,049

87,956

87,039

72,989

75,900

74,400

79,700

69,800

82,700

58,400

71,600

69,000

74,300

70,000

55,800

49,300

51,200

47,500

50,000

35,800

33,400

31,900

33,100

30,400

21,900

22,500

22,600

19,100

14,400

14,000

12,400

11,300

9,300

9,100

9,800

9,400

6,600

6,800

> Total Current Liabilities

0
6,800
6,500
6,600
9,400
9,800
9,100
9,400
11,200
12,400
14,000
14,300
19,000
22,600
22,500
22,000
30,400
33,100
32,000
33,400
35,800
50,000
47,600
51,100
49,300
55,700
70,000
74,300
69,000
71,600
58,300
78,500
65,600
75,500
70,200
75,500
72,989
87,039
87,956
74,049
65,443
66,621
74,017
71,377
81,102
70,250
91,116
75,679
77,812
88,173
87,957
100,736
86,600
89,049
93,977
99,952
85,051
93,251
97,518
106,566
98,368
123,321
116,732
124,743
188,415
213,569
209,170
223,392
265,026
299,052
307,750
295,292
292,143
213,110
198,563
256,305
289,167
271,200
270,933
285,112
272,570
298,137
336,369
436,879
437,284
419,151
415,846
406,333
439,577
551,671
592,952
478,353
517,173
600,352
630,264
820,906
803,445
775,428
824,766
856,761
878,668
822,776
760,208
934,568
936,077
1,001,493
996,543
1,004,567
728,838
774,316
759,537
770,444
689,619
618,909
626,627
725,337
846,241
540,584
526,841
582,761
620,662
651,809
633,849
763,579
971,341
1,166,547
1,189,945
1,235,803
1,065,629
883,859
970,193
951,547

951,547

970,193

883,859

1,065,629

1,235,803

1,189,945

1,166,547

971,341

763,579

633,849

651,809

620,662

582,761

526,841

540,584

846,241

725,337

626,627

618,909

689,619

770,444

759,537

774,316

728,838

1,004,567

996,543

1,001,493

936,077

934,568

760,208

822,776

878,668

856,761

824,766

775,428

803,445

820,906

630,264

600,352

517,173

478,353

592,952

551,671

439,577

406,333

415,846

419,151

437,284

436,879

336,369

298,137

272,570

285,112

270,933

271,200

289,167

256,305

198,563

213,110

292,143

295,292

307,750

299,052

265,026

223,392

209,170

213,569

188,415

124,743

116,732

123,321

98,368

106,566

97,518

93,251

85,051

99,952

93,977

89,049

86,600

100,736

87,957

88,173

77,812

75,679

91,116

70,250

81,102

71,377

74,017

66,621

65,443

74,049

87,956

87,039

72,989

75,500

70,200

75,500

65,600

78,500

58,300

71,600

69,000

74,300

70,000

55,700

49,300

51,100

47,600

50,000

35,800

33,400

32,000

33,100

30,400

22,000

22,500

22,600

19,000

14,300

14,000

12,400

11,200

9,400

9,100

9,800

9,400

6,600

6,500

6,800

Short-term Debt

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,700
1,700
1,700
0
0
3,000
3,000
4,500
4,500
3,500
4,100
2,600
2,500
1,500
5,200
5,600
5,300
4,200
3,300
3,519
3,376
8,525
8,472
8,473
8,495
8,507
8,380
8,398
950
964
973
984
482
489
494
744
715
674
1,291
526
531
542
551
62,796
655
665
678
75,904
84,447
77,990
72,956
140,682
158,715
164,696
151,385
166,294
75,586
63,398
119,603
158,213
134,700
126,762
129,862
127,467
133,438
154,903
243,917
254,931
244,945
232,960
213,107
261,122
368,637
398,219
278,035
316,050
384,000
375,000
549,000
549,500
498,000
542,500
573,000
622,000
558,000
488,000
611,000
671,000
704,000
686,250
655,000
407,500
437,000
414,500
398,937
360,930
266,531
244,302
288,765
502,317
138,069
66,581
49,988
142,878
124,982
95,428
148,496
420,564
611,000
652,152
653,982
506,486
338,991
399,990
324,997

324,997

399,990

338,991

506,486

653,982

652,152

611,000

420,564

148,496

95,428

124,982

142,878

49,988

66,581

138,069

502,317

288,765

244,302

266,531

360,930

398,937

414,500

437,000

407,500

655,000

686,250

704,000

671,000

611,000

488,000

558,000

622,000

573,000

542,500

498,000

549,500

549,000

375,000

384,000

316,050

278,035

398,219

368,637

261,122

213,107

232,960

244,945

254,931

243,917

154,903

133,438

127,467

129,862

126,762

134,700

158,213

119,603

63,398

75,586

166,294

151,385

164,696

158,715

140,682

72,956

77,990

84,447

75,904

678

665

655

62,796

551

542

531

526

1,291

674

715

744

494

489

482

984

973

964

950

8,398

8,380

8,507

8,495

8,473

8,472

8,525

3,376

3,519

3,300

4,200

5,300

5,600

5,200

1,500

2,500

2,600

4,100

3,500

4,500

3,000

1,700

Short Long Term Debt

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
549,000
0
0
0
573,000
0
558,000
488,000
611,000
671,000
1,304,891
686,250
655,000
407,500
437,000
414,500
398,937
346,998
251,528
229,500
288,765
486,824
121,596
49,983
49,988
124,971
124,982
74,990
148,496
400,000
611,000
633,000
653,982
506,486
338,991
399,990
324,997

324,997

399,990

338,991

506,486

653,982

633,000

611,000

400,000

148,496

74,990

124,982

124,971

49,988

49,983

121,596

486,824

288,765

229,500

251,528

346,998

398,937

414,500

437,000

407,500

655,000

686,250

1,304,891

671,000

611,000

488,000

558,000

573,000

549,000

Accounts payable

0
1,100
2,600
3,100
5,400
4,900
4,300
4,300
5,000
5,900
5,500
7,200
9,000
10,200
8,300
9,200
13,200
10,000
8,500
10,800
14,000
23,400
14,100
18,700
17,500
23,900
9,900
12,500
13,000
15,700
7,500
26,800
12,000
13,700
11,200
19,600
16,399
18,908
17,914
13,714
11,135
11,029
13,366
10,887
20,888
7,987
17,855
9,427
17,013
20,930
12,600
19,160
14,848
19,467
18,786
14,723
12,957
16,193
18,404
19,842
25,034
24,240
23,193
24,374
27,316
28,366
21,786
32,510
25,301
25,357
28,937
28,006
23,541
26,472
21,465
19,133
24,104
23,190
25,273
22,669
23,334
29,888
31,032
36,551
40,614
29,706
31,728
35,288
38,716
37,584
38,131
29,941
42,794
41,425
58,255
44,743
44,183
58,212
53,614
52,648
52,458
50,085
44,127
60,057
62,249
58,606
60,583
66,968
70,409
68,015
65,457
69,534
70,143
67,606
75,515
72,172
74,210
73,903
71,933
74,558
87,175
93,016
86,684
116,140
120,881
127,262
110,144
110,221
117,709
107,664
112,609
110,643

110,643

112,609

107,664

117,709

110,221

110,144

127,262

120,881

116,140

86,684

93,016

87,175

74,558

71,933

73,903

74,210

72,172

75,515

67,606

70,143

69,534

65,457

68,015

70,409

66,968

60,583

58,606

62,249

60,057

44,127

50,085

52,458

52,648

53,614

58,212

44,183

44,743

58,255

41,425

42,794

29,941

38,131

37,584

38,716

35,288

31,728

29,706

40,614

36,551

31,032

29,888

23,334

22,669

25,273

23,190

24,104

19,133

21,465

26,472

23,541

28,006

28,937

25,357

25,301

32,510

21,786

28,366

27,316

24,374

23,193

24,240

25,034

19,842

18,404

16,193

12,957

14,723

18,786

19,467

14,848

19,160

12,600

20,930

17,013

9,427

17,855

7,987

20,888

10,887

13,366

11,029

11,135

13,714

17,914

18,908

16,399

19,600

11,200

13,700

12,000

26,800

7,500

15,700

13,000

12,500

9,900

23,900

17,500

18,700

14,100

23,400

14,000

10,800

8,500

10,000

13,200

9,200

8,300

10,200

9,000

7,200

5,500

5,900

5,000

4,300

4,900

5,400

3,100

2,600

1,100

Other Current Liabilities

0
5,700
3,900
3,500
4,000
4,900
4,800
5,100
6,200
6,500
8,500
7,100
10,000
12,400
14,200
12,800
17,200
21,400
21,800
20,900
21,800
26,600
30,500
29,400
27,300
27,300
56,600
57,700
53,400
53,400
49,300
46,500
48,000
56,500
54,800
52,600
53,071
64,755
61,517
51,863
33,430
34,090
39,091
38,890
38,845
47,911
58,486
51,710
51,497
57,405
66,597
72,807
62,756
60,700
67,006
73,785
62,951
68,093
70,229
78,208
2,237
89,476
84,434
90,715
75,960
92,265
99,350
107,248
88,300
103,966
103,659
104,616
91,477
100,218
102,706
104,959
94,616
99,629
108,184
118,598
107,650
121,898
136,799
141,383
126,092
128,478
134,664
137,746
118,470
123,470
134,161
148,919
134,519
147,245
167,449
195,351
177,942
190,441
203,738
205,530
178,267
188,842
202,074
236,131
174,763
210,181
220,507
253,418
210,384
228,380
238,431
260,683
215,195
241,326
263,824
322,938
231,686
292,295
345,728
415,648
348,970
392,681
410,609
458,909
388,991
387,510
386,840
433,662
403,595
399,425
420,312
478,712

478,712

420,312

399,425

403,595

433,662

386,840

387,510

388,991

458,909

410,609

392,681

348,970

415,648

345,728

292,295

231,686

322,938

263,824

241,326

215,195

260,683

238,431

228,380

210,384

253,418

220,507

210,181

174,763

236,131

202,074

188,842

178,267

205,530

203,738

190,441

177,942

195,351

167,449

147,245

134,519

148,919

134,161

123,470

118,470

137,746

134,664

128,478

126,092

141,383

136,799

121,898

107,650

118,598

108,184

99,629

94,616

104,959

102,706

100,218

91,477

104,616

103,659

103,966

88,300

107,248

99,350

92,265

75,960

90,715

84,434

89,476

2,237

78,208

70,229

68,093

62,951

73,785

67,006

60,700

62,756

72,807

66,597

57,405

51,497

51,710

58,486

47,911

38,845

38,890

39,091

34,090

33,430

51,863

61,517

64,755

53,071

52,600

54,800

56,500

48,000

46,500

49,300

53,400

57,700

56,600

27,300

29,400

30,500

26,600

21,800

20,900

21,800

21,400

17,200

12,800

14,200

12,400

10,000

7,100

8,500

6,500

6,200

5,100

4,800

4,900

4,000

3,500

3,900

5,700

> Long-term Liabilities

0
0
100
0
0
0
0
-100
100
0
0
100
100
0
0
-100
0
0
-100
0
0
0
-100
100
0
100
0
1,400
0
0
100
4,200
4,200
4,200
4,200
400
0
0
0
0
0
0
0
0
0
0
0
6,200
5,755
5,641
6,203
7,847
9,540
10,095
9,227
16,625
15,422
14,538
13,986
14,800
13,627
21,023
20,655
24,956
45,995
48,048
44,923
40,464
38,195
37,376
33,616
31,951
32,533
114,826
116,692
37,643
37,985
38,258
44,712
37,751
40,000
43,627
46,862
54,342
56,940
58,225
59,970
61,012
61,766
62,809
67,391
233,949
232,899
229,911
430,897
445,716
593,490
693,391
691,247
702,227
673,766
674,963
685,176
704,349
709,926
721,751
721,182
762,691
789,636
787,218
786,356
776,138
939,479
933,779
922,132
929,313
931,949
1,146,729
1,079,451
1,079,005
1,003,288
1,012,117
996,435
983,632
981,550
983,630
974,123
902,225
901,668
893,086
818,804
823,848

823,848

818,804

893,086

901,668

902,225

974,123

983,630

981,550

983,632

996,435

1,012,117

1,003,288

1,079,005

1,079,451

1,146,729

931,949

929,313

922,132

933,779

939,479

776,138

786,356

787,218

789,636

762,691

721,182

721,751

709,926

704,349

685,176

674,963

673,766

702,227

691,247

693,391

593,490

445,716

430,897

229,911

232,899

233,949

67,391

62,809

61,766

61,012

59,970

58,225

56,940

54,342

46,862

43,627

40,000

37,751

44,712

38,258

37,985

37,643

116,692

114,826

32,533

31,951

33,616

37,376

38,195

40,464

44,923

48,048

45,995

24,956

20,655

21,023

13,627

14,800

13,986

14,538

15,422

16,625

9,227

10,095

9,540

7,847

6,203

5,641

5,755

6,200

400

4,200

100

1,400

100

-100

100

-100

100

Long term Debt Total

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,856
3,639
3,418
3,194
2,966
2,735
2,501
2,263
2,021
1,776
1,394
1,141
884
624
150,359
150,090
150,000
350,000
350,000
500,000
598,925
599,556
597,085
600,021
597,958
599,137
593,110
594,868
600,891
604,149
606,075
609,005
603,130
602,416
601,348
699,334
700,552
696,634
698,910
697,363
899,562
853,316
858,492
778,747
780,079
778,025
775,205
773,381
767,995
760,814
694,387
696,362
696,844
0
0

696,844

696,362

694,387

760,814

767,995

773,381

775,205

778,025

780,079

778,747

858,492

853,316

899,562

697,363

698,910

696,634

700,552

699,334

601,348

602,416

603,130

609,005

606,075

604,149

600,891

594,868

593,110

599,137

597,958

600,021

597,085

599,556

598,925

500,000

350,000

150,000

150,090

150,359

624

884

1,141

1,394

1,776

2,021

2,263

2,501

2,735

2,966

3,194

3,418

3,639

3,856

Other Liabilities

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,716
5,304
5,120
6,825
8,127
8,050
7,224
7,264
7,303
7,674
7,542
8,774
7,945
9,166
9,058
11,355
24,853
26,670
24,356
20,040
20,055
19,798
17,194
14,924
15,298
16,313
16,104
15,079
16,120
16,462
20,582
15,672
16,798
19,509
23,381
28,553
32,096
34,647
37,544
36,590
37,670
39,382
43,904
49,642
51,024
51,096
53,137
54,028
53,377
55,205
55,120
55,753
58,148
60,586
65,468
71,952
75,094
83,357
83,828
131,263
180,631
184,088
183,940
174,790
171,190
163,896
159,012
162,828
169,159
178,505
155,434
220,513
224,541
232,038
218,410
208,427
118,527
117,586
120,175
106,594
107,129
196,242
0
0

196,242

107,129

106,594

120,175

117,586

118,527

208,427

218,410

232,038

224,541

220,513

155,434

178,505

169,159

162,828

159,012

163,896

171,190

174,790

183,940

184,088

180,631

131,263

83,828

83,357

75,094

71,952

65,468

60,586

58,148

55,753

55,120

55,205

53,377

54,028

53,137

51,096

51,024

49,642

43,904

39,382

37,670

36,590

37,544

34,647

32,096

28,553

23,381

19,509

16,798

15,672

20,582

16,462

16,120

15,079

16,104

16,313

15,298

14,924

17,194

19,798

20,055

20,040

24,356

26,670

24,853

11,355

9,058

9,166

7,945

8,774

7,542

7,674

7,303

7,264

7,224

8,050

8,127

6,825

5,120

5,304

5,716

Deferred Long Term Liability

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
22,680
28,647
23,288
24,522
27,707
28,848
34,111
34,656
34,944
35,306
35,720
35,806
36,165
37,992
52,375
51,049
49,247
49,309
63,353
62,463
63,132
62,031
76,444
43,384
46,677
51,445
72,302
73,038
71,630
67,450
60,898
27,529
100,821
39,899
29,267
32,931
32,415
33,734
33,024
38,908
36,599
27,590
11,707
18,566
120,608
15,306
8,935
7,461
10,852
14,486
8,150
5,826
5,568
0
0

5,568

5,826

8,150

14,486

10,852

7,461

8,935

15,306

120,608

18,566

11,707

27,590

36,599

38,908

33,024

33,734

32,415

32,931

29,267

39,899

100,821

27,529

60,898

67,450

71,630

73,038

72,302

51,445

46,677

43,384

76,444

62,031

63,132

62,463

63,353

49,309

49,247

51,049

52,375

37,992

36,165

35,806

35,720

35,306

34,944

34,656

34,111

28,848

27,707

24,522

23,288

28,647

22,680

> Total Stockholder Equity

0
28,700
29,600
31,500
37,100
67,300
68,800
70,400
73,800
75,900
79,000
83,600
87,100
90,400
94,200
99,800
105,500
112,000
270,900
279,100
288,700
298,800
309,100
322,700
323,400
322,100
305,000
302,700
306,500
314,000
322,000
307,800
317,800
329,500
308,700
284,300
288,813
289,050
266,404
261,747
257,145
275,991
288,867
301,730
314,262
305,299
319,698
340,973
353,351
372,094
402,819
413,292
426,945
424,057
408,729
397,660
387,445
392,229
380,764
369,010
363,059
357,034
387,585
409,861
412,084
384,552
420,140
438,323
433,636
428,461
437,327
438,194
445,828
470,574
499,634
514,569
497,120
524,261
546,614
574,235
596,868
608,774
585,942
539,579
566,876
589,933
617,507
636,223
631,254
549,546
534,846
518,186
512,216
452,868
229,388
117,516
34,022
8,468
-38,892
-84,125
-73,922
-8,638
54,850
-108,352
-74,090
-86,335
-48,622
-54,106
-49,272
-41,127
-1,604
-9,513
51,562
171,246
202,418
177,473
107,674
272,963
440,576
632,088
702,696
747,460
754,754
689,992
639,798
457,008
475,999
608,737
841,101
1,093,861
1,297,407
1,484,530

1,484,530

1,297,407

1,093,861

841,101

608,737

475,999

457,008

639,798

689,992

754,754

747,460

702,696

632,088

440,576

272,963

107,674

177,473

202,418

171,246

51,562

-9,513

-1,604

-41,127

-49,272

-54,106

-48,622

-86,335

-74,090

-108,352

54,850

-8,638

-73,922

-84,125

-38,892

8,468

34,022

117,516

229,388

452,868

512,216

518,186

534,846

549,546

631,254

636,223

617,507

589,933

566,876

539,579

585,942

608,774

596,868

574,235

546,614

524,261

497,120

514,569

499,634

470,574

445,828

438,194

437,327

428,461

433,636

438,323

420,140

384,552

412,084

409,861

387,585

357,034

363,059

369,010

380,764

392,229

387,445

397,660

408,729

424,057

426,945

413,292

402,819

372,094

353,351

340,973

319,698

305,299

314,262

301,730

288,867

275,991

257,145

261,747

266,404

289,050

288,813

284,300

308,700

329,500

317,800

307,800

322,000

314,000

306,500

302,700

305,000

322,100

323,400

322,700

309,100

298,800

288,700

279,100

270,900

112,000

105,500

99,800

94,200

90,400

87,100

83,600

79,000

75,900

73,800

70,400

68,800

67,300

37,100

31,500

29,600

28,700

Common Stock

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,000
4,000
3,986
4,001
4,016
4,025
4,036
4,082
4,101
4,135
4,157
4,193
4,198
4,233
4,301
4,354
4,410
4,439
4,489
4,513
4,516
4,522
4,533
4,559
4,579
4,594
4,628
4,638
4,656
4,662
4,688
4,700
4,716
9,450
9,487
9,502
9,531
9,539
9,563
9,583
9,616
9,633
9,679
9,729
9,762
9,797
9,856
9,884
9,910
9,923
9,957
9,970
9,991
10,016
10,061
10,068
10,081
10,119
10,155
10,163
10,170
10,195
10,226
10,235
10,213
10,258
10,255
10,283
10,312
10,334
10,374
10,395
10,412
10,428
10,468
10,485
10,504
10,509
10,535
10,548
10,559
10,571
10,591
10,603
10,628
10,646
10,668
10,675
10,681
10,688
10,700
10,707
10,709
10,719
10,732
10,738
10,745
10,751

10,751

10,745

10,738

10,732

10,719

10,709

10,707

10,700

10,688

10,681

10,675

10,668

10,646

10,628

10,603

10,591

10,571

10,559

10,548

10,535

10,509

10,504

10,485

10,468

10,428

10,412

10,395

10,374

10,334

10,312

10,283

10,255

10,258

10,213

10,235

10,226

10,195

10,170

10,163

10,155

10,119

10,081

10,068

10,061

10,016

9,991

9,970

9,957

9,923

9,910

9,884

9,856

9,797

9,762

9,729

9,679

9,633

9,616

9,583

9,563

9,539

9,531

9,502

9,487

9,450

4,716

4,700

4,688

4,662

4,656

4,638

4,628

4,594

4,579

4,559

4,533

4,522

4,516

4,513

4,489

4,439

4,410

4,354

4,301

4,233

4,198

4,193

4,157

4,135

4,101

4,082

4,036

4,025

4,016

4,001

3,986

4,000

Retained Earnings Total Equity

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
894,475
929,169
965,540
1,002,152
1,050,809
1,089,316
1,127,326
1,168,069
1,219,386
1,262,239
1,305,593
1,350,453
1,404,448
1,450,135
1,493,393
1,539,978
1,597,196
1,649,337
1,675,299
1,721,893
231,070
274,005
318,356
364,375
431,577
488,033
540,401
609,420
694,777
765,288
803,545
880,348
989,039
1,082,292
1,167,928
1,270,609
1,396,315
1,505,152
1,595,648
1,705,646
1,854,586
2,000,805
2,175,595
2,379,852
2,582,434
2,757,669
2,920,440
3,114,405
3,246,384
3,427,322
3,599,529
3,813,583
4,037,819
0
0

4,037,819

3,813,583

3,599,529

3,427,322

3,246,384

3,114,405

2,920,440

2,757,669

2,582,434

2,379,852

2,175,595

2,000,805

1,854,586

1,705,646

1,595,648

1,505,152

1,396,315

1,270,609

1,167,928

1,082,292

989,039

880,348

803,545

765,288

694,777

609,420

540,401

488,033

431,577

364,375

318,356

274,005

231,070

1,721,893

1,675,299

1,649,337

1,597,196

1,539,978

1,493,393

1,450,135

1,404,448

1,350,453

1,305,593

1,262,239

1,219,386

1,168,069

1,127,326

1,089,316

1,050,809

1,002,152

965,540

929,169

894,475

Accumulated Other Comprehensive Income

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-17,800
-20,700
-22,900
-24,900
-27,200
-29,700
-30,400
-33,300
-35,700
-38,600
-41,000
-43,600
-46,000
-3,700
-3,500
-4,105
-4,351
-5,334
-4,964
-5,990
-6,627
-5,641
-6,694
-6,574
-4,362
-3,770
-2,511
-2,529
411
1,411
4,703
6,856
7,073
7,097
11,966
10,010
6,258
4,792
2,182
2,350
5,548
8,394
12,418
13,761
15,225
20,333
24,906
33,885
33,557
25,711
5,675
-2,981
4,766
8,440
10,341
6,543
2,924
11,429
13,467
19,587
26,468
18,709
15,443
19,481
8,858
14,579
15,954
11,687
10,493
15,562
13,622
14,445
15,031
1,990
-8,071
-24,049
-22,275
-37,493
-42,265
-37,515
-35,465
-35,081
-43,053
-38,379
-38,388
-34,648
-36,470
-34,206
-42,559
-42,187
-41,791
-40,015
-40,583
-45,565
-46,182
-55,246
-57,032
-61,925
-53,615
-59,536
-48,391
-52,057
-53,484
-47,348
-67,705
-80,894
-77,796
-76,615
-73,665
-74,891
-71,206

-71,206

-74,891

-73,665

-76,615

-77,796

-80,894

-67,705

-47,348

-53,484

-52,057

-48,391

-59,536

-53,615

-61,925

-57,032

-55,246

-46,182

-45,565

-40,583

-40,015

-41,791

-42,187

-42,559

-34,206

-36,470

-34,648

-38,388

-38,379

-43,053

-35,081

-35,465

-37,515

-42,265

-37,493

-22,275

-24,049

-8,071

1,990

15,031

14,445

13,622

15,562

10,493

11,687

15,954

14,579

8,858

19,481

15,443

18,709

26,468

19,587

13,467

11,429

2,924

6,543

10,341

8,440

4,766

-2,981

5,675

25,711

33,557

33,885

24,906

20,333

15,225

13,761

12,418

8,394

5,548

2,350

2,182

4,792

6,258

10,010

11,966

7,097

7,073

6,856

4,703

1,411

411

-2,529

-2,511

-3,770

-4,362

-6,574

-6,694

-5,641

-6,627

-5,990

-4,964

-5,334

-4,351

-4,105

-3,500

-3,700

-46,000

-43,600

-41,000

-38,600

-35,700

-33,300

-30,400

-29,700

-27,200

-24,900

-22,900

-20,700

-17,800

Capital Surplus

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
613,416
626,521
641,645
665,035
680,093
694,201
702,575
716,779
726,619
742,022
757,214
779,261
787,191
798,332
825,320
847,138
856,350
866,213
888,293
912,582
921,678
931,808
940,534
952,943
972,360
994,299
1,011,895
1,030,147
1,046,473
1,060,689
1,073,931
1,094,159
1,109,157
1,128,484
1,138,216
1,155,875
1,170,962
1,189,554
1,213,517
1,230,485
1,247,456
1,274,069
1,294,849
1,321,086
1,339,413
1,358,813
1,377,320
1,400,025
1,419,709
1,437,528
1,463,215
1,489,903
1,515,197
0
0

1,515,197

1,489,903

1,463,215

1,437,528

1,419,709

1,400,025

1,377,320

1,358,813

1,339,413

1,321,086

1,294,849

1,274,069

1,247,456

1,230,485

1,213,517

1,189,554

1,170,962

1,155,875

1,138,216

1,128,484

1,109,157

1,094,159

1,073,931

1,060,689

1,046,473

1,030,147

1,011,895

994,299

972,360

952,943

940,534

931,808

921,678

912,582

888,293

866,213

856,350

847,138

825,320

798,332

787,191

779,261

757,214

742,022

726,619

716,779

702,575

694,201

680,093

665,035

641,645

626,521

613,416

Treasury Stock

-4,157,257

-3,843,749

-3,570,691

-3,326,021

-3,142,301

-2,953,923

-2,799,890

-2,788,412

-2,788,052

-2,788,310

-2,600,543

-2,461,698

-2,370,377

-2,350,034

-2,288,899

-2,185,152

-2,111,647

-2,005,813

-1,911,528

-1,856,307

-1,805,523

-1,691,204

-1,633,443

-1,408,183

-1,392,875

-1,369,412

-1,316,417

-1,222,812

-1,137,616

-2,591,714

-2,453,266

-2,303,575

-2,031,125

-1,904,604

-1,829,378

-1,744,319

-1,667,709

-1,525,023

-1,457,184

-1,415,940

-1,379,676

-1,352,169

-1,320,376

-1,230,848

-1,163,102

-1,104,504

-1,060,647

-1,034,658

-1,001,081

-975,061

-914,759

-889,581

-871,206

-846,448

-830,390

-820,468

-800,325

-749,318

-696,668

-677,509

-670,359

-612,644

-577,826

-565,947

-557,339

-514,791

-472,096

-437,127

-398,718

-377,867

-348,327

-313,140

-277,206

-241,545

-219,449

-206,759

-192,512

-178,357

-147,465

-134,479

-117,067

-83,573

-72,247

Other Stockholders Equity

0
35,500
35,300
36,000
41,200
70,200
70,100
70,000
71,700
34,400
73,000
73,200
73,900
74,600
74,800
76,100
77,700
79,300
232,800
233,900
236,500
256,500
271,700
278,200
280,000
283,100
285,400
286,800
289,800
294,600
299,500
317,800
323,100
329,200
297,100
265,800
264,282
257,856
227,676
209,962
199,426
211,177
216,549
219,211
227,994
209,114
208,557
155,991
156,257
155,317
169,013
163,800
157,459
130,420
95,369
62,490
36,530
25,107
-5,516
-34,702
-59,128
-94,141
-91,407
-97,833
-119,240
-169,912
-165,243
-181,895
-223,149
-267,375
-276,391
-279,051
-288,856
-305,544
-311,727
-329,661
-376,384
-382,867
-403,746
-414,569
-434,727
-478,387
-531,993
-613,113
-630,631
-648,281
-669,302
-695,340
-740,947
-875,463
-940,932
-998,948
-1,052,362
-1,169,522
-1,432,109
-1,559,907
-1,674,048
-210,562
-285,617
-370,474
-411,037
-415,033
-408,414
-616,034
-655,505
-753,119
-789,674
-831,609
-905,882
-998,092
-1,052,213
-1,146,159
-1,189,567
-1,195,034
-1,267,728
-1,382,564
-1,553,317
-1,535,194
-1,508,932
-1,500,538
-1,628,288
-1,797,258
-1,961,539
-2,187,652
-2,437,959
-2,732,378
-2,881,138
-2,923,715
-2,906,599
-2,881,031
-2,888,497
-2,899,586

-2,899,586

-2,888,497

-2,881,031

-2,906,599

-2,923,715

-2,881,138

-2,732,378

-2,437,959

-2,187,652

-1,961,539

-1,797,258

-1,628,288

-1,500,538

-1,508,932

-1,535,194

-1,553,317

-1,382,564

-1,267,728

-1,195,034

-1,189,567

-1,146,159

-1,052,213

-998,092

-905,882

-831,609

-789,674

-753,119

-655,505

-616,034

-408,414

-415,033

-411,037

-370,474

-285,617

-210,562

-1,674,048

-1,559,907

-1,432,109

-1,169,522

-1,052,362

-998,948

-940,932

-875,463

-740,947

-695,340

-669,302

-648,281

-630,631

-613,113

-531,993

-478,387

-434,727

-414,569

-403,746

-382,867

-376,384

-329,661

-311,727

-305,544

-288,856

-279,051

-276,391

-267,375

-223,149

-181,895

-165,243

-169,912

-119,240

-97,833

-91,407

-94,141

-59,128

-34,702

-5,516

25,107

36,530

62,490

95,369

130,420

157,459

163,800

169,013

155,317

156,257

155,991

208,557

209,114

227,994

219,211

216,549

211,177

199,426

209,962

227,676

257,856

264,282

265,800

297,100

329,200

323,100

317,800

299,500

294,600

289,800

286,800

285,400

283,100

280,000

278,200

271,700

256,500

236,500

233,900

232,800

79,300

77,700

76,100

74,800

74,600

73,900

73,200

73,000

34,400

71,700

70,000

70,100

70,200

41,200

36,000

35,300

35,500

Balance Sheet

Currency in USD. All numbers in thousands.

	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31	2000-12-31	1999-12-31	1998-12-31	1997-12-31	1996-12-31	1995-12-31	1994-12-31	1993-12-31	1992-12-31	1991-12-31
Accounts Payable	110,643	110,221	116,140	74,558	72,172	69,534	66,968	60,057	52,648	44,743	29,941	35,288	36,551	22,669	19,133	28,006	32,510	24,374	19,842	14,723	19,160	9,427	10,887	13,714	19,600	26,800	12,500	18,700	10,800	9,200	7,200	4,300	3,100
Accumulated Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accumulated Depreciation	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accumulated Other Comprehensive Income	-71,206	-77,796	-53,484	-53,615	-46,182	-41,791	-36,470	-43,053	-42,265	-8,071	13,622	15,954	15,443	13,467	10,341	5,675	24,906	12,418	2,182	11,966	4,703	-2,511	-6,694	-4,964	-3,500	-41,000	-30,400	-22,900	0	0	0	0	0
Additional Paid In Capital	0	0	0	0	0	0	1,073,931	1,011,895	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Lease Obligations	119,473	121,664	107,308	94,772	82,753	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Stock	10,751	10,719	10,688	10,646	10,571	10,509	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Surpluse	0	1,463,215	1,377,320	1,294,849	1,213,517	1,138,216	1,073,931	1,011,895	940,534	888,293	825,320	757,214	702,575	641,645	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash	453,932	112,546	144,454	383,928	90,326	123,794	187,675	154,901	128,994	322,536	279,058	223,986	183,895	156,915	106,728	78,868	60,360	61,666	67,151	47,156	186,717	113,788	66,666	46,007	58,600	109,100	107,000	127,700	149,300	25,200	18,900	17,200	9,300
Cash And Equivalents	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash And Short Term Investments	453,932	112,546	144,454	383,928	90,326	123,794	471,930	391,850	342,585	322,536	279,058	223,986	183,895	156,915	106,728	78,868	60,360	96,666	132,731	137,272	220,705	147,191	79,559	75,203	58,600	109,100	107,000	127,700	149,300	25,200	18,900	17,200	9,300
Common Stock	10,751	10,719	10,688	10,646	10,571	10,509	10,428	10,334	10,258	10,195	10,119	10,016	9,923	9,797	9,633	9,539	9,450	4,662	4,594	4,522	4,439	4,233	4,135	4,025	4,000	0	0	0	0	0	0	0	0
Common Stock Shares Outstanding	83,978	84,600	86,572	86,722	87,542	88,470	89,567	90,884	93,649	101,503	107,970	112,310	116,428	119,118	121,364	124,498	128,910	131,814	136,220	143,200	143,724	140,172	138,560	144,324	159,024	152,000	150,714	157,108	140,984	133,000	133,793	106,667	80,000
Common Stock Total Equity	0	10,719	10,688	10,646	10,571	10,509	10,428	10,334	10,258	10,195	10,119	10,016	9,923	9,797	9,633	9,539	9,450	4,662	4,594	4,522	4,439	4,233	4,135	4,025	4,000	0	0	0	0	0	0	0	0
Current Deferred Revenue	37,195	37,938	40,034	42,567	41,462	41,290	29,181	27,380	25,583	31,812	21,458	20,192	15,028	13,983	12,610	11,285	10,678	8,976	7,965	10,153	8,275	13,569	13,220	0	0	0	0	0	0	0	0	0	0
Deferred Long Term Asset Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Long Term Liab	0	8,150	8,935	11,707	33,024	29,267	60,898	72,302	76,444	63,353	52,375	35,720	34,111	23,288	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Earning Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Good Will	365,961	361,795	359,345	243,347	239,724	214,489	199,873	178,228	178,934	184,450	180,521	174,994	172,610	149,112	148,705	138,768	236,414	104,826	88,127	92,937	54,994	52,321	0	0	0	0	0	0	0	0	0	0	0
Intangible Assets	84,500	97,672	99,035	52,543	58,468	41,825	43,846	46,155	55,909	65,122	58,844	62,833	69,209	55,752	63,907	68,327	236,414	43,353	118,746	124,494	61,766	56,157	0	0	0	0	0	0	0	8,200	8,900	10,300	0
Inventory	380,282	367,823	269,030	209,873	195,019	173,303	164,318	158,034	188,833	160,342	133,427	140,946	133,099	127,885	110,425	115,926	98,804	95,996	69,369	76,424	75,333	75,086	86,194	65,935	47,500	55,400	60,200	48,400	28,200	20,800	14,600	12,800	5,100
Liabilities And Stockholders Equity	3,259,925	2,746,765	2,437,203	2,294,561	1,832,475	1,537,349	1,713,416	1,530,704	1,474,993	1,384,211	1,230,516	1,103,602	1,030,814	897,144	808,527	765,437	702,179	559,560	490,676	514,237	521,875	416,652	373,107	335,796	360,200	390,500	377,000	373,900	312,500	121,700	98,000	79,700	38,100
Long Term Debt	622,883	694,387	775,205	858,492	698,910	601,348	606,075	593,110	597,085	350,000	150,359	1,394	2,501	3,418	4,281	5,094	5,727	6,447	0	519	0	0	0	0	0	0	0	0	0	0	0	0	0
Long Term Debt Total	0	694,387	775,205	858,492	698,910	601,348	606,075	593,110	597,085	350,000	150,359	1,394	2,501	3,418	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long Term Investments	56,193	55,500	13,348	12,065	13,657	10,894	9,949	10,978	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Negative Goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Debt	493,948	1,235,823	779,247	524,552	897,349	876,491	1,073,400	1,049,209	1,041,091	576,464	149,336	-9,485	62,523	-23,635	17,156	77,611	18,323	-54,541	-66,600	-45,473	-185,437	-112,815	-58,286	-37,535	-55,000	-99,700	-102,900	-124,700	-147,600	-25,200	-18,900	-17,200	-9,300
Net Invested Capital	2,432,410	1,348,369	1,613,693	1,540,568	1,165,148	990,772	1,206,969	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Receivables	457,445	400,619	368,348	331,429	269,312	248,855	234,597	204,494	188,318	152,380	158,038	138,324	141,275	120,080	115,107	111,498	108,384	81,389	71,688	65,639	53,976	45,689	50,772	57,266	58,400	47,900	47,300	66,600	47,300	25,800	21,400	11,900	10,500
Net Tangible Assets	0	149,270	689,992	336,198	-120,719	-265,827	-297,825	-332,735	-318,968	-132,056	278,821	398,396	297,760	369,371	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Working Capital	543,707	-134,326	192,076	479,977	-45,698	-116,272	-32,582	-88,984	-35,127	-61,508	174,353	163,204	87,348	175,479	120,033	60,598	82,271	177,520	192,679	201,640	269,853	213,441	164,199	141,781	156,900	184,800	199,900	250,600	228,600	76,500	62,500	48,000	19,800
Non Current Assets Total	1,764,671	1,645,288	1,481,548	1,231,823	1,152,836	883,177	741,431	685,120	653,359	624,813	577,810	534,065	506,587	436,553	432,189	409,547	396,516	257,297	191,431	212,645	151,286	127,532	137,531	119,966	127,800	127,200	102,800	72,200	50,500	23,200	21,200	22,300	11,700
Non Current Liabilities Other	0	199,688	208,427	208,806	197,379	145,523	95,718	38,937	28,698	32,363	31,215	23,898	17,730	11,045	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Non Current Liabilities Total	823,848	902,225	983,632	1,079,005	929,313	776,138	762,691	704,349	702,227	445,716	233,949	61,012	54,342	37,751	37,643	31,951	40,464	24,956	14,800	16,625	7,847	6,200	0	0	400	4,200	1,400	100	0	-100	100	-100	0
Non Currrent Assets Other	448,476	425,632	397,369	337,152	299,042	170,218	100,969	53,050	33,496	23,200	10,930	13,023	289,810	234,828	232,243	219,901	11,606	6,237	6,988	-7,626	-4,561	-8,539	88,316	74,305	88,200	85,700	61,800	35,800	25,000	1,600	300	300	700
Noncontrolling Interest In Consolidated Entity	0	0	0	707	352	280	264	139	130	73	28	34	14	46	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets	0	387,479	893,881	676,656	240,192	189,593	118,616	103,315	73,325	71,654	57,231	51,061	47,991	26,222	19,631	12,806	18,250	9,490	6,988	5,834	9,214	6,348	67,300	74,305	0	0	0	0	0	0	0	0	0
Other Current Assets	203,595	220,489	173,823	137,508	124,982	108,220	101,140	91,206	101,898	124,140	82,183	66,281	65,958	55,711	44,078	49,598	14,509	11,328	11,679	8,797	6,800	6,267	4,812	17,426	67,900	50,900	59,700	59,000	37,200	26,700	21,900	15,500	1,500
Other Current Liab	478,712	433,662	458,909	415,648	322,938	260,683	253,418	236,131	205,530	195,351	148,919	137,746	141,383	118,598	104,959	104,616	107,248	90,715	78,208	73,785	72,807	51,710	38,890	51,863	52,600	46,500	57,700	29,400	20,900	12,800	7,100	5,100	3,500
Other Liab	0	106,594	208,427	220,513	162,828	174,790	156,616	111,239	105,142	54,028	49,642	36,590	28,553	15,672	15,079	14,924	20,040	11,355	8,774	7,264	6,825	0	0	0	0	0	0	0	0	0	0	0	0
Other Stockholder Equity	-2,899,586	-2,923,715	-2,187,652	-1,500,538	-1,382,564	-1,146,159	-831,609	-616,034	-370,474	-1,559,907	-998,948	-695,340	-613,113	-414,569	-329,661	-279,051	-181,895	-97,833	-34,702	62,490	163,800	155,991	219,211	209,962	265,800	317,800	286,800	278,200	233,900	76,100	73,200	70,000	36,000
Preferred Stock Redeemable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Total Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Property Plant And Equipment Gross	1,602,493	649,474	1,341,159	646,338	614,452	437,270	379,096	357,422	333,026	303,587	281,214	245,177	216,777	201,725	199,946	189,646	141,852	99,628	65,697	62,630	45,224	49,455	49,215	45,661	39,600	41,500	41,000	36,400	0	0	0	0	0
Property Plant And Equipment Net	702,177	649,474	587,667	555,167	533,845	437,270	379,096	357,422	333,026	303,587	281,214	245,177	216,777	201,725	199,946	189,646	141,852	99,628	65,697	62,630	45,224	49,455	49,215	45,661	39,600	41,500	41,000	36,400	25,500	13,400	12,000	11,700	11,000
Property Plant Equipment	0	649,474	587,667	555,167	533,845	437,270	379,096	357,422	333,026	303,587	281,214	245,177	216,777	201,725	199,946	189,646	141,852	99,628	65,697	62,630	45,224	49,455	49,215	45,661	0	0	0	0	0	0	0	0	0
Retained Earnings	4,444,571	3,599,529	2,920,440	2,175,595	1,595,648	1,167,928	803,545	540,401	318,356	1,675,299	1,493,393	1,305,593	1,127,326	965,540	824,256	702,031	585,862	490,614	396,936	318,682	240,350	183,260	137,871	100,251	63,600	31,000	46,300	67,400	45,200	23,700	10,400	400	-4,500
Retained Earnings Total Equity	0	3,599,529	2,920,440	2,175,595	1,595,648	1,167,928	803,545	540,401	318,356	1,675,299	1,493,393	1,305,593	1,127,326	965,540	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Short Long Term Debt	324,997	653,982	148,496	49,988	288,765	398,937	655,000	611,000	573,000	549,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Short Long Term Debt Total	947,880	1,348,369	923,701	908,480	987,675	1,000,285	1,261,075	1,204,110	1,170,085	899,000	428,394	214,501	246,418	133,280	123,884	156,479	78,683	7,125	551	1,683	1,280	973	8,380	8,472	3,600	9,400	4,100	3,000	1,700	0	0	0	0
Short Term Debt	324,997	653,982	148,496	49,988	288,765	398,937	655,000	611,000	573,000	549,000	278,035	213,107	243,917	129,862	119,603	151,385	72,956	678	551	1,291	494	973	8,380	8,472	3,300	5,200	4,100	3,000	1,700	0	0	0	0
Short Term Investments	0	0	0	0	0	0	284,255	236,949	213,591	0	0	0	0	0	0	0	0	35,000	65,580	90,116	33,988	33,403	12,893	29,196	0	0	0	0	0	0	0	0	0
Temporary Equity Redeemable Noncontrolling Interests	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Assets	3,259,925	2,746,765	2,437,203	2,294,561	1,832,475	1,537,349	1,713,416	1,530,704	1,474,993	1,384,211	1,230,516	1,103,602	1,030,814	897,144	808,527	765,437	702,179	559,560	490,676	514,237	521,875	416,652	373,107	335,796	360,200	390,500	377,000	373,900	312,500	121,700	98,000	79,700	38,100
Total Current Assets	1,495,254	1,101,477	955,655	1,062,738	679,639	654,172	971,985	845,584	821,634	759,398	652,706	569,537	524,227	460,591	376,338	355,890	305,663	302,263	299,245	301,592	370,589	289,120	235,576	215,830	232,400	263,300	274,200	301,700	262,000	98,500	76,800	57,400	26,400
Total Current Liabilities	951,547	1,235,803	763,579	582,761	725,337	770,444	1,004,567	934,568	856,761	820,906	478,353	406,333	436,879	285,112	256,305	295,292	223,392	124,743	106,566	99,952	100,736	75,679	71,377	74,049	75,500	78,500	74,300	51,100	33,400	22,000	14,300	9,400	6,600
Total Liab	1,775,395	2,138,028	1,747,211	1,661,766	1,654,650	1,546,582	1,767,258	1,638,917	1,558,988	1,266,622	712,302	467,345	491,221	322,863	293,948	327,243	263,856	149,699	121,366	116,577	108,583	75,679	71,377	74,049	75,900	82,700	74,300	51,200	33,400	21,900	14,400	9,300	6,600
Total Permanent Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Stockholder Equity	1,484,530	608,737	689,992	632,088	177,473	-9,513	-54,106	-108,352	-84,125	117,516	518,186	636,223	539,579	574,235	514,569	438,194	438,323	409,861	369,010	397,660	413,292	340,973	301,730	261,747	284,300	307,800	302,700	322,700	279,100	99,800	83,600	70,400	31,500
Treasury Stock	0	0	-3,570,691	-2,799,890	-2,600,543	-2,288,899	-1,911,528	-1,633,443	-1,316,417	-2,453,266	-1,829,378	-1,457,184	-1,320,376	-1,060,647	-914,759	-830,390	-696,668	-577,826	-472,096	-348,327	-219,449	-178,357	-147,465	-134,479	0	0	0	0	0	0	0	0	0
Warrants	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-12-31	2003-09-30	2003-06-30	2003-03-31	2002-12-31	2002-09-30	2002-06-30	2002-03-31	2001-12-31	2001-09-30	2001-06-30	2001-03-31	2000-12-31	2000-09-30	2000-06-30	2000-03-31	1999-12-31	1999-09-30	1999-06-30	1999-03-31	1998-12-31	1998-09-30	1998-06-30	1998-03-31	1997-12-31	1997-09-30	1997-06-30	1997-03-31	1996-12-31	1996-09-30	1996-06-30	1996-03-31	1995-12-31	1995-09-30	1995-06-30	1995-03-31	1994-12-31	1994-09-30	1994-06-30	1994-03-31	1993-12-31	1993-09-30	1993-06-30	1993-03-31	1992-12-31	1992-09-30	1992-06-30	1992-03-31	1991-12-31	1991-09-30	1991-06-30	1991-03-31
Accounts Payable	110,643	112,609	107,664	117,709	110,221	110,144	127,262	120,881	116,140	86,684	93,016	87,175	74,558	71,933	73,903	74,210	72,172	75,515	67,606	70,143	69,534	65,457	68,015	70,409	66,968	60,583	58,606	62,249	60,057	44,127	50,085	52,458	52,648	53,614	58,212	44,183	44,743	58,255	41,425	42,794	29,941	38,131	37,584	38,716	35,288	31,728	29,706	40,614	36,551	31,032	29,888	23,334	22,669	25,273	23,190	24,104	19,133	21,465	26,472	23,541	28,006	28,937	25,357	25,301	32,510	21,786	28,366	27,316	24,374	23,193	24,240	25,034	19,842	18,404	16,193	12,957	14,723	18,786	19,467	14,848	19,160	12,600	20,930	17,013	9,427	17,855	7,987	20,888	10,887	13,366	11,029	11,135	13,714	17,914	18,908	16,399	19,600	11,200	13,700	12,000	26,800	7,500	15,700	13,000	12,500	9,900	23,900	17,500	18,700	14,100	23,400	14,000	10,800	8,500	10,000	13,200	9,200	8,300	10,200	9,000	7,200	5,500	5,900	5,000	4,300	4,300	4,900	5,400	3,100	2,600	1,100	-
Accumulated Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Accumulated Depreciation	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Accumulated Other Comprehensive Income	-71,206	-74,891	-73,665	-76,615	-77,796	-80,894	-67,705	-47,348	-53,484	-52,057	-48,391	-59,536	-53,615	-61,925	-57,032	-55,246	-46,182	-45,565	-40,583	-40,015	-41,791	-42,187	-42,559	-34,206	-36,470	-34,648	-38,388	-38,379	-43,053	-35,081	-35,465	-37,515	-42,265	-37,493	-22,275	-24,049	-8,071	1,990	15,031	14,445	13,622	15,562	10,493	11,687	15,954	14,579	8,858	19,481	15,443	18,709	26,468	19,587	13,467	11,429	2,924	6,543	10,341	8,440	4,766	-2,981	5,675	25,711	33,557	33,885	24,906	20,333	15,225	13,761	12,418	8,394	5,548	2,350	2,182	4,792	6,258	10,010	11,966	7,097	7,073	6,856	4,703	1,411	411	-2,529	-2,511	-3,770	-4,362	-6,574	-6,694	-5,641	-6,627	-5,990	-4,964	-5,334	-4,351	-4,105	-3,500	-3,700	-46,000	-43,600	-41,000	-38,600	-35,700	-33,300	-30,400	-29,700	-27,200	-24,900	-22,900	-20,700	-17,800	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Additional Paid In Capital	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1,073,931	0	0	0	1,011,895	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Capital Lease Obligations	119,473	121,362	117,030	117,381	121,664	112,280	117,779	110,195	107,308	110,158	107,565	96,100	94,772	87,253	85,070	80,836	82,753	81,143	84,334	82,887	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Capital Stock	10,751	10,745	10,738	10,732	10,719	10,709	10,707	10,700	10,688	10,681	10,675	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Capital Surpluse	0	0	1,515,197	1,489,903	1,463,215	1,437,528	1,419,709	1,400,025	1,377,320	1,358,813	1,339,413	1,321,086	1,294,849	1,274,069	1,247,456	1,230,485	1,213,517	1,189,554	1,170,962	1,155,875	1,138,216	1,128,484	1,109,157	1,094,159	1,073,931	1,060,689	1,046,473	1,030,147	1,011,895	994,299	972,360	952,943	940,534	931,808	921,678	912,582	888,293	866,213	856,350	847,138	825,320	798,332	787,191	779,261	757,214	742,022	726,619	716,779	702,575	694,201	680,093	665,035	641,645	626,521	613,416	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Cash	453,932	331,696	132,838	111,367	112,546	99,176	114,362	204,618	144,454	145,203	232,134	351,163	383,928	175,587	105,293	81,395	90,326	103,996	110,845	116,616	123,794	146,877	174,559	159,229	187,675	169,019	165,975	160,408	154,901	150,072	141,139	132,953	128,994	141,150	163,152	182,160	322,536	292,735	305,048	286,203	279,058	264,811	251,013	228,364	223,986	221,441	201,813	185,491	183,895	181,499	159,398	153,459	156,915	133,512	117,975	106,354	106,728	106,728	103,744	86,295	78,868	84,586	75,265	60,220	60,360	58,507	49,588	53,937	61,666	50,950	50,023	35,339	67,151	57,768	52,354	44,579	47,156	146,534	164,659	180,510	186,717	176,857	151,434	133,451	113,788	105,197	68,570	81,478	66,666	69,037	49,495	27,870	46,007	38,726	73,654	68,369	58,600	74,700	107,100	91,300	109,100	138,700	129,600	108,900	107,000	105,500	119,200	109,800	127,700	125,500	139,400	128,700	149,300	185,800	31,500	34,700	25,200	20,600	22,400	22,100	18,900	21,600	21,500	20,000	17,200	13,200	11,500	2,200	9,300	10,300	20,800	-
Cash And Equivalents	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Cash And Short Term Investments	453,932	331,696	132,838	111,367	112,546	99,176	114,362	204,618	144,454	145,203	232,134	351,163	383,928	175,587	105,293	81,395	90,326	103,996	110,845	116,616	123,794	146,877	174,559	159,229	471,930	454,104	422,898	400,341	391,850	391,474	370,202	350,570	342,585	349,549	344,022	321,375	322,536	292,735	305,048	286,203	279,058	264,811	251,013	228,364	223,986	221,441	201,813	185,491	183,895	181,499	159,398	153,459	156,915	133,512	117,975	106,354	106,728	106,728	103,744	86,295	78,868	84,586	75,265	60,220	60,360	58,507	49,588	53,937	96,666	94,591	77,057	92,997	132,731	129,456	130,957	110,201	137,272	196,574	212,716	209,421	220,705	216,180	190,125	175,431	147,191	127,526	90,155	96,851	79,559	79,365	68,216	45,552	75,203	86,004	124,417	110,350	58,600	120,900	107,100	91,300	109,100	138,700	129,600	108,900	107,000	105,500	119,200	109,800	127,700	125,500	139,400	128,700	149,300	185,800	31,500	34,700	25,200	20,600	22,400	22,100	18,900	21,600	21,500	20,000	17,200	13,200	11,500	2,200	9,300	10,300	20,800	-
Common Stock	10,751	10,745	10,738	10,732	10,719	10,709	10,707	10,700	10,688	10,681	10,675	10,668	10,646	10,628	10,603	10,591	10,571	10,559	10,548	10,535	10,509	10,504	10,485	10,468	10,428	10,412	10,395	10,374	10,334	10,312	10,283	10,255	10,258	10,213	10,235	10,226	10,195	10,170	10,163	10,155	10,119	10,081	10,068	10,061	10,016	9,991	9,970	9,957	9,923	9,910	9,884	9,856	9,797	9,762	9,729	9,679	9,633	9,616	9,583	9,563	9,539	9,531	9,502	9,487	9,450	4,716	4,700	4,688	4,662	4,656	4,638	4,628	4,594	4,579	4,559	4,533	4,522	4,516	4,513	4,489	4,439	4,410	4,354	4,301	4,233	4,198	4,193	4,157	4,135	4,101	4,082	4,036	4,025	4,016	4,001	3,986	4,000	4,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Common Stock Shares Outstanding	83,933	83,993	83,983	83,959	83,815	84,113	84,858	85,564	86,142	86,511	86,654	86,917	86,904	86,690	86,402	86,705	87,212	87,667	87,615	87,549	87,807	88,453	88,596	88,944	89,045	89,256	89,878	89,994	90,589	91,138	90,817	90,838	91,788	92,897	94,306	95,521	96,860	100,800	103,590	104,676	105,474	106,484	108,772	110,980	111,580	112,176	112,422	112,878	110,416	116,014	117,454	118,180	114,914	118,552	119,292	120,058	116,066	121,336	121,394	121,212	118,344	123,730	124,880	127,116	121,730	127,964	128,804	130,168	124,548	130,924	132,056	133,672	127,200	136,176	136,240	137,756	131,820	141,868	145,692	145,748	139,100	143,908	142,124	142,080	135,248	138,528	140,772	140,068	135,532	136,227	137,462	138,345	132,330	142,600	146,585	146,073	139,722	160,000	160,000	162,222	153,684	160,000	156,923	152,000	152,000	153,636	168,000	180,000	180,000	156,364	158,000	155,556	135,000	135,000	130,667	133,333	130,909	130,909	130,000	124,444	130,000	130,000	120,000	112,000	100,000	100,000	120,000	100,000	80,000	80,000	60,000	75,168
Common Stock Total Equity	0	0	10,738	10,732	10,719	10,709	10,707	10,700	10,688	10,681	10,675	10,668	10,646	10,628	10,603	10,591	10,571	10,559	10,548	10,535	10,509	10,504	10,485	10,468	10,428	10,412	10,395	10,374	10,334	10,312	10,283	10,255	10,258	10,213	10,235	10,226	10,195	10,170	10,163	10,155	10,119	10,081	10,068	10,061	10,016	9,991	9,970	9,957	9,923	9,910	9,884	9,856	9,797	9,762	9,729	9,679	9,633	9,616	9,583	9,563	9,539	9,531	9,502	9,487	9,450	4,716	4,700	4,688	4,662	4,656	4,638	4,628	4,594	4,579	4,559	4,533	4,522	4,516	4,513	4,489	4,439	4,410	4,354	4,301	4,233	4,198	4,193	4,157	4,135	4,101	4,082	4,036	4,025	4,016	4,001	3,986	4,000	4,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Current Deferred Revenue	37,195	37,282	37,779	37,839	37,938	40,809	40,775	40,905	40,034	41,128	41,130	41,639	42,567	42,599	36,317	38,028	41,462	42,986	43,446	43,351	41,290	41,149	40,921	40,545	29,181	29,203	28,706	28,065	27,380	26,007	25,849	25,943	25,583	24,914	28,775	31,820	31,812	29,560	27,682	23,810	21,458	22,441	21,980	21,269	20,192	16,494	16,022	15,647	15,028	13,635	12,913	14,119	13,983	10,714	13,681	12,234	12,610	10,994	10,834	10,831	11,285	10,458	11,014	10,743	10,678	10,044	8,491	9,235	8,976	8,440	8,950	8,301	7,965	8,343	8,434	8,617	10,153	7,511	8,167	8,252	8,275	8,271	9,356	8,318	13,569	13,811	13,402	12,971	13,220	13,053	13,007	12,405	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Deferred Long Term Asset Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Deferred Long Term Liab	0	0	5,568	5,826	8,150	14,486	10,852	7,461	8,935	15,306	120,608	18,566	11,707	27,590	36,599	38,908	33,024	33,734	32,415	32,931	29,267	39,899	100,821	27,529	60,898	67,450	71,630	73,038	72,302	51,445	46,677	43,384	76,444	62,031	63,132	62,463	63,353	49,309	49,247	51,049	52,375	37,992	36,165	35,806	35,720	35,306	34,944	34,656	34,111	28,848	27,707	24,522	23,288	28,647	22,680	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Earning Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Good Will	365,961	361,766	364,206	362,942	361,795	355,292	355,528	360,968	359,345	355,240	353,842	242,586	243,347	238,100	235,426	233,211	239,724	212,171	215,157	214,517	214,489	216,046	195,974	201,022	199,873	199,521	196,670	180,601	178,228	180,952	180,657	181,941	178,934	180,392	179,705	176,932	184,450	176,537	181,619	180,466	180,521	180,988	171,403	172,459	174,994	174,614	170,929	175,105	172,610	150,018	154,191	152,498	149,112	148,597	143,252	146,534	148,705	148,137	142,930	136,158	138,768	231,379	242,137	244,781	236,414	235,881	230,562	227,369	104,826	132,723	133,033	119,255	88,127	88,397	87,815	91,092	92,937	0	0	0	54,994	53,499	53,438	52,280	52,321	51,781	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Intangible Assets	84,500	87,129	90,932	94,361	97,672	99,968	100,594	105,188	99,035	94,976	96,757	53,969	52,543	53,467	55,619	57,948	58,468	35,662	37,989	39,499	41,825	42,420	39,036	41,893	43,846	45,251	46,089	45,686	46,155	47,566	49,729	53,257	55,909	58,650	57,517	59,911	65,122	59,210	55,550	57,281	58,844	61,387	58,103	61,036	62,833	63,363	64,627	68,426	69,209	50,607	53,044	54,715	55,752	57,554	57,873	61,304	63,907	214,974	207,682	200,748	68,327	231,379	242,137	244,781	236,414	235,881	230,562	43,353	43,353	132,723	133,033	118,746	118,746	119,904	115,373	120,810	124,494	69,663	68,057	67,755	61,766	57,938	57,264	56,098	56,157	51,781	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10,300	10,800	8,100	8,200	8,600	8,100	8,300	8,900	9,200	9,500	10,000	10,300	10,300	10,700	10,800	0	0	-	-
Inventory	380,282	393,974	395,141	391,011	367,823	354,975	332,565	301,638	269,030	258,484	241,392	225,559	209,873	217,597	229,377	211,644	195,019	204,893	196,876	189,468	173,303	179,684	176,487	179,039	164,318	176,749	169,693	172,183	158,034	168,468	175,688	183,759	188,833	192,405	184,500	173,370	160,342	156,007	145,400	141,134	133,427	145,987	140,938	148,242	140,946	147,474	143,703	141,104	133,099	137,143	133,934	127,054	127,885	131,555	122,032	122,384	110,425	124,488	122,924	123,575	115,926	112,907	106,182	99,878	98,804	96,273	91,551	106,373	95,996	93,242	85,540	81,229	69,369	80,206	81,765	78,481	76,424	85,998	78,905	75,863	75,333	69,295	69,801	69,382	75,086	75,199	75,541	85,145	86,194	83,842	79,510	77,492	65,935	62,870	56,747	47,187	47,500	48,400	47,500	46,800	55,400	43,000	51,000	55,800	60,200	63,000	71,300	60,900	48,400	41,000	40,200	33,400	28,200	25,400	27,400	24,700	20,800	20,800	20,000	18,300	14,600	13,900	12,700	13,200	12,800	12,400	11,600	10,300	5,100	4,600	4,700	-
Liabilities And Stockholders Equity	3,259,925	3,086,404	2,870,806	2,808,398	2,746,765	2,640,067	2,607,185	2,592,689	2,437,203	2,385,744	2,412,149	2,327,385	2,294,561	2,047,407	1,960,713	1,886,245	1,832,475	1,751,481	1,724,237	1,680,968	1,537,349	1,544,530	1,520,685	1,469,492	1,713,416	1,669,334	1,637,137	1,572,091	1,530,704	1,500,370	1,489,241	1,478,647	1,474,993	1,477,210	1,477,370	1,431,014	1,384,211	1,290,632	1,283,193	1,262,324	1,230,516	1,195,238	1,164,071	1,132,638	1,103,602	1,093,351	1,067,317	1,061,105	1,030,814	969,199	950,575	909,478	897,144	862,297	833,735	824,284	808,527	814,889	798,510	770,504	765,437	778,693	764,889	736,857	702,179	674,233	646,169	646,494	559,560	524,972	501,378	475,242	490,676	492,630	500,250	487,918	514,237	512,404	523,201	523,085	521,875	497,219	465,908	436,918	416,652	410,814	375,549	395,364	373,107	362,884	342,612	322,588	335,796	354,360	376,089	361,802	360,200	383,100	409,200	387,600	390,500	380,400	385,600	375,500	377,000	375,000	377,900	372,700	373,900	356,600	348,800	324,500	312,500	302,800	145,100	135,900	121,700	116,700	113,000	106,200	98,000	93,000	88,300	85,100	79,700	77,900	77,100	46,500	38,100	36,200	35,500	-
Long Term Debt	622,883	618,813	696,844	696,362	694,387	760,814	767,995	773,381	775,205	778,025	780,079	778,747	858,492	853,316	899,562	697,363	698,910	696,634	700,552	699,334	601,348	602,416	603,130	609,005	606,075	604,149	600,891	594,868	593,110	599,137	597,958	600,021	597,085	599,556	598,925	500,000	350,000	350,000	150,000	150,090	150,359	624	884	1,141	1,394	1,776	2,021	2,263	2,501	2,735	2,966	3,194	3,418	3,639	3,856	4,070	4,281	84,489	84,694	4,896	5,094	5,157	5,350	5,540	5,727	5,911	6,092	6,271	6,447	6,625	6,795	0	0	0	0	0	519	500	500	500	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Long Term Debt Total	0	0	696,844	696,362	694,387	760,814	767,995	773,381	775,205	778,025	780,079	778,747	858,492	853,316	899,562	697,363	698,910	696,634	700,552	699,334	601,348	602,416	603,130	609,005	606,075	604,149	600,891	594,868	593,110	599,137	597,958	600,021	597,085	599,556	598,925	500,000	350,000	350,000	150,000	150,090	150,359	624	884	1,141	1,394	1,776	2,021	2,263	2,501	2,735	2,966	3,194	3,418	3,639	3,856	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Long Term Investments	56,193	54,333	55,391	54,271	55,500	51,760	52,892	12,014	13,348	9,790	10,489	11,185	12,065	12,599	104,406	13,785	13,657	13,082	12,386	11,621	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Negative Goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Net Debt	493,948	687,107	902,997	1,091,481	1,235,823	1,406,918	1,264,633	1,078,958	779,247	817,970	672,927	648,655	524,552	814,965	1,000,935	1,183,628	897,349	903,281	925,569	1,012,603	876,491	870,039	865,571	857,276	1,073,400	1,121,380	1,138,916	1,105,460	1,049,209	937,065	1,014,819	1,089,068	1,041,091	1,000,906	933,773	867,340	576,464	432,265	228,952	179,937	149,336	134,032	118,508	33,899	-9,485	13,295	45,153	71,703	62,523	-23,861	-22,994	-22,798	-23,635	-3,111	20,581	55,929	17,156	41,159	56,536	84,895	77,611	85,267	88,800	86,002	18,323	25,394	40,951	28,238	-54,541	-43,660	-42,573	-35,339	-66,600	-57,226	-51,823	-44,053	-45,473	-145,360	-163,444	-179,113	-185,437	-176,368	-150,952	-132,467	-112,815	-104,233	-67,620	-73,080	-58,286	-60,530	-41,000	-19,397	-37,535	-30,201	-70,278	-64,850	-55,000	-66,300	-97,600	-81,500	-99,700	-137,200	-127,100	-106,300	-102,900	-102,000	-114,700	-105,300	-124,700	-122,500	-139,400	-128,700	-147,600	-184,100	-29,800	-34,700	-25,200	-20,600	-22,400	-22,100	-18,900	-21,600	-21,500	-20,000	-17,200	-13,200	-11,500	-2,200	-9,300	-10,300	-20,800	-
Net Invested Capital	2,432,410	1,018,803	1,035,835	1,202,848	1,348,369	1,869,813	1,836,003	1,813,179	1,613,693	1,607,769	1,652,521	1,606,414	1,540,568	1,343,875	1,294,121	1,291,861	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Net Receivables	457,445	452,699	461,858	446,025	400,619	475,228	412,898	465,618	368,348	425,029	382,308	423,101	331,429	382,005	354,949	333,803	269,312	304,072	321,906	306,641	248,855	295,689	312,885	291,157	234,597	248,597	265,843	245,570	204,494	217,560	225,424	225,291	188,318	201,829	212,350	196,231	152,380	160,467	168,641	179,919	158,038	151,568	159,119	158,988	138,324	141,374	147,159	160,981	141,275	134,923	149,314	137,551	120,080	120,454	127,138	130,519	115,107	115,141	118,782	115,253	111,498	112,053	120,565	125,245	108,384	103,407	106,684	104,791	81,389	79,301	84,473	81,916	71,688	68,098	73,139	75,617	65,639	57,950	59,288	61,466	53,976	50,672	50,783	51,582	45,689	47,611	48,004	51,683	50,772	53,993	56,482	56,839	57,266	62,361	63,294	62,686	58,400	55,900	57,900	58,000	47,900	43,900	49,200	51,700	47,300	48,700	46,500	62,300	66,600	63,200	59,500	55,800	47,300	37,100	34,200	29,600	25,800	23,100	23,600	24,400	21,400	18,200	16,100	14,000	11,900	10,500	30,200	7,700	10,500	4,500	4,600	-
Net Tangible Assets	0	0	638,723	383,798	149,270	20,739	886	173,642	689,992	754,754	747,460	406,141	336,198	149,009	-18,082	-183,485	-120,719	-45,415	-81,900	-202,454	-265,827	-260,070	-276,137	-292,187	-297,825	-293,394	-329,094	-300,377	-332,735	-173,668	-239,024	-309,120	-318,968	-277,934	-228,754	-202,821	-132,056	-6,359	215,699	274,469	278,821	292,471	320,040	397,759	398,396	379,530	354,377	323,345	297,760	385,317	401,539	389,655	369,371	340,463	323,136	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Net Working Capital	543,707	414,037	295,166	83,817	-134,326	-131,086	-123,722	118,431	192,076	304,188	349,417	477,136	479,977	341,838	239,028	-124,890	-45,698	76,755	93,389	8,027	-116,272	-55,340	-34,484	-27,131	-32,582	-53,821	-82,835	-57,489	-88,984	67,892	-1,666	-69,662	-35,127	8,630	57,606	5,464	-61,508	72,357	101,355	165,993	174,353	32,271	63,231	154,818	163,204	154,928	136,156	107,582	87,348	174,383	195,434	192,871	175,479	158,978	139,352	109,202	120,033	187,164	171,227	75,640	60,598	45,627	40,012	57,340	82,271	84,579	68,899	108,341	177,520	175,162	148,473	182,591	192,679	202,158	214,080	201,293	201,640	266,443	282,192	280,278	269,853	269,401	243,971	239,889	213,441	179,104	163,483	172,049	164,199	161,915	156,664	141,119	141,781	146,211	178,709	168,856	156,900	174,000	195,500	183,900	184,800	219,400	213,500	196,200	199,900	201,100	229,500	225,600	250,600	238,200	245,800	240,400	228,600	235,000	79,400	79,600	76,500	71,200	68,800	66,500	62,500	57,400	53,800	51,500	48,000	46,700	45,100	14,700	19,800	22,300	-	-
Non Current Assets Total	1,764,671	1,702,174	1,691,781	1,658,952	1,645,288	1,581,208	1,564,360	1,502,917	1,481,548	1,447,707	1,410,923	1,229,587	1,231,823	1,178,728	1,181,101	1,164,894	1,152,836	1,048,099	1,011,939	983,322	883,177	840,333	780,853	767,785	741,431	726,612	718,479	693,503	685,120	672,270	668,131	669,641	653,359	643,814	644,336	622,105	624,813	588,011	581,486	579,158	577,810	570,015	549,169	538,243	534,065	522,577	512,010	516,239	506,587	458,447	457,004	444,037	436,553	432,386	423,183	425,915	432,189	429,162	414,173	402,721	409,547	425,316	425,825	414,491	396,516	380,484	363,701	349,738	257,297	233,078	229,584	194,283	191,431	192,954	192,919	201,574	212,645	151,984	151,960	156,207	151,286	139,861	133,764	119,217	127,532	140,594	141,816	142,213	137,531	126,952	119,327	116,026	119,966	120,193	110,341	119,957	127,800	138,900	138,200	138,100	127,200	102,700	100,500	110,300	102,800	103,900	92,700	97,800	72,200	70,800	53,000	48,300	50,500	35,800	32,600	25,900	23,200	23,000	21,600	20,700	21,200	21,600	22,100	22,400	22,300	22,100	22,200	22,400	11,700	7,400	4,500	-
Non Current Liabilities Other	0	199,991	190,674	199,480	199,688	198,823	204,783	200,708	208,427	203,104	232,038	205,975	208,806	198,545	210,568	195,678	197,379	191,764	200,812	207,214	145,523	144,041	83,267	84,573	95,718	49,583	49,230	42,020	38,937	34,594	30,328	30,361	28,698	29,660	31,334	31,027	32,363	31,588	30,664	31,760	31,215	28,775	25,760	24,819	23,898	22,888	21,260	20,021	17,730	15,279	12,954	12,284	11,045	12,426	11,722	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Non Current Liabilities Total	823,848	818,804	893,086	901,668	902,225	974,123	983,630	981,550	983,632	996,435	1,012,117	1,003,288	1,079,005	1,079,451	1,146,729	931,949	929,313	922,132	933,779	939,479	776,138	786,356	787,218	789,636	762,691	721,182	721,751	709,926	704,349	685,176	674,963	673,766	702,227	691,247	693,391	593,490	445,716	430,897	229,911	232,899	233,949	67,391	62,809	61,766	61,012	59,970	58,225	56,940	54,342	46,862	43,627	40,000	37,751	44,712	38,258	37,985	37,643	116,692	114,826	32,533	31,951	33,616	37,376	38,195	40,464	44,923	48,048	45,995	24,956	20,655	21,023	13,627	14,800	13,986	14,538	15,422	16,625	9,227	10,095	9,540	7,847	6,203	5,641	5,755	6,200	0	0	0	0	0	0	0	0	0	0	0	400	4,200	4,200	4,200	4,200	100	0	0	1,400	0	100	0	100	-100	0	0	0	-100	0	0	-100	0	0	100	100	0	0	100	-100	0	0	0	0	100	-	-
Non Currrent Assets Other	448,476	1,015,073	1,008,511	476,113	425,632	299,745	420,574	300,463	397,369	282,493	372,810	255,979	337,152	234,005	144,773	228,008	299,042	203,224	186,131	179,620	170,218	152,919	131,755	120,477	100,969	97,353	94,603	89,946	327,698	61,994	62,247	63,531	320,333	35,551	31,399	27,357	321,226	16,227	12,054	14,603	296,596	15,353	17,283	15,208	288,888	52,961	291,430	299,312	47,991	43,954	39,606	34,076	29,334	25,625	25,344	21,014	18,614	17,646	224,513	15,265	11,636	15,282	17,084	18,616	11,606	17,738	15,333	13,573	6,237	9,190	7,756	7,755	6,988	-5,755	-5,956	-6,453	-7,626	-8,254	-8,298	-7,402	44,296	-10,348	-10,333	-9,857	-8,539	3,927	92,304	92,776	88,316	77,923	58,463	57,759	74,305	78,440	70,837	80,635	88,200	98,800	96,900	96,400	85,700	62,600	60,100	68,800	61,800	61,400	51,600	58,900	35,800	35,200	23,000	22,400	25,000	1,600	1,700	1,600	1,600	1,400	900	400	300	400	400	400	300	400	100	200	700	600	500	-
Noncontrolling Interest In Consolidated Entity	0	0	0	0	0	0	0	0	0	706	763	739	707	539	437	381	352	304	303	308	280	241	278	290	264	231	228	178	139	136	140	135	130	89	83	57	73	83	62	36	28	49	45	41	34	28	8	5	14	26	37	40	46	38	16	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Other Assets	0	0	0	390,900	387,479	373,190	398,553	335,568	893,881	874,322	860,668	685,624	676,656	254,802	256,754	248,965	240,192	224,705	207,256	150,149	189,593	171,887	151,822	140,624	362,335	359,099	353,700	332,270	327,698	322,606	320,970	326,631	320,333	323,477	318,295	312,278	321,226	296,310	294,774	296,932	296,596	295,857	282,675	284,501	288,888	290,938	291,430	299,312	289,810	244,579	246,841	241,289	234,828	231,776	226,469	228,852	232,243	232,620	224,513	216,013	219,901	246,661	259,221	263,397	254,664	253,619	245,895	240,942	157,669	141,913	140,789	127,010	125,734	128,018	129,198	138,830	150,015	93,655	95,451	107,814	106,062	88,029	82,892	70,454	78,077	90,963	92,304	92,776	88,316	77,923	71,201	70,497	74,305	78,440	70,837	80,635	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Other Current Assets	203,595	205,861	189,188	201,043	220,489	33,512	183,000	21,817	173,823	17,393	145,392	12,043	137,508	9,108	11,308	17,085	124,982	14,966	12,561	13,169	108,220	12,754	11,908	8,839	101,140	12,881	13,031	15,800	91,206	10,034	6,815	8,843	101,898	6,552	10,045	117,933	124,140	60,154	48,829	43,905	82,183	35,553	63,832	33,082	66,281	35,055	62,632	57,290	40,321	29,934	24,034	21,387	29,508	19,488	19,974	16,240	18,890	15,993	38,887	21,745	28,121	19,624	13,019	12,130	14,509	11,259	11,793	10,530	11,328	10,793	9,544	10,524	11,679	10,047	9,689	9,572	8,797	6,038	5,788	20,128	6,800	5,882	5,819	5,801	6,267	5,950	5,998	5,337	4,812	5,877	5,753	5,901	17,426	22,932	21,290	21,622	67,900	19,000	58,500	53,400	50,900	52,100	55,300	48,800	59,700	53,900	48,200	41,900	59,000	56,100	56,700	58,300	37,200	18,700	19,400	21,000	26,700	29,200	25,400	20,700	21,900	17,700	15,900	15,500	15,500	19,700	1,600	3,900	1,500	9,400	900	-
Other Current Liab	478,712	420,312	399,425	403,595	433,662	386,840	387,510	388,991	458,909	410,609	392,681	348,970	415,648	345,728	292,295	231,686	322,938	263,824	241,326	215,195	260,683	238,431	228,380	210,384	253,418	220,507	210,181	174,763	236,131	202,074	188,842	178,267	205,530	203,738	190,441	177,942	195,351	167,449	147,245	134,519	148,919	134,161	123,470	118,470	137,746	134,664	128,478	126,092	141,383	136,799	121,898	107,650	118,598	108,184	99,629	94,616	104,959	102,706	100,218	91,477	104,616	103,659	103,966	88,300	107,248	99,350	92,265	75,960	90,715	84,434	89,476	2,237	78,208	70,229	68,093	62,951	73,785	67,006	60,700	62,756	72,807	66,597	57,405	51,497	51,710	58,486	47,911	38,845	38,890	39,091	34,090	33,430	51,863	61,517	64,755	53,071	52,600	54,800	56,500	48,000	46,500	49,300	53,400	53,400	57,700	56,600	27,300	27,300	29,400	30,500	26,600	21,800	20,900	21,800	21,400	17,200	12,800	14,200	12,400	10,000	7,100	8,500	6,500	6,200	5,100	4,800	4,900	4,000	3,500	3,900	5,700	-
Other Liab	0	0	196,242	107,129	106,594	120,175	117,586	118,527	208,427	218,410	232,038	224,541	220,513	155,434	178,505	169,159	162,828	159,012	163,896	171,190	174,790	183,940	184,088	180,631	131,263	83,828	83,357	75,094	71,952	65,468	60,586	58,148	55,753	55,120	55,205	53,377	54,028	53,137	51,096	51,024	49,642	43,904	39,382	37,670	36,590	37,544	34,647	32,096	28,553	23,381	19,509	16,798	15,672	20,582	16,462	16,120	15,079	16,104	16,313	15,298	14,924	17,194	19,798	20,055	20,040	24,356	26,670	24,853	11,355	9,058	9,166	7,945	8,774	7,542	7,674	7,303	7,264	7,224	8,050	8,127	6,825	5,120	5,304	5,716	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Other Stockholder Equity	-2,899,586	-2,888,497	-2,881,031	-2,906,599	-2,923,715	-2,881,138	-2,732,378	-2,437,959	-2,187,652	-1,961,539	-1,797,258	-1,628,288	-1,500,538	-1,508,932	-1,535,194	-1,553,317	-1,382,564	-1,267,728	-1,195,034	-1,189,567	-1,146,159	-1,052,213	-998,092	-905,882	-831,609	-789,674	-753,119	-655,505	-616,034	-408,414	-415,033	-411,037	-370,474	-285,617	-210,562	-1,674,048	-1,559,907	-1,432,109	-1,169,522	-1,052,362	-998,948	-940,932	-875,463	-740,947	-695,340	-669,302	-648,281	-630,631	-613,113	-531,993	-478,387	-434,727	-414,569	-403,746	-382,867	-376,384	-329,661	-311,727	-305,544	-288,856	-279,051	-276,391	-267,375	-223,149	-181,895	-165,243	-169,912	-119,240	-97,833	-91,407	-94,141	-59,128	-34,702	-5,516	25,107	36,530	62,490	95,369	130,420	157,459	163,800	169,013	155,317	156,257	155,991	208,557	209,114	227,994	219,211	216,549	211,177	199,426	209,962	227,676	257,856	264,282	265,800	297,100	329,200	323,100	317,800	299,500	294,600	289,800	286,800	285,400	283,100	280,000	278,200	271,700	256,500	236,500	233,900	232,800	79,300	77,700	76,100	74,800	74,600	73,900	73,200	73,000	34,400	71,700	70,000	70,100	70,200	41,200	36,000	35,300	35,500	-
Preferred Stock Redeemable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Preferred Stock Total Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Property Plant And Equipment Gross	1,602,493	804,883	797,418	665,439	649,474	722,508	0	0	0	0	654,978	637,528	646,338	632,359	633,302	624,770	614,452	575,561	551,537	529,697	437,270	409,980	394,021	384,246	379,096	367,513	364,779	361,233	357,422	349,664	347,161	343,010	333,026	320,337	326,041	309,827	303,587	291,701	286,712	282,226	281,214	274,158	266,494	253,742	245,177	231,639	220,580	216,927	216,777	213,868	210,163	202,748	201,725	200,610	196,714	197,063	199,946	196,542	189,660	186,708	189,646	178,655	166,604	151,094	141,852	126,865	117,806	108,796	99,628	91,165	88,795	67,273	65,697	64,936	63,721	62,744	62,630	58,329	56,509	48,393	45,224	51,832	50,872	48,763	49,455	49,631	49,512	49,437	49,215	49,029	48,126	45,529	45,661	41,753	39,504	39,322	39,600	40,100	41,300	41,700	41,500	40,100	40,400	41,500	41,000	42,500	41,100	38,900	36,400	35,600	30,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Property Plant And Equipment Net	702,177	687,101	683,270	665,439	649,474	722,508	594,224	701,193	587,667	680,347	550,255	637,528	555,167	632,359	633,302	624,770	533,845	575,561	551,537	529,697	437,270	409,980	394,021	384,246	379,096	367,513	364,779	361,233	357,422	349,664	347,161	343,010	333,026	320,337	326,041	309,827	303,587	291,701	286,712	282,226	281,214	274,158	266,494	253,742	245,177	231,639	220,580	216,927	216,777	213,868	210,163	202,748	201,725	200,610	196,714	197,063	199,946	196,542	189,660	186,708	189,646	178,655	166,604	151,094	141,852	126,865	117,806	108,796	99,628	91,165	88,795	67,273	65,697	64,936	63,721	62,744	62,630	58,329	56,509	48,393	45,224	51,832	50,872	48,763	49,455	49,631	49,512	49,437	49,215	49,029	48,126	45,529	45,661	41,753	39,504	39,322	39,600	40,100	41,300	41,700	41,500	40,100	40,400	41,500	41,000	42,500	41,100	38,900	36,400	35,600	30,000	25,900	25,500	23,900	20,100	16,200	13,400	13,000	12,600	12,000	12,000	12,000	12,200	12,000	11,700	11,400	11,400	11,400	11,000	6,800	4,000	-
Property Plant Equipment	0	0	683,270	665,439	649,474	612,405	594,224	593,457	587,667	573,385	550,255	543,963	555,167	547,624	550,895	546,158	533,845	496,584	469,982	449,103	437,270	409,980	394,021	384,246	379,096	367,513	364,779	361,233	357,422	349,664	347,161	343,010	333,026	320,337	326,041	309,827	303,587	291,701	286,712	282,226	281,214	274,158	266,494	253,742	245,177	231,639	220,580	216,927	216,777	213,868	210,163	202,748	201,725	200,610	196,714	197,063	199,946	196,542	189,660	186,708	189,646	178,655	166,604	151,094	141,852	126,865	117,806	108,796	99,628	91,165	88,795	67,273	65,697	64,936	63,721	62,744	62,630	58,329	56,509	48,393	45,224	51,832	50,872	48,763	49,455	49,631	49,512	49,437	49,215	49,029	48,126	45,529	45,661	41,753	39,504	39,322	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Retained Earnings	4,444,571	4,250,050	4,037,819	3,813,583	3,599,529	3,427,322	3,246,384	3,114,405	2,920,440	2,757,669	2,582,434	2,379,852	2,175,595	2,000,805	1,854,586	1,705,646	1,595,648	1,505,152	1,396,315	1,270,609	1,167,928	1,082,292	989,039	880,348	803,545	765,288	694,777	609,420	540,401	488,033	431,577	364,375	318,356	274,005	231,070	1,721,893	1,675,299	1,649,337	1,597,196	1,539,978	1,493,393	1,450,135	1,404,448	1,350,453	1,305,593	1,262,239	1,219,386	1,168,069	1,127,326	1,089,316	1,050,809	1,002,152	965,540	929,169	894,475	857,282	824,256	793,305	761,769	728,102	702,031	678,476	652,777	613,413	585,862	560,334	534,539	512,875	490,614	465,942	440,989	415,209	396,936	376,909	356,305	336,372	318,682	301,747	282,051	258,141	240,350	227,985	212,012	195,322	183,260	170,503	158,020	145,056	137,871	128,043	117,826	107,860	100,251	90,450	81,181	71,653	63,600	54,800	46,300	38,300	31,000	61,100	55,100	50,000	46,300	49,300	66,200	68,300	67,400	58,100	60,100	52,200	45,200	38,100	32,700	27,800	23,700	19,400	15,800	13,200	10,400	6,000	41,500	2,100	400	-1,300	-2,900	-4,100	-4,500	-5,700	-6,800	-
Retained Earnings Total Equity	0	0	4,037,819	3,813,583	3,599,529	3,427,322	3,246,384	3,114,405	2,920,440	2,757,669	2,582,434	2,379,852	2,175,595	2,000,805	1,854,586	1,705,646	1,595,648	1,505,152	1,396,315	1,270,609	1,167,928	1,082,292	989,039	880,348	803,545	765,288	694,777	609,420	540,401	488,033	431,577	364,375	318,356	274,005	231,070	1,721,893	1,675,299	1,649,337	1,597,196	1,539,978	1,493,393	1,450,135	1,404,448	1,350,453	1,305,593	1,262,239	1,219,386	1,168,069	1,127,326	1,089,316	1,050,809	1,002,152	965,540	929,169	894,475	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Short Long Term Debt	324,997	399,990	338,991	506,486	653,982	633,000	611,000	400,000	148,496	74,990	124,982	124,971	49,988	49,983	121,596	486,824	288,765	229,500	251,528	346,998	398,937	414,500	437,000	407,500	655,000	686,250	1,304,891	671,000	611,000	488,000	558,000	0	573,000	0	0	0	549,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Short Long Term Debt Total	947,880	1,018,803	1,035,835	1,202,848	1,348,369	1,506,094	1,378,995	1,283,576	923,701	963,173	905,061	999,818	908,480	990,552	1,106,228	1,265,023	987,675	1,007,277	1,036,414	1,129,219	1,000,285	1,016,916	1,040,130	1,016,505	1,261,075	1,290,399	1,304,891	1,265,868	1,204,110	1,087,137	1,155,958	1,222,021	1,170,085	1,142,056	1,096,925	1,049,500	899,000	725,000	534,000	466,140	428,394	398,843	369,521	262,263	214,501	234,736	246,966	257,194	246,418	157,638	136,404	130,661	133,280	130,401	138,556	162,283	123,884	147,887	160,280	171,190	156,479	169,853	164,065	146,222	78,683	83,901	90,539	82,175	7,125	7,290	7,450	551	551	542	531	526	1,683	1,174	1,215	1,397	1,280	489	482	984	973	964	950	8,398	8,380	8,507	8,495	8,473	8,472	8,525	3,376	3,519	3,600	8,400	9,500	9,800	9,400	1,500	2,500	2,600	4,100	3,500	4,500	4,500	3,000	3,000	0	0	1,700	1,700	1,700	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Short Term Debt	324,997	399,990	338,991	506,486	653,982	652,152	611,000	420,564	148,496	95,428	124,982	142,878	49,988	66,581	138,069	502,317	288,765	244,302	266,531	360,930	398,937	414,500	437,000	407,500	655,000	686,250	704,000	671,000	611,000	488,000	558,000	622,000	573,000	542,500	498,000	549,500	549,000	375,000	384,000	316,050	278,035	398,219	368,637	261,122	213,107	232,960	244,945	254,931	243,917	154,903	133,438	127,467	129,862	126,762	134,700	158,213	119,603	63,398	75,586	166,294	151,385	164,696	158,715	140,682	72,956	77,990	84,447	75,904	678	665	655	62,796	551	542	531	526	1,291	674	715	744	494	489	482	984	973	964	950	8,398	8,380	8,507	8,495	8,473	8,472	8,525	3,376	3,519	3,300	4,200	5,300	5,600	5,200	1,500	2,500	2,600	4,100	3,500	4,500	4,500	3,000	3,000	0	0	1,700	1,700	1,700	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Short Term Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	284,255	285,085	256,923	239,933	236,949	241,402	229,063	217,617	213,591	208,399	180,870	139,215	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	35,000	35,000	43,641	27,034	57,658	65,580	71,688	78,603	65,622	90,116	50,040	48,057	28,911	33,988	39,323	38,691	41,980	33,403	22,329	21,585	15,373	12,893	10,328	18,721	17,682	29,196	47,278	50,763	41,981	0	46,200	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Temporary Equity Redeemable Noncontrolling Interests	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Total Assets	3,259,925	3,086,404	2,870,806	2,808,398	2,746,765	2,640,067	2,607,185	2,592,689	2,437,203	2,385,744	2,412,149	2,327,385	2,294,561	2,047,407	1,960,713	1,886,245	1,832,475	1,751,481	1,724,237	1,680,968	1,537,349	1,544,530	1,520,685	1,469,492	1,713,416	1,669,334	1,637,137	1,572,091	1,530,704	1,500,370	1,489,241	1,478,647	1,474,993	1,477,210	1,477,370	1,431,014	1,384,211	1,290,632	1,283,193	1,262,324	1,230,516	1,195,238	1,164,071	1,132,638	1,103,602	1,093,351	1,067,317	1,061,105	1,030,814	969,199	950,575	909,478	897,144	862,297	833,735	824,284	808,527	814,889	798,510	770,504	765,437	778,693	764,889	736,857	702,179	674,233	646,169	646,494	559,560	524,972	501,378	475,242	490,676	492,630	500,250	487,918	514,237	512,404	523,201	523,085	521,875	497,219	465,908	436,918	416,652	410,814	375,549	395,364	373,107	362,884	342,612	322,588	335,796	354,360	376,089	361,802	360,200	383,100	409,200	387,600	390,500	380,400	385,600	375,500	377,000	375,000	377,900	372,700	373,900	356,600	348,800	324,500	312,500	302,800	145,100	135,900	121,700	116,700	113,000	106,200	98,000	93,000	88,300	85,100	79,700	77,900	77,100	46,500	38,100	36,200	35,500	-
Total Current Assets	1,495,254	1,384,230	1,179,025	1,149,446	1,101,477	1,058,859	1,042,825	1,089,772	955,655	938,037	1,001,226	1,097,798	1,062,738	868,679	779,612	721,351	679,639	703,382	712,298	697,646	654,172	704,197	739,832	701,707	971,985	942,722	918,658	878,588	845,584	828,100	821,110	809,006	821,634	833,396	833,034	808,909	759,398	702,621	701,707	683,166	652,706	625,223	614,902	594,395	569,537	570,774	555,307	544,866	524,227	510,752	493,571	465,441	460,591	429,911	410,552	398,369	376,338	385,727	384,337	367,783	355,890	353,377	339,064	322,366	305,663	293,749	282,468	296,756	302,263	291,894	271,794	280,959	299,245	299,676	307,331	286,344	301,592	360,420	371,241	366,878	370,589	357,358	332,144	317,701	289,120	270,220	233,733	253,151	235,576	235,932	223,285	206,562	215,830	234,167	265,748	241,845	232,400	244,200	271,000	249,500	263,300	277,700	285,100	265,200	274,200	271,100	285,200	274,900	301,700	285,800	295,800	276,200	262,000	267,000	112,500	110,000	98,500	93,700	91,400	85,500	76,800	71,400	66,200	62,700	57,400	55,800	54,900	24,100	26,400	28,800	31,000	-
Total Current Liabilities	951,547	970,193	883,859	1,065,629	1,235,803	1,189,945	1,166,547	971,341	763,579	633,849	651,809	620,662	582,761	526,841	540,584	846,241	725,337	626,627	618,909	689,619	770,444	759,537	774,316	728,838	1,004,567	996,543	1,001,493	936,077	934,568	760,208	822,776	878,668	856,761	824,766	775,428	803,445	820,906	630,264	600,352	517,173	478,353	592,952	551,671	439,577	406,333	415,846	419,151	437,284	436,879	336,369	298,137	272,570	285,112	270,933	271,200	289,167	256,305	198,563	213,110	292,143	295,292	307,750	299,052	265,026	223,392	209,170	213,569	188,415	124,743	116,732	123,321	98,368	106,566	97,518	93,251	85,051	99,952	93,977	89,049	86,600	100,736	87,957	88,173	77,812	75,679	91,116	70,250	81,102	71,377	74,017	66,621	65,443	74,049	87,956	87,039	72,989	75,500	70,200	75,500	65,600	78,500	58,300	71,600	69,000	74,300	70,000	55,700	49,300	51,100	47,600	50,000	35,800	33,400	32,000	33,100	30,400	22,000	22,500	22,600	19,000	14,300	14,000	12,400	11,200	9,400	9,100	9,800	9,400	6,600	6,500	6,800	-
Total Liab	1,775,395	1,788,997	1,776,945	1,967,297	2,138,028	2,164,068	2,150,177	1,952,891	1,747,211	1,630,284	1,663,926	1,623,950	1,661,766	1,606,292	1,687,313	1,778,190	1,654,650	1,548,759	1,552,688	1,629,098	1,546,582	1,545,893	1,561,534	1,518,474	1,767,258	1,717,725	1,723,244	1,646,003	1,638,917	1,445,384	1,497,739	1,552,434	1,558,988	1,516,013	1,468,819	1,396,935	1,266,622	1,061,161	830,263	750,072	712,302	660,343	614,480	501,343	467,345	475,816	477,376	494,224	491,221	383,231	341,764	312,570	322,863	315,645	309,458	327,152	293,948	315,255	327,936	324,676	327,243	341,366	336,428	303,221	263,856	254,093	261,617	234,410	149,699	137,387	144,344	111,995	121,366	111,504	107,789	100,473	116,577	103,204	99,144	96,140	108,583	94,160	93,814	83,567	75,679	91,116	70,250	81,102	71,377	74,017	66,621	65,443	74,049	87,956	87,039	72,989	75,900	74,400	79,700	69,800	82,700	58,400	71,600	69,000	74,300	70,000	55,800	49,300	51,200	47,500	50,000	35,800	33,400	31,900	33,100	30,400	21,900	22,500	22,600	19,100	14,400	14,000	12,400	11,300	9,300	9,100	9,800	9,400	6,600	6,600	6,800	-
Total Permanent Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-58,818	-40,849	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Total Stockholder Equity	1,484,530	1,297,407	1,093,861	841,101	608,737	475,999	457,008	639,798	689,992	754,754	747,460	702,696	632,088	440,576	272,963	107,674	177,473	202,418	171,246	51,562	-9,513	-1,604	-41,127	-49,272	-54,106	-48,622	-86,335	-74,090	-108,352	54,850	-8,638	-73,922	-84,125	-38,892	8,468	34,022	117,516	229,388	452,868	512,216	518,186	534,846	549,546	631,254	636,223	617,507	589,933	566,876	539,579	585,942	608,774	596,868	574,235	546,614	524,261	497,120	514,569	499,634	470,574	445,828	438,194	437,327	428,461	433,636	438,323	420,140	384,552	412,084	409,861	387,585	357,034	363,059	369,010	380,764	392,229	387,445	397,660	408,729	424,057	426,945	413,292	402,819	372,094	353,351	340,973	319,698	305,299	314,262	301,730	288,867	275,991	257,145	261,747	266,404	289,050	288,813	284,300	308,700	329,500	317,800	307,800	322,000	314,000	306,500	302,700	305,000	322,100	323,400	322,700	309,100	298,800	288,700	279,100	270,900	112,000	105,500	99,800	94,200	90,400	87,100	83,600	79,000	75,900	73,800	70,400	68,800	67,300	37,100	31,500	29,600	28,700	-
Treasury Stock	0	0	0	0	0	0	-4,157,257	-3,843,749	-3,570,691	-3,326,021	-3,142,301	-2,953,923	-2,799,890	-2,788,412	-2,788,052	-2,788,310	-2,600,543	-2,461,698	-2,370,377	-2,350,034	-2,288,899	-2,185,152	-2,111,647	-2,005,813	-1,911,528	-1,856,307	-1,805,523	-1,691,204	-1,633,443	-1,408,183	-1,392,875	-1,369,412	-1,316,417	-1,222,812	-1,137,616	-2,591,714	-2,453,266	-2,303,575	-2,031,125	-1,904,604	-1,829,378	-1,744,319	-1,667,709	-1,525,023	-1,457,184	-1,415,940	-1,379,676	-1,352,169	-1,320,376	-1,230,848	-1,163,102	-1,104,504	-1,060,647	-1,034,658	-1,001,081	-975,061	-914,759	-889,581	-871,206	-846,448	-830,390	-820,468	-800,325	-749,318	-696,668	-677,509	-670,359	-612,644	-577,826	-565,947	-557,339	-514,791	-472,096	-437,127	-398,718	-377,867	-348,327	-313,140	-277,206	-241,545	-219,449	-206,759	-206,759	-192,512	-178,357	-178,357	-178,357	-147,465	-147,465	-147,465	-147,465	-147,465	-134,479	-117,067	-83,573	-72,247	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Warrants	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-

Cash Flow

Currency in USD. All numbers in thousands.

	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31	2000-12-31	1999-12-31	1998-12-31	1997-12-31	1996-12-31	1995-12-31	1994-12-31	1993-12-31	1992-12-31	1991-12-31
Begin Period Cash Flow	112,546	144,454	383,928	90,326	123,794	187,675	154,901	128,994	322,536	279,058	223,986	183,895	156,915	106,728	78,868	60,360	61,666	67,151	47,156	96,942	113,788	66,666	46,007	58,576	109,100	107,000	127,700	149,300	25,200	18,900	18,000	9,300	7,600
Capital Expenditures	133,631	148,838	119,549	107,626	155,224	122,936	76,704	64,787	82,921	60,698	78,636	69,050	100,221	39,302	57,843	89,971	66,244	71,355	24,199	31,705	16,896	15,087	17,381	15,520	12,400	48,100	35,500	11,800	15,900	4,400	2,100	2,300	9,400
Cash And Cash Equivalents Changes	0	-23,302	-234,835	290,271	-32,779	-63,881	32,774	25,907	-193,542	43,478	55,072	40,091	26,980	50,187	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash Flows Other Operating	0	-113,868	-62,696	46,865	-47,148	-47,450	47,418	8,119	18,087	-25,073	-4,325	3,933	-1,339	-13,208	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change In Cash	341,386	-31,908	-239,474	293,602	-33,468	-63,881	32,774	25,907	-193,542	43,478	55,072	40,091	26,980	50,187	27,860	18,508	-1,306	-5,485	19,995	-49,786	72,929	47,122	20,659	-12,569	-50,500	2,100	-20,800	-21,500	124,000	6,200	900	7,900	1,700
Change In Working Capital	-72,429	-273,530	-137,523	-31,761	-104,969	-91,640	8,380	3,002	-69,811	-9,718	-3,063	2,263	6,512	-3,135	-11,559	-33,206	-1,011	-10,236	10,745	-13,637	21,818	33,060	-13,105	-31,254	800	8,100	5,400	-35,000	-20,500	-3,200	-6,100	-8,600	-300
Change Receivables	0	-41,398	-33,141	-60,722	-22,472	-18,401	-24,918	-22,554	-50,142	-3,626	-15,946	3,487	-24,809	-6,914	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change To Account Receivables	-53,871	-41,398	-33,141	-60,722	-22,472	-18,401	-24,918	-22,554	-50,142	-3,626	-15,946	3,487	-24,809	-6,914	-1,155	-10,266	-25,535	-6,583	-5,162	-5,162	-5,567	7,800	5,554	1,077	0	0	0	0	0	0	0	0	0
Change To Inventory	-28,651	-121,731	-52,919	-18,885	-37,306	-25,623	-19,062	7,648	-34,969	-38,310	-1,347	-13,752	-6,310	-19,469	6,223	-18,468	-5,230	-25,679	7,433	758	71	11,405	-20,319	-28,506	5,200	4,900	-11,200	-19,200	-7,400	-6,200	-1,600	-4,300	-600
Change To Liabilities	0	3,467	11,233	981	1,957	-166	4,942	9,789	-2,787	57,290	18,555	8,595	38,789	36,456	0	1,144	37,775	22,234	15,085	0	26,112	14,665	734	0	0	0	0	0	0	0	0	0	0
Change To Netincome	0	25,525	148,224	1,695	48,324	31,504	18,449	30,454	23,652	4,726	6,669	-2,676	4,413	-5,308	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change To Operating Activities	0	-102,849	-137,523	-31,761	-34,788	-39,731	47,418	12,491	23,525	11,319	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	114,908	111,900	104,596	95,998	88,011	83,178	83,140	78,218	68,956	58,888	54,596	52,408	48,202	45,956	49,773	48,819	41,100	29,816	24,369	18,427	18,897	20,124	22,229	19,481	17,200	15,900	14,400	10,400	5,700	4,500	3,800	3,500	1,000
Dividends Paid	0	0	-46,565	-51,328	36,106	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
End Period Cash Flow	453,932	112,546	144,454	383,928	90,326	123,794	187,675	154,901	128,994	322,536	279,058	223,986	183,895	156,915	106,728	78,868	60,360	61,666	67,151	47,156	186,717	113,788	66,666	46,007	58,600	109,100	106,900	127,800	149,200	25,100	18,900	17,200	9,300
Exchange Rate Changes	0	0	0	0	0	-4,768	6,202	-54	-5,948	-8,517	-2,414	1,157	933	1,313	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Free Cash Flow	772,879	394,146	635,997	540,437	303,934	277,148	296,572	269,784	133,443	175,148	167,360	161,232	120,479	139,531	115,875	53,372	68,880	38,471	92,353	63,674	100,259	88,166	28,983	12,720	40,200	-2,000	-22,000	-3,800	-9,100	10,400	5,300	-2,400	-5,600
Investments	-144,048	-195,350	-292,967	-109,376	-205,528	284,038	-47,405	-24,035	-215,183	5,400	0	0	0	-4,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Issuance Of Capital Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Borrowings	0	430,065	23,500	-94,650	-10,429	-256,040	44,000	37,944	272,717	469,200	212,917	-31,917	113,040	9,330	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income	845,042	679,089	744,844	582,131	427,792	377,047	263,269	222,054	192,135	181,951	187,794	178,287	161,754	141,320	122,235	116,169	94,014	93,678	78,254	78,332	57,090	45,389	37,620	36,632	32,600	-15,200	-21,100	32,600	21,500	13,300	9,700	4,900	3,200
Other Cashflows From Financing Activities	-13,110	498,634	114,925	244,627	133,577	36,935	82,622	86,262	306,429	516,114	266,417	38,842	158,711	57,134	21,560	102,147	79,259	8,530	-2,057	-356	-510	-7,462	-144	-3,322	-6,400	-2,600	-1,500	-1,900	1,600	-11,400	100	-20,900	-100
Other Cashflows From Investing Activities	0	-46,512	-173,418	-2,418	-50,559	-29,685	-16,899	-1,964	-10,302	-19,890	-8,447	-513	-44,532	-282	0	0	0	0	0	0	0	0	0	8,534	0	0	0	0	0	0	0	0	0
Other Non Cash Items	7,556	10,820	9,251	8,826	2,884	5,133	2,888	-9,475	57	-14,204	-11,943	-16,658	-17,260	-17,662	-1,624	-4,574	1,319	-8,139	7,526	7,523	20,404	930	0	0	0	37,300	14,800	0	100	200	0	100	-100
Sale Purchase Of Stock	-71,920	-830,317	-762,339	-203,418	-309,711	-378,694	-290,638	-304,086	-401,981	-618,158	-367,761	-132,268	-255,505	-143,090	-83,099	-132,342	-118,387	-105,711	-123,769	-129,191	-35,817	-29,830	-12,986	-70,257	-64,200	0	0	0	0	0	0	0	0
Stock Based Compensation	59,739	49,770	37,755	30,951	39,278	25,157	23,517	19,891	19,884	18,099	16,539	15,952	15,496	13,262	11,623	10,501	8,776	10,842	135	135	138	0	0	0	0	0	0	0	0	0	0	0	0
Total Cash From Financing Activities	-441,996	-370,936	-697,414	-248,416	-286,409	-597,799	-208,016	-217,824	-95,552	-103,438	-102,451	-125,343	-97,657	-86,769	-95,295	-30,790	-18,187	-76,259	-106,985	-110,171	-5,162	-25,343	914	-63,350	-64,000	3,200	1,500	10,000	159,700	2,400	2,400	29,400	14,200
Total Cash From Operating Activities	906,510	542,984	755,546	648,063	459,158	400,084	373,276	334,571	216,364	235,846	245,996	230,282	220,700	178,833	173,718	143,343	135,124	109,826	116,552	95,379	117,155	103,253	46,364	28,240	52,600	46,100	13,500	8,000	6,800	14,800	7,400	-100	3,800
Total Cashflows From Investing Activities	0	-195,350	-292,967	-109,376	-205,528	138,602	-138,688	-90,786	-308,406	-80,413	-86,059	-66,005	-96,996	-43,190	0	0	0	0	12,594	0	0	0	0	24,225	0	0	0	0	0	0	0	0	0

	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-12-31	2003-09-30	2003-06-30	2003-03-31	2002-12-31	2002-09-30	2002-06-30	2002-03-31	2001-12-31	2001-09-30	2001-06-30	2001-03-31	2000-12-31	2000-09-30	2000-06-30	2000-03-31	1999-12-31	1999-09-30	1999-06-30	1999-03-31	1998-12-31	1998-09-30	1998-06-30	1998-03-31	1997-12-31	1997-09-30	1997-06-30	1997-03-31	1996-12-31	1996-09-30	1996-06-30	1996-03-31	1995-12-31	1995-09-30	1995-06-30	1995-03-31	1994-12-31	1994-09-30	1994-06-30	1994-03-31	1993-12-31	1993-09-30	1993-06-30	1993-03-31	1992-12-31	1992-09-30	1992-06-30	1992-03-31	1991-12-31	1991-09-30
Begin Period Cash Flow	331,696	132,838	111,367	112,546	99,176	114,362	204,618	144,454	145,203	232,134	351,163	383,928	175,587	105,293	81,395	90,326	103,996	110,845	116,616	123,794	146,877	174,559	159,229	187,675	169,019	165,975	160,408	154,901	150,072	141,139	132,953	128,994	141,150	163,152	182,160	322,536	292,735	305,048	286,203	279,058	264,811	251,013	228,364	223,986	221,441	201,813	185,491	183,895	181,499	159,398	153,459	156,915	133,512	117,975	106,354	106,728	106,728	103,744	86,295	78,868	84,586	75,265	60,220	60,360	58,507	49,588	53,937	61,666	50,950	50,023	35,339	67,151	57,768	52,354	44,579	47,156	146,534	164,659	180,510	186,717	176,857	151,434	133,451	113,788	105,197	68,570	81,478	66,666	69,037	49,495	34,863	46,007	38,726	73,654	68,369	58,576	74,700	107,100	91,400	109,100	9,100	20,800	108,900	107,000	0	9,400	109,700	127,700	0	10,800	128,700	149,300	154,200	0	34,800	25,200	0	600	22,100	18,900	100	100	18,800	18,000	100	28,900	9,400	9,300	0	0
Capital Expenditures	32,556	34,094	27,470	39,511	39,229	37,685	30,086	41,838	31,788	45,017	22,581	20,163	14,190	19,210	24,556	49,670	45,911	37,326	33,781	38,206	39,844	31,715	27,651	23,726	22,014	16,124	14,919	23,647	14,831	12,088	15,962	21,906	15,404	20,644	23,856	23,017	18,019	17,094	14,112	11,473	17,005	17,273	23,938	20,420	22,262	18,929	14,855	10,346	13,537	13,754	16,598	9,575	10,412	11,309	8,964	8,617	16,035	21,682	12,058	9,302	24,429	22,684	34,232	17,275	65,063	17,934	21,226	91,041	27,621	9,240	27,537	6,957	5,903	6,510	7,250	4,536	8,274	4,525	12,903	6,003	1,790	5,944	6,073	3,089	3,549	4,004	3,741	3,793	5,352	3,822	5,569	2,638	3,823	5,065	3,239	3,393	5,100	1,600	2,000	3,700	41,800	2,300	1,100	2,900	24,100	2,500	3,700	5,200	2,900	3,400	3,700	1,800	1,100	4,900	8,400	3,700	1,400	1,100	1,200	700	200	500	800	600	800	600	400	500	3,800	2,900
Cash And Cash Equivalents Changes	0	0	21,811	-1,680	7,479	-9,026	-81,143	59,388	104	-84,198	-120,925	-29,816	203,642	69,472	22,055	-4,898	-14,887	-4,812	-6,471	-6,609	-23,083	-27,682	15,330	-28,446	18,656	3,044	5,567	5,507	4,829	8,933	8,186	3,959	-12,156	-22,002	-19,008	-140,376	29,801	-12,313	18,845	7,145	14,247	13,798	22,649	4,378	2,545	19,628	16,322	1,596	2,396	22,101	5,939	-3,456	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash Flows Other Operating	0	0	-20,175	-5,916	-22,883	6,088	-43,232	-53,841	-3,248	751	-831	-59,368	26,719	22,301	65,136	-67,291	18,448	-12,925	28	-52,699	17,078	-8,747	-3,479	-52,302	58,152	10,692	17,105	-38,531	-529	16,374	19,790	-27,516	-22,954	8,249	17,313	15,479	-21,698	-425	-4,262	1,312	-9,042	310	-1,894	6,301	3,394	3,375	329	-3,165	-4,395	-4,237	4,631	2,662	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change In Cash	122,236	198,858	21,471	-1,179	13,370	-15,186	-90,256	60,164	-749	-86,931	-119,029	-32,765	208,341	70,294	23,898	-8,931	-13,670	-6,849	-5,771	-7,178	-23,083	-27,682	15,330	-28,446	18,656	3,044	5,567	5,507	4,829	8,933	8,186	3,959	-12,156	-22,002	-19,008	-140,376	29,801	-12,313	18,845	7,145	14,247	13,798	22,649	4,378	2,545	19,628	16,322	1,596	2,396	22,101	5,939	-3,456	23,403	15,537	11,621	-374	0	2,984	17,449	7,427	-5,718	9,321	15,045	-140	1,853	8,919	-4,349	-7,729	10,716	927	14,684	-31,812	9,383	5,414	7,775	-2,577	-99,378	-18,125	-15,851	-6,207	9,860	25,423	17,983	19,663	8,591	36,627	-12,908	14,812	-2,371	19,542	14,632	-11,144	7,281	-34,928	5,285	9,793	-16,100	-32,400	15,700	-17,700	-29,700	9,100	20,800	1,900	1,400	-13,600	9,400	-18,000	2,200	-13,900	10,800	-20,600	1,300	154,200	-3,300	9,600	4,500	-1,800	600	3,200	-2,700	100	100	800	4,000	100	28,900	100	700	-10,500
Change In Working Capital	41,823	16,058	-59,701	-70,609	-43,933	-22,646	-92,709	-114,242	17,229	-27,232	-7,958	-119,562	45,081	18,573	26,127	-121,542	20,479	-8,137	-17,369	-99,942	34,680	-17,593	-23,289	-85,438	62,065	15,671	-2,809	-66,547	12,202	18,772	20,448	-48,420	-2,558	4,391	3,861	-75,504	-19,900	23,360	10,163	-23,342	8,410	16,709	10,107	-38,289	23,040	18,989	-1,087	-38,679	1,201	25,542	2,887	-23,299	6,953	6,769	10,585	-27,442	14,910	-2,676	8,340	-30,874	-11,868	4,486	15,493	-41,622	3,189	756	24,194	-29,150	4,842	-4,931	14,508	-24,655	14,448	10,086	10,009	-23,798	3,077	-1,866	3,938	-18,786	2,615	-6,681	13,969	11,915	-11,490	22,697	11,213	10,640	602	6,573	-190	-20,090	-8,280	-5,104	-5,508	-12,362	4,400	-2,100	11,900	-13,400	-6,800	3,900	10,700	300	-900	4,000	9,100	-6,800	-8,800	-12,800	1,500	-14,900	-12,300	-1,500	-7,300	600	-3,300	-600	2,500	-1,800	-2,800	-2,400	-500	-400	-1,400	-1,900	-3,700	-1,600	-1,100	-100
Change Receivables	0	0	-17,025	-44,133	-6,337	18,733	-16,263	-37,531	15,909	1,671	4,014	-54,735	11,687	-15,132	-19,215	-38,062	1,979	13,248	-4,278	-33,421	14,640	-169	-11,072	-21,800	-6,194	13,676	-12,971	-19,429	-5,907	7,000	-2,143	-21,504	882	6,102	-5,688	-51,438	4,838	1,322	11,921	-21,707	-3,151	11,366	-439	-23,722	3,232	8,447	9,626	-17,818	-8,628	8,032	-9,780	-14,433	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change To Account Receivables	686	6,601	-17,025	-44,133	-6,337	18,733	-16,263	-37,531	15,909	1,671	4,014	-54,735	11,687	-15,132	-19,215	-38,062	1,979	13,248	-4,278	-33,421	14,640	-169	-11,072	-21,800	-6,194	13,676	-12,971	-19,429	-5,907	7,000	-2,143	-21,504	882	6,102	-5,688	-51,438	4,838	1,322	11,921	-21,707	-3,151	11,366	-439	-23,722	3,232	8,447	9,626	-17,818	-8,628	8,032	-9,780	-14,433	2	9,628	849	-17,393	-23	5,969	-1,029	-6,072	-10,266	0	0	-13,543	-25,535	0	0	-16,428	-6,583	0	0	-10,084	-5,162	0	0	-10,728	-5,162	0	0	-6,889	-5,567	0	0	-5,804	7,800	5,143	4,177	0	5,554	2,743	0	-5,242	1,077	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change To Inventory	2,996	7,259	-15,019	-23,887	-22,110	-50,272	-30,495	-18,854	-6,028	-26,479	-12,493	-7,919	6,206	4,163	-14,820	-14,434	-724	-13,671	-8,390	-14,521	1,792	-10,590	-8,755	-8,070	3,904	-4,116	-13,481	-5,369	10,151	-2,717	-1,550	1,764	-7,731	-11,215	-5,881	-10,142	-25,672	-7,063	-7,775	2,200	5,013	-4,706	6,818	-8,472	4,326	-5,182	-4,209	-8,687	3,422	-4,040	-6,589	897	2,991	-9,483	-798	-12,179	14,368	-1,269	1,191	-8,067	-4,331	-7,177	-6,483	-477	-2,508	-4,524	4,885	-3,083	-2,551	-7,518	-3,898	-11,712	10,773	1,990	-3,191	-2,139	11,241	-6,892	-3,064	-527	-5,906	622	-353	5,708	345	341	9,667	1,052	-2,358	-4,195	-2,208	-11,558	-6,116	-7,407	-10,445	-4,538	-1,400	-900	-700	8,200	-12,000	7,900	4,800	4,200	2,500	9,400	-11,600	-11,500	-7,300	100	-6,800	-5,200	-2,800	2,000	-2,700	-3,900	0	-800	-1,800	-3,600	-700	-1,200	500	-200	0	-900	-1,700	-1,700	100	100
Change To Liabilities	0	0	-7,482	3,327	7,397	2,805	-2,719	-4,016	6,850	1,225	-173	2,460	469	7,241	-4,974	-1,755	776	5,211	-4,729	699	1,170	1,913	17	-3,266	6,203	-4,581	6,538	-3,218	8,487	-1,885	4,351	-1,164	27,245	1,255	-1,883	-29,404	22,632	29,526	10,279	-5,147	15,590	9,739	5,622	-12,396	12,088	12,349	-6,833	-9,009	10,802	25,787	14,625	-12,425	34,086	22,554	11,740	165	0	0	0	0	1,144	0	0	0	37,775	13,404	11,909	0	22,234	14,927	16,143	0	15,085	4,866	1,330	0	0	0	0	0	26,112	16,215	22,922	11,273	14,665	29,064	8,096	11,339	734	2,044	0	0	0	3,148	3,651	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change To Netincome	0	0	7,924	12,136	16,434	2,161	-1,542	8,472	106,865	89,636	64,388	14,638	-25,666	3,571	9,437	14,353	21,801	9,118	7,149	10,256	-5,308	14,209	12,547	10,056	-787	3,772	7,008	8,456	15,185	4,597	3,597	7,075	13,870	9,076	2,668	-1,962	5,974	2,219	-340	-3,127	1,154	3,553	1,369	593	-3,524	27	397	424	5,169	-875	-328	447	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change To Operating Activities	0	0	0	-5,307	-15,283	7,163	-41,825	-52,904	-85,562	-99,590	-70,439	-119,562	-62,340	26,039	69,421	-64,881	19,982	-8,948	3,779	-49,601	18,483	-2,433	-3,479	-52,302	47,418	10,692	17,105	-38,531	12,491	12,642	16,026	0	23,525	0	0	0	11,319	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	29,737	28,985	27,855	28,331	28,720	28,547	28,122	26,511	27,695	26,467	25,377	25,057	24,561	24,651	23,582	23,204	22,589	22,446	21,621	21,355	20,604	20,878	20,892	20,804	21,520	20,727	20,586	20,307	20,241	19,767	19,664	18,546	17,729	18,283	16,790	16,154	15,278	15,521	14,695	13,394	13,466	13,773	13,844	13,513	13,918	12,799	12,986	12,705	12,814	12,045	11,879	11,464	11,839	11,485	11,386	11,246	12,555	12,506	11,665	13,047	12,649	12,190	12,585	11,395	11,562	10,267	10,224	9,047	8,079	7,528	7,551	6,658	6,278	6,138	6,137	5,816	5,237	5,128	3,748	4,314	4,640	4,412	4,933	4,912	4,763	5,679	5,008	4,674	6,825	5,082	5,173	5,149	5,379	4,727	4,845	4,530	4,400	4,300	4,200	4,300	4,200	3,800	3,300	4,600	3,900	3,700	3,800	3,000	3,400	3,500	1,400	2,100	1,300	1,700	1,500	1,200	1,400	1,000	1,000	1,100	600	1,000	1,200	1,000	500	1,000	1,100	900	500	100
Dividends Paid	0	-1,382	-284,710	-157,097	0	26,878	0	0	59,572	0	0	0	94,277	0	0	0	28,739	0	0	0	38,201	0	0	0	0	0	0	0	9,185	0	0	0	4,779	0	0	0	157,033	0	0	0	8,066	0	0	0	6,156	0	0	0	62,920	0	0	0	19,047	0	0	0	13,104	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
End Period Cash Flow	453,932	331,696	132,838	111,367	112,546	99,176	114,362	204,618	144,454	145,203	232,134	351,163	383,928	175,587	105,293	81,395	90,326	103,996	110,845	116,616	123,794	146,877	174,559	159,229	187,675	169,019	165,975	160,408	154,901	150,072	141,139	132,953	128,994	141,150	163,152	182,160	322,536	292,735	305,048	286,203	279,058	264,811	251,013	228,364	223,986	221,441	201,813	185,491	183,895	181,499	159,398	153,459	156,915	133,512	117,975	106,354	106,728	106,728	103,744	86,295	78,868	84,586	75,265	60,220	60,360	58,507	49,588	53,937	61,666	50,950	50,023	35,339	67,151	57,768	52,354	44,579	47,156	146,534	164,659	180,510	186,717	176,857	151,434	133,451	113,788	105,197	68,570	81,478	66,666	69,037	49,495	34,863	46,007	38,726	73,654	68,369	58,600	74,700	15,700	91,400	-29,700	9,100	20,800	108,900	1,400	-13,600	9,400	109,700	2,200	-13,900	10,800	128,700	1,300	154,200	-3,300	34,800	4,500	-1,800	600	22,100	-2,700	100	100	18,800	4,000	100	28,900	9,400	700	-10,500
Exchange Rate Changes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-1,081	119	-5,141	1,335	75	1,718	2,477	1,932	-4,396	811	201	3,330	-881	-4,479	1,325	-1,913	-4,223	-5,859	344	1,221	-1,138	1,776	-1,414	-1,638	518	1,100	-781	320	-1,104	-228	996	1,269	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Free Cash Flow	217,295	238,339	172,844	144,401	134,199	151,315	35,764	72,868	178,176	142,188	211,374	104,259	204,744	173,906	183,586	-21,799	109,502	94,939	103,321	-3,828	95,804	78,993	91,179	11,172	99,112	94,560	95,273	7,627	85,284	88,227	94,953	1,320	58,492	56,302	56,310	-37,661	9,284	76,169	67,650	22,045	49,262	62,454	55,380	264	54,532	55,759	48,761	4,838	43,645	61,454	46,494	15,643	38,438	43,589	46,916	10,588	43,414	22,940	46,199	3,322	9,065	18,990	36,697	-20,064	104,994	14,123	43,297	-92,428	10,793	17,384	20,274	-9,980	34,144	31,910	30,553	-4,254	18,898	19,786	20,325	4,665	23,609	20,222	29,973	26,455	5,778	36,161	25,565	20,662	10,404	18,423	9,753	-9,597	5,383	4,662	6,230	-3,555	14,600	9,000	22,000	-5,400	-37,200	11,300	18,100	5,800	-20,500	-500	7,000	-8,000	800	-4,000	7,000	-7,600	-2,700	700	-9,100	2,000	1,100	3,000	4,900	1,400	1,300	700	1,900	1,400	0	100	-1,700	-800	-3,300	-1,900
Investments	-30,435	-27,838	-27,470	-39,511	-49,229	-49,197	-25,000	-41,838	-44,040	-49,677	-174,663	-24,587	-15,690	-19,460	-24,556	-49,670	-95,911	-37,326	-34,085	-38,206	284,038	0	0	284,038	-2,423	-25,363	-16,603	-3,016	2,517	-10,858	-13,801	-1,893	-8,507	-26,345	-43,111	-137,220	5,400	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Issuance Of Capital Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Borrowings	0	0	-161,244	-147,500	-54,435	22,000	211,000	251,500	73,500	-50,000	-50,000	-50,000	-30	-121,940	-170,790	198,110	59,257	-22,025	-95,607	47,946	-15,540	-22,500	29,500	-247,500	-31,250	-17,750	33,000	60,000	123,001	-70,000	-64,000	48,943	29,319	44,428	48,560	150,410	173,951	190,799	66,842	37,608	28,575	29,322	107,258	47,762	-20,235	-12,230	-10,228	10,776	88,780	21,199	5,758	-2,697	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income	194,521	212,231	224,236	214,054	172,207	180,938	131,979	193,965	162,771	175,178	202,606	204,289	174,958	146,321	148,996	111,856	90,544	108,838	125,701	102,709	85,677	93,214	108,680	89,476	38,290	70,514	85,407	69,058	52,371	56,452	67,206	46,025	44,390	44,229	56,938	46,578	25,951	52,163	57,244	46,593	43,237	45,692	53,998	44,867	43,360	42,873	51,320	40,734	37,998	38,496	48,654	36,606	36,380	34,715	37,197	33,028	30,961	31,536	33,667	26,071	23,555	25,699	39,364	27,551	25,528	25,795	21,664	21,027	24,672	24,953	25,780	18,273	20,027	20,604	19,933	17,690	16,935	19,696	23,910	17,791	12,365	15,973	16,690	12,062	12,757	12,483	12,964	7,185	9,828	10,217	9,966	7,609	9,801	9,269	9,528	8,034	8,900	8,400	8,000	7,300	-30,100	6,000	5,100	3,800	-3,100	-16,800	-2,100	900	9,200	8,500	7,900	7,000	7,100	5,400	5,000	4,000	4,300	3,600	2,600	2,800	3,700	2,600	2,000	1,400	1,700	1,500	1,200	500	1,300	1,000
Other Cashflows From Financing Activities	-1,324	-4,973	280,563	155,317	352,107	67,964	214,910	338,153	115,504	10,057	8,277	17,594	176,854	18,110	-161,467	208,320	118,190	8,514	6,868	110,948	3,606	12,424	65,354	14,551	-62,564	-9,606	43,644	72,526	191,753	15,779	-50,111	54,682	22,648	93,797	103,918	170,448	320,514	196,074	72,939	55,572	21,876	36,622	111,482	66,268	4,494	-855	-4,097	21,290	127,838	31,285	19,064	19,187	4,833	1,566	-7,407	48,324	1,343	4,930	-6,436	18,461	-12,271	8,674	18,640	70,149	2,896	-5,492	5,663	76,192	495	2,747	1,158	4,130	-1	-786	1	-1,271	-5,103	588	5,855	-254	-10,952	10,046	9,864	-5,328	-6,784	-4,869	-37,292	-11,860	-13,130	-3,331	-9,369	7,803	-91	-3,102	-129	14,499	-4,800	-28,500	-300	-100	-37,300	-1,000	-100	-1,500	-2,700	-1,000	-2,100	-500	-5,900	-200	-2,200	-1,700	-100	-4,800	1,700	2,200	800	-6,100	-6,400	300	-400	100	-100	500	3,300	100	28,900	-7,000	-100	-11,500
Other Cashflows From Investing Activities	0	0	0	0	0	-11,512	-25,000	-10,000	-12,252	-4,660	-152,082	-4,424	-1,500	-250	0	-668	-50,000	-255	-304	0	-6,735	-22,950	0	0	-2,050	-320	-12,180	-2,349	-1,964	0	0	0	-2,102	-7,817	0	-383	-17,599	-6,355	5,400	-1,336	-822	-10,466	2,841	2,841	-2,658	2,100	43	2,102	-45,155	-2,595	136	3,082	0	0	0	0	0	0	1,377	1,377	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8,534	9,631	9,367	9,565	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non Cash Items	2,104	1,752	1,737	1,963	1,330	2,586	4,577	2,327	-18	3,406	5,344	519	1,110	1,665	1,835	4,216	1,387	750	119	628	119	3,401	522	1,091	976	881	171	860	-4,207	-4,497	-404	-367	-581	7,519	207	-7,089	-6,221	-920	-662	-6,400	-6,177	-876	-365	-4,525	-7,683	-3,457	-1,671	-3,847	-2,434	207	-3,755	-6,019	-8,889	2,495	2,588	-1,740	-1,316	-4,859	2,217	-15	3,324	406	2,307	1,017	-8,260	-897	10,948	-2,888	-7,971	-3,075	1,730	-4,764	1,976	2,319	2,401	830	240	84	2,547	4,606	8,654	11,561	-6	195	-92	-814	-240	240	0	0	0	0	0	0	0	0	2,000	0	-100	100	37,300	-100	100	0	3,700	11,100	-100	100	-100	200	-100	0	100	0	100	-100	100	100	0	0	0	0	-100	0	0	100	100	-100	-200	0
Sale Purchase Of Stock	-36,850	-35,301	-9,676	-9,597	-74,074	-172,793	-306,817	-276,633	-244,817	-181,783	-188,494	-147,245	-11,574	-361	-64	-191,419	-140,689	-86,252	-20,861	-61,705	-105,872	-74,218	-106,562	-92,042	-54,116	-58,265	-107,044	-71,213	-212,524	-15,026	-23,056	-53,480	-92,924	-88,960	-86,450	-133,647	-149,190	-272,342	-126,347	-70,279	-84,851	-76,575	-142,557	-63,778	-41,116	-36,146	-27,376	-27,630	-89,489	-67,597	-58,479	-39,940	-25,933	-33,433	-25,996	-57,728	-25,133	-18,241	-24,739	-14,986	-9,913	-20,098	-50,976	-51,355	-18,703	-7,151	-57,714	-34,819	-11,879	-8,604	-42,533	-42,695	-34,969	-38,409	-20,851	-29,540	-35,187	-35,934	-35,653	-22,417	-12,312	0	-14,248	-9,257	0	0	0	0	12,986	0	0	-12,986	-19,890	-40,806	-1,537	-8,024	-36,900	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Stock Based Compensation	15,223	15,224	15,362	13,930	13,279	12,948	12,370	11,173	9,713	9,530	9,637	8,875	7,943	7,927	7,797	7,284	16,655	9,391	6,898	6,334	6,209	6,596	6,392	5,960	5,755	6,020	6,087	5,655	4,870	5,094	5,005	4,922	5,124	5,118	4,990	4,652	4,636	4,643	4,712	4,108	4,274	4,157	4,159	3,949	4,268	4,012	3,863	3,809	3,999	3,996	3,536	3,965	3,475	3,185	3,258	3,344	2,774	2,908	3,011	2,930	-726	0	0	-131	8,776	0	0	2,416	10,842	3,098	0	2,843	135	0	0	0	135	0	0	46	138	0	0	0	0	0	0	1,836	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Cash From Financing Activities	-101,844	-43,038	-151,033	-146,081	-116,720	-148,829	-91,907	-13,480	-165,820	-221,726	-180,217	-129,651	398	-104,184	-161,531	16,901	-74,389	-99,751	-109,488	-2,781	-117,806	-84,294	-70,708	-324,991	-78,058	-67,871	-63,400	1,313	-76,612	-69,247	-73,167	1,202	-59,158	-39,663	-33,532	36,801	42,339	-76,268	-54,549	-14,960	-33,055	-40,331	-31,317	2,252	-49,847	-37,231	-31,701	-6,564	4,010	-36,530	-41,687	-23,450	-11,490	-32,072	-33,603	-9,604	-44,755	-22,404	-31,421	3,285	-20,680	-5,742	-29,136	24,768	-12,521	-6,974	-47,981	49,289	-9,305	-259	-38,125	-28,570	-31,070	-33,715	-13,992	-28,208	-33,361	-35,346	-29,798	-11,666	-6,312	10,046	-4,384	-4,512	5,352	952	-33,915	2,268	3,340	1,189	7,700	-11,315	-18,051	-41,812	402	-3,889	-41,100	-28,300	2,900	2,500	2,500	-400	2,200	-1,100	1,000	-800	700	600	4,800	1,500	2,500	1,200	1,300	154,200	3,300	900	1,000	300	600	500	1,200	300	100	800	300	100	28,900	100	700	0
Total Cash From Operating Activities	249,851	272,433	200,314	183,912	173,428	189,000	65,850	114,706	209,964	187,205	233,955	124,422	218,934	193,116	208,142	27,871	155,413	132,265	137,102	34,378	135,648	110,708	118,830	34,898	121,126	110,684	110,192	31,274	100,115	100,315	110,915	23,226	73,896	76,946	80,166	-14,644	27,303	93,263	81,762	33,518	66,267	79,727	79,318	20,684	76,794	74,688	63,616	15,184	57,182	75,208	63,092	25,218	48,850	54,898	55,880	19,205	59,449	44,622	58,257	12,624	33,494	41,674	70,929	-2,789	39,931	32,057	64,523	-1,387	38,414	26,624	47,811	-3,023	40,047	38,420	37,803	282	27,172	24,311	33,228	10,668	25,399	26,166	36,046	29,544	9,327	40,165	29,306	24,455	15,756	22,245	15,322	-6,959	9,206	9,727	9,469	-162	19,700	10,600	24,000	-1,700	4,600	13,600	19,200	8,700	3,600	2,000	10,700	-2,800	3,700	-600	10,700	-5,800	-3,800	5,600	-700	5,700	2,500	4,100	6,100	2,100	1,500	1,200	2,700	2,000	800	700	-1,300	-300	500	1,000
Total Cashflows From Investing Activities	0	0	-27,470	-39,511	-49,229	-49,197	-55,086	-41,838	-44,040	-49,677	-174,663	-24,587	-15,690	-19,460	-24,556	-49,670	-95,911	-37,326	-34,085	-38,206	-39,844	-54,215	-27,651	260,312	-24,487	-41,487	-43,702	-29,012	-14,278	-22,946	-29,763	-23,799	-26,013	-54,806	-66,967	-160,620	-35,618	-23,449	-8,712	-12,634	-17,827	-27,374	-23,938	-16,920	-24,920	-18,929	-14,812	-7,344	-57,692	-16,349	-16,462	-6,493	-43,190	-28,804	-17,517	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4,115	0	12,594	12,176	11,141	26,221	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7,803	24,225	8,017	10,166	14,499	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Income Statement

Currency in USD. All numbers in thousands.

	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31	2000-12-31	1999-12-31	1998-12-31	1997-12-31	1996-12-31	1995-12-31	1994-12-31	1993-12-31	1992-12-31	1991-12-31
Cost Of Revenue	1,470,983	1,362,986	1,325,928	1,135,615	1,041,359	971,700	871,676	799,987	711,622	669,691	620,940	594,190	572,183	524,769	505,352	494,264	459,033	359,588	315,195	270,164	245,688	219,945	202,750	170,775	164,900	142,200	119,800	102,900	75,200	48,700	34,200	21,700	11,800
Depreciation And Amortization	114,908	111,900	104,596	95,998	88,011	83,178	83,140	78,218	68,956	58,888	54,596	52,408	48,202	45,956	49,773	48,819	41,100	29,816	24,369	18,427	18,897	20,124	22,229	19,481	17,200	15,900	14,400	10,400	5,700	4,500	3,800	3,500	1,000
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Ebit	1,097,128	898,765	932,028	694,524	552,846	491,335	413,028	350,239	239,168	260,255	266,762	262,563	236,225	203,881	175,969	172,456	136,183	127,781	114,879	107,641	80,273	65,815	56,552	53,251	46,800	59,400	23,400	38,700	28,800	22,700	12,800	4,100	1,800
Ebitda	1,097,128	1,010,665	1,036,624	790,522	640,857	574,513	496,168	428,457	308,124	319,143	321,358	314,971	284,427	249,837	225,742	221,275	177,283	157,597	139,248	126,068	99,170	85,939	78,781	72,732	64,000	75,300	37,800	49,100	34,500	27,200	16,600	7,600	2,800
Effect Of Accounting Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Extraordinary Items	0	0	0	0	0	-2,100	-31,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Gross Profit	2,189,970	2,004,338	1,889,432	1,571,040	1,365,549	1,241,542	1,097,382	975,436	890,270	816,116	756,118	699,148	646,506	578,623	526,281	529,766	463,522	379,529	322,900	279,017	230,304	192,725	183,331	196,657	191,300	177,700	143,200	164,800	113,400	77,700	58,900	36,000	18,700
Income Before Tax	1,061,176	859,972	902,654	661,985	522,218	457,742	381,057	321,846	273,141	246,555	263,261	260,617	234,422	202,129	174,539	170,187	134,843	130,750	118,472	111,103	83,254	68,770	58,781	58,247	52,600	-1,200	-32,200	55,300	37,000	22,800	15,100	6,100	3,500
Income Tax Expense	216,134	180,883	157,810	79,854	94,426	80,695	117,788	99,792	81,006	64,604	75,467	82,330	72,668	60,809	52,304	54,018	40,829	37,224	40,670	33,165	26,278	23,381	21,161	21,615	20,000	14,000	-11,100	22,700	15,500	9,500	5,400	1,200	300
Interest Expense	35,952	38,793	29,374	32,539	30,628	33,593	31,971	28,393	26,771	13,700	3,501	1,946	1,803	1,752	1,430	4,589	4,179	462	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Income	2,233	1,065	434	586	427	1,151	5,254	3,656	26,771	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	1	355	72	16	125	9	57	45	-6	20	32	36	10	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income	845,042	679,089	744,845	581,776	427,720	377,031	263,144	222,045	192,078	181,906	187,800	178,267	161,786	141,284	122,225	116,169	94,014	93,678	78,254	78,332	57,090	45,389	37,620	36,632	32,600	-15,200	-21,100	32,600	21,500	13,300	9,700	4,900	3,200
Net Income Applicable To Common Shares	0	679,089	744,845	581,776	427,720	377,031	263,144	222,045	192,078	181,906	187,800	178,267	161,786	141,284	122,225	116,169	94,014	93,678	78,254	78,332	57,090	45,389	37,620	36,632	0	0	0	0	0	0	0	0	0
Net Income From Continuing Ops	822,728	679,089	744,844	582,131	427,792	377,047	263,269	222,054	192,135	181,951	187,794	178,287	307,090	141,320	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Interest Income	-43,630	-38,793	-29,374	-32,539	-30,628	-33,593	-31,971	-28,393	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Non Operating Income Net Other	0	1,065	434	586	427	1,151	5,254	3,656	2,468	1,729	1,885	1,902	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Non Recurring	0	0	0	0	0	0	0	0	8,212	8,212	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Income	1,097,128	898,765	932,028	694,524	552,846	491,335	413,028	350,239	299,912	260,255	266,762	262,563	236,225	203,881	175,969	172,456	136,183	127,933	115,331	108,035	80,387	65,815	56,552	53,251	46,800	29,100	-4,400	47,000	32,900	22,800	13,900	5,100	2,600
Other Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Operating Expenses	2,563,825	2,468,559	2,283,332	2,012,131	1,854,062	1,721,907	1,556,030	1,425,184	1,293,768	1,225,552	1,110,296	1,030,775	982,464	899,511	855,664	851,574	786,372	611,184	522,764	441,146	395,605	346,855	329,529	314,181	309,400	290,800	267,400	220,700	155,700	103,600	79,200	52,600	27,900
Preferred Stock And Other Adjustments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reconciled Depreciation	113,891	111,900	104,596	95,998	88,011	83,178	83,140	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Research Development	190,951	254,820	161,009	141,249	133,193	117,863	109,182	101,122	99,681	98,263	88,003	82,014	76,042	68,597	65,124	70,552	67,338	53,617	40,948	35,402	32,319	29,329	28,426	28,292	27,300	21,500	17,100	12,200	10,200	8,200	0	0	0
Selling And Marketing Expenses	566,066	524,505	486,735	434,435	418,193	387,406	354,294	317,058	299,955	283,708	243,492	216,962	204,850	179,626	167,748	169,693	151,882	115,882	101,990	85,710	71,846	57,087	0	0	0	0	0	0	0	0	0	0	0
Selling General Administrative	335,825	326,248	309,660	300,832	261,317	244,938	220,878	207,017	182,510	173,890	157,861	137,609	129,389	126,519	117,440	115,586	260,001	197,979	166,621	135,580	117,598	97,581	98,353	95,633	100,000	111,200	116,100	95,200	0	0	0	0	0
Tax Provision	211,995	180,883	157,810	79,854	94,426	80,695	117,788	99,792	81,006	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Operating Expenses	1,092,842	1,105,573	957,404	876,516	812,703	750,207	684,354	625,197	582,146	555,861	489,356	436,585	410,281	374,742	350,312	357,310	327,339	251,596	207,569	170,982	149,917	126,910	126,779	143,406	144,500	148,600	147,600	117,800	80,500	54,900	45,000	30,900	16,100
Total Other Income Expense Net	-35,952	-38,793	-29,374	-32,539	-30,628	-33,593	-31,971	-28,393	-8,212	-13,700	-3,501	-1,946	-1,803	-1,752	-1,430	-2,269	-1,340	152	452	394	114	2,955	2,229	4,996	5,800	-30,300	-27,800	8,300	4,100	100	1,100	1,000	800
Total Revenue	3,660,953	3,367,324	3,215,360	2,706,655	2,406,908	2,213,242	1,969,058	1,775,423	1,601,892	1,485,807	1,377,058	1,293,338	1,218,689	1,103,392	1,031,633	1,024,030	922,555	739,117	638,095	549,181	475,992	412,670	386,081	367,432	356,200	319,900	263,000	267,700	188,600	126,400	93,100	57,700	30,500

	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-12-31	2003-09-30	2003-06-30	2003-03-31	2002-12-31	2002-09-30	2002-06-30	2002-03-31	2001-12-31	2001-09-30	2001-06-30	2001-03-31	2000-12-31	2000-09-30	2000-06-30	2000-03-31	1999-12-31	1999-09-30	1999-06-30	1999-03-31	1998-12-31	1998-09-30	1998-06-30	1998-03-31	1997-12-31	1997-09-30	1997-06-30	1997-03-31	1996-12-31	1996-09-30	1996-06-30	1996-03-31	1995-12-31	1995-09-30	1995-06-30	1995-03-31	1994-12-31	1994-09-30	1994-06-30	1994-03-31	1993-12-31	1993-09-30	1993-06-30	1993-03-31	1992-12-31	1992-09-30	1992-06-30	1992-03-31	1991-12-31	1991-09-30	1991-06-30	1991-03-31
Cost Of Revenue	375,434	367,545	370,780	357,224	343,641	335,035	346,514	337,796	344,669	337,500	336,834	306,925	311,436	299,183	258,250	266,746	274,297	260,353	262,250	244,459	249,025	239,805	248,313	234,557	233,647	217,974	216,225	203,830	202,370	201,578	206,026	190,013	181,990	182,113	180,586	166,933	169,794	170,187	171,604	158,106	165,408	152,514	154,885	148,132	150,488	144,840	150,960	147,902	148,320	142,287	143,829	137,747	138,986	127,421	132,198	126,164	137,404	128,643	127,283	112,022	122,772	122,944	129,310	119,238	122,725	110,907	122,825	102,576	95,940	89,181	92,328	82,139	82,054	76,740	80,055	76,346	75,363	63,053	65,377	66,371	64,757	60,971	62,175	57,785	56,886	53,774	55,795	53,490	51,600	51,101	52,488	42,412	44,320	42,704	42,007	41,744	41,100	40,700	42,700	40,500	36,600	34,700	36,600	34,300	35,700	32,100	26,200	25,900	27,500	25,900	27,200	22,400	22,700	19,600	18,100	15,000	14,000	12,500	12,000	10,300	10,000	8,400	8,600	8,000	6,400	5,000	5,400	4,800	3,300	2,900	3,000	-
Depreciation And Amortization	29,737	28,985	27,855	28,331	28,720	28,900	28,122	26,654	27,695	26,467	25,377	25,057	24,561	24,651	23,582	23,204	22,589	22,446	21,621	21,355	20,604	20,878	20,892	20,804	21,520	20,727	20,586	20,307	20,241	19,767	19,664	18,546	17,729	18,283	16,790	16,154	15,278	15,521	14,695	13,394	13,466	13,773	13,844	13,513	13,918	12,799	12,986	12,705	12,814	12,045	11,879	11,464	11,839	11,485	11,386	11,246	12,555	12,506	11,665	13,047	12,649	12,190	12,585	11,395	11,562	10,267	10,224	9,047	8,079	7,528	7,551	6,658	6,278	6,138	6,137	5,816	5,237	5,128	3,748	4,314	4,640	4,412	4,933	4,912	4,763	5,679	5,008	4,674	6,825	5,082	5,173	5,149	5,379	4,727	4,845	4,530	4,400	4,300	4,200	4,300	4,200	3,800	3,300	4,600	3,900	3,700	3,800	3,000	3,400	3,500	1,400	2,100	1,300	1,700	1,500	1,200	1,400	1,000	1,000	1,100	600	1,000	1,200	1,000	500	1,000	1,100	900	500	100	200	-
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Ebit	215,565	246,298	268,289	252,068	197,807	244,828	150,944	248,344	171,496	226,084	233,876	247,674	160,534	172,064	193,317	144,465	93,042	139,888	164,308	133,178	94,743	117,492	145,766	113,623	76,288	101,813	123,740	93,326	63,584	89,310	105,090	74,613	49,182	80,791	88,862	56,649	19,523	72,502	83,707	70,517	47,862	65,941	64,919	61,632	49,509	63,385	62,831	47,702	55,805	56,546	71,717	53,901	51,140	49,950	54,973	48,481	44,285	44,253	37,511	38,685	38,169	38,997	58,891	38,719	36,742	36,097	32,467	30,877	29,470	34,462	36,987	26,862	30,184	30,123	28,776	26,037	23,275	28,404	30,982	25,168	15,320	23,286	24,334	17,447	18,500	18,300	18,699	10,886	14,869	15,447	15,048	16,337	14,350	13,514	13,879	11,508	12,800	12,000	10,300	9,000	45,600	5,900	5,000	3,000	4,000	28,400	-6,900	-2,200	11,600	10,900	8,800	7,300	7,300	8,500	7,400	5,700	7,900	5,400	5,200	4,000	5,500	3,400	2,500	1,600	1,600	1,300	1,000	400	2,800	-500	400	-
Ebitda	245,302	275,283	296,144	280,399	226,527	273,728	179,066	274,998	199,191	252,551	259,253	272,731	185,095	196,715	216,899	167,669	115,631	162,334	185,929	154,533	115,347	138,370	166,658	134,427	97,808	122,540	144,326	113,633	83,825	109,077	124,754	93,159	66,911	99,074	105,652	72,803	34,801	88,023	98,402	83,911	61,328	79,714	78,763	75,145	63,427	76,184	75,817	60,407	68,619	68,591	83,596	65,365	62,979	61,435	66,359	59,727	56,840	56,759	49,176	51,732	50,818	51,187	71,476	50,114	48,304	46,364	42,691	39,924	37,549	41,990	44,538	33,520	36,462	36,261	34,913	31,853	28,512	33,532	34,730	29,482	19,960	27,698	29,267	22,359	23,263	23,979	23,707	15,560	21,694	20,529	20,221	21,486	19,729	18,241	18,724	16,038	17,200	16,300	14,500	13,300	49,800	9,700	8,300	7,600	7,900	32,100	-3,100	800	15,000	14,400	10,200	9,400	8,600	10,200	8,900	6,900	9,300	6,400	6,200	5,100	6,100	4,400	3,700	2,600	2,100	2,300	2,100	1,300	3,300	-400	600	6,300
Effect Of Accounting Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Extraordinary Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-2,100	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Gross Profit	526,167	547,982	572,850	542,971	484,927	506,626	514,032	498,753	456,421	472,921	489,308	470,782	409,502	422,606	379,342	359,590	331,149	344,950	357,853	331,597	300,361	305,643	332,439	303,099	272,474	274,002	292,715	258,191	240,626	246,730	260,543	227,537	217,695	224,274	232,757	215,544	182,165	213,336	218,518	202,097	188,665	185,783	197,698	183,974	169,050	170,635	184,689	174,774	158,881	158,667	174,033	154,925	144,771	142,207	149,284	142,361	132,931	130,477	138,440	124,433	120,521	128,149	151,260	129,836	122,244	118,478	114,221	108,579	96,269	98,199	99,036	86,025	84,916	81,329	80,575	76,080	68,911	71,058	72,002	67,046	60,081	59,090	59,671	51,462	49,009	50,760	49,895	43,061	43,532	46,421	49,513	49,014	48,299	47,680	51,545	49,134	47,500	45,700	48,800	49,100	46,100	43,800	44,300	43,500	36,100	39,600	32,700	34,600	47,100	43,900	38,700	35,000	31,500	29,100	28,400	24,200	22,000	19,400	19,100	17,100	16,800	15,400	14,500	11,500	10,000	9,700	9,400	7,000	6,000	4,600	4,400	6,300
Income Before Tax	239,668	267,891	285,929	267,688	213,215	234,183	171,083	241,491	191,883	218,950	251,731	240,090	177,436	163,954	183,822	136,773	108,506	132,798	156,122	124,792	107,045	109,039	137,309	104,349	89,686	92,049	114,585	84,737	77,127	81,524	96,886	66,309	59,785	64,829	81,603	66,924	29,862	68,208	80,742	67,743	59,959	64,478	78,028	60,797	63,084	62,512	75,371	59,650	54,696	55,618	70,935	53,173	50,466	49,263	54,284	48,116	43,904	43,817	48,773	38,045	35,268	38,437	58,248	38,234	36,723	35,582	31,633	30,905	30,315	35,071	37,620	27,744	31,033	31,041	29,757	26,641	24,028	29,234	31,811	26,030	15,999	24,020	25,098	18,137	19,328	18,914	19,642	10,886	15,356	15,964	15,572	11,889	15,435	14,713	15,245	12,854	14,400	13,600	12,900	11,800	-25,600	9,800	8,400	6,200	-5,800	-24,400	-3,600	1,500	15,600	14,500	13,400	11,800	12,200	9,300	8,500	6,800	7,400	6,200	4,500	4,600	6,200	3,900	3,100	2,100	2,000	1,800	1,500	700	-500	2,000	700	-
Income Tax Expense	45,147	55,660	61,693	53,634	41,008	53,245	39,104	47,526	29,112	43,772	49,125	35,801	2,478	17,633	34,826	24,917	17,962	23,960	30,421	22,083	21,368	15,825	28,629	14,873	51,396	21,535	29,178	15,679	24,756	25,072	29,680	20,284	15,395	20,600	24,665	20,346	3,911	16,045	23,498	21,150	16,722	18,786	24,029	15,930	19,724	19,639	24,051	18,916	16,698	17,122	22,281	16,567	14,086	14,548	17,087	15,088	12,943	12,281	15,106	11,974	11,713	12,738	18,884	10,683	11,195	9,787	9,969	9,878	5,643	10,118	11,879	9,584	11,137	10,547	9,934	9,052	7,172	9,647	7,974	8,372	3,748	8,047	8,408	6,075	6,571	6,431	6,678	3,701	5,528	5,747	5,606	4,280	5,634	5,444	5,717	4,820	5,500	5,200	4,900	4,500	4,500	3,800	3,300	2,400	-2,700	-7,500	-1,500	600	6,400	5,900	5,500	4,800	5,100	3,900	3,600	2,800	3,100	2,600	1,900	1,800	2,500	1,300	1,000	700	300	300	300	200	-1,800	1,000	100	-
Interest Expense	-5,634	-7,392	10,215	12,711	13,312	10,998	7,983	6,996	7,308	7,134	7,522	7,584	7,659	8,110	9,495	7,692	7,125	7,090	8,186	8,386	8,302	8,453	8,457	9,274	8,122	9,764	9,155	8,589	6,698	7,786	8,204	8,304	7,126	7,750	7,259	5,879	4,939	4,294	2,965	2,774	1,369	1,463	735	835	343	873	446	757	1,109	928	782	728	674	687	689	365	381	436	403	640	2,269	1,242	1,213	1,031	1,340	1,202	1,454	634	462	159	76	113	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Interest Income	3,631	1,255	327	416	235	353	334	143	169	122	91	52	169	208	69	140	268	86	33	8,346	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Minority Interest	0	0	0	0	0	0	0	0	0	57	763	32	168	102	56	29	48	1	-5	28	39	-37	-11	25	33	3	50	39	2	-3	4	6	41	6	26	-16	-10	21	26	8	-21	4	4	7	6	20	3	-9	52	-11	-3	-6	9	21	4	2	10	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Net Income	194,521	212,231	224,236	214,054	172,207	180,938	131,979	193,965	162,771	175,235	202,582	204,257	174,790	146,219	148,940	111,827	90,496	108,837	125,706	102,681	85,638	93,251	108,691	89,451	38,257	70,511	85,357	69,019	52,369	56,455	67,202	46,019	44,349	44,223	56,912	46,594	25,961	52,142	57,218	46,585	43,258	45,688	53,995	44,860	43,354	42,853	51,317	40,743	38,010	38,507	48,657	36,612	36,371	34,694	37,193	33,026	30,951	31,536	33,667	26,071	23,555	25,699	39,364	27,551	25,528	25,795	21,664	21,027	24,672	24,953	25,780	18,273	20,027	20,604	19,933	17,690	16,935	19,696	23,910	17,791	12,365	15,973	16,690	12,062	12,757	12,483	12,964	7,185	9,828	10,217	9,966	7,609	9,801	9,269	9,528	8,034	8,900	8,400	8,000	7,300	-30,100	6,000	5,100	3,800	-3,100	-16,900	-2,100	900	9,200	8,600	7,900	7,000	7,100	5,400	4,900	4,000	4,300	3,600	2,600	2,800	3,700	2,600	2,100	1,400	1,700	1,500	1,200	500	1,300	1,000	600	-
Net Income Applicable To Common Shares	0	0	224,236	214,054	172,207	180,938	131,979	193,965	162,771	175,235	202,582	204,257	174,790	146,219	148,940	111,827	90,496	108,837	125,706	102,681	85,638	93,251	108,691	89,451	38,257	70,511	85,357	69,019	52,369	56,455	67,202	46,019	44,349	44,223	56,912	46,594	25,961	52,142	57,218	46,585	43,257	45,688	53,995	44,860	43,354	42,853	51,317	40,743	38,010	38,507	48,657	36,612	36,371	34,694	37,193	33,026	30,951	31,536	33,667	26,071	23,555	25,699	39,364	27,551	25,528	25,795	21,664	21,027	24,672	24,953	25,780	18,273	20,027	20,604	19,933	17,690	16,935	19,696	23,910	17,791	12,365	15,973	16,690	12,062	12,757	12,483	12,964	7,185	9,828	10,217	9,966	7,609	9,801	9,269	9,528	8,034	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Net Income From Continuing Ops	194,521	212,231	224,236	214,054	172,207	180,938	131,979	193,965	162,771	175,178	202,606	204,289	174,958	146,321	148,996	111,856	90,544	108,838	125,701	102,709	85,677	93,214	108,680	89,476	38,290	70,514	85,407	69,058	52,371	56,452	67,206	46,025	44,390	44,229	56,938	46,578	25,951	52,163	57,244	46,593	43,236	45,692	53,999	44,867	43,360	42,873	51,320	40,734	183,334	38,496	48,654	36,606	0	34,715	37,197	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Net Interest Income	-5,634	-7,392	-10,215	-12,711	-13,312	-10,645	-7,983	-6,853	-7,308	-7,012	-7,522	-7,532	-7,659	-7,902	-9,426	-7,552	-7,125	-7,004	-8,153	-8,346	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Non Operating Income Net Other	0	0	327	416	235	353	334	143	169	122	91	52	169	208	69	140	268	86	33	40	258	142	172	579	1,595	1,400	1,176	1,083	1,057	851	928	820	800	684	559	425	457	313	488	471	541	456	444	444	949	473	480	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Non Recurring	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8,212	8,212	0	0	8,212	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Operating Income	245,302	275,283	296,144	280,399	226,527	244,828	179,066	248,344	199,191	225,962	259,253	247,622	185,095	171,856	193,248	144,325	115,631	139,802	164,275	133,138	115,347	117,350	145,594	113,044	97,808	100,413	122,564	92,243	83,825	88,459	104,162	73,793	66,911	71,895	88,303	72,803	34,801	72,189	83,219	70,046	61,328	65,485	78,763	61,188	63,427	62,912	75,817	60,407	55,299	56,096	71,298	53,532	50,804	49,814	54,835	48,428	44,147	44,205	49,176	38,441	35,849	38,997	58,891	38,719	36,742	36,097	32,467	30,877	29,470	34,462	37,026	26,975	30,184	30,123	28,886	26,138	23,275	28,404	31,055	25,301	15,320	23,286	24,334	17,447	18,500	18,300	18,699	10,886	14,869	15,447	15,048	11,188	14,350	13,514	13,879	11,508	12,800	12,000	11,600	10,300	10,000	7,900	6,700	4,600	-900	2,000	-5,200	-400	13,600	12,700	11,100	9,600	9,800	8,900	8,000	6,300	7,000	5,800	5,500	4,300	5,800	3,600	2,800	1,800	1,800	1,600	1,300	500	1,100	700	500	6,300
Other Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Other Operating Expenses	656,299	640,244	647,486	619,796	602,041	596,833	681,480	588,205	601,899	584,459	566,889	530,085	535,843	549,933	444,344	482,011	489,815	465,501	455,828	442,918	434,039	428,098	435,158	424,612	408,313	391,563	386,376	369,778	359,171	359,849	362,407	343,757	332,774	326,280	325,040	309,674	317,158	311,334	306,903	290,157	292,745	272,812	273,820	270,918	256,111	252,563	259,832	262,269	251,902	244,858	246,564	239,140	232,953	219,814	226,647	220,097	226,188	214,915	216,547	198,014	207,444	212,096	221,679	210,355	208,227	193,288	204,579	180,278	162,739	152,918	154,338	141,189	136,786	127,946	131,744	126,288	120,999	105,707	106,324	108,116	109,518	96,775	97,512	91,800	87,395	86,234	86,991	85,665	80,263	82,075	86,953	75,089	78,269	76,870	79,673	79,370	75,800	74,400	79,900	79,300	72,700	70,600	74,200	73,200	72,700	69,700	64,100	60,900	61,000	57,100	54,800	47,800	44,400	39,800	38,500	32,900	29,000	26,100	25,600	23,100	21,000	20,200	20,300	17,700	14,600	13,100	13,500	11,300	8,200	6,800	6,900	-
Preferred Stock And Other Adjustments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Reconciled Depreciation	29,737	28,985	27,855	28,331	28,720	28,547	28,122	26,511	27,695	26,467	25,377	25,057	24,561	24,651	23,582	23,204	22,589	22,446	21,621	21,355	20,604	20,878	20,892	20,804	21,520	20,727	20,586	20,307	20,241	19,767	19,664	18,546	17,729	18,283	16,790	16,154	15,278	15,521	14,695	13,394	13,466	13,773	13,844	13,513	13,918	12,799	12,986	12,705	12,814	12,045	11,879	11,464	11,839	11,485	11,386	11,246	12,555	12,506	11,665	13,047	12,649	12,190	12,585	11,395	11,562	10,267	10,224	9,047	8,079	7,528	7,551	6,658	6,278	6,138	6,137	5,816	5,237	5,128	3,748	4,314	4,640	4,412	4,933	4,912	4,763	5,679	5,008	4,674	6,825	5,082	5,173	5,149	5,379	4,727	4,845	4,530	4,400	4,300	4,200	4,300	4,200	3,800	3,300	4,600	3,900	3,700	3,800	3,000	3,400	3,500	1,400	2,100	1,300	1,700	1,500	1,200	1,400	1,000	1,000	1,100	600	1,000	1,200	1,000	500	1,000	1,100	900	500	100	200	-
Research Development	51,812	47,967	46,505	44,667	43,418	48,013	123,221	40,168	45,306	40,427	37,697	37,579	38,777	37,517	31,645	33,310	35,160	34,260	32,259	31,514	30,138	29,192	29,510	29,023	28,809	27,585	26,998	25,790	25,418	25,672	25,412	24,620	25,496	24,862	24,317	25,006	24,869	24,847	25,433	23,114	22,496	21,568	22,181	21,758	21,050	20,349	20,058	20,557	20,203	19,406	18,621	17,812	17,479	17,203	17,206	16,709	16,008	16,583	16,594	15,939	17,184	17,920	18,274	17,295	16,769	17,281	17,317	15,971	13,951	13,696	13,292	12,678	10,636	10,543	9,995	9,774	9,373	8,824	8,685	8,520	8,302	8,376	8,304	7,337	7,082	7,339	7,726	7,182	6,437	6,956	7,608	7,425	7,556	6,750	7,193	6,794	6,300	6,300	7,500	7,200	6,400	5,200	4,900	5,000	5,100	4,600	3,800	3,500	3,200	3,100	3,100	2,800	2,500	2,600	2,700	2,500	1,900	2,200	2,100	2,000	0	0	0	0	0	0	0	0	0	0	-	-
Selling And Marketing Expenses	142,032	135,698	140,532	147,804	131,935	130,021	130,257	132,292	128,458	124,434	119,032	114,811	115,909	108,202	94,181	116,143	105,694	104,551	101,364	106,584	95,904	95,146	96,255	100,101	90,539	88,818	87,693	87,244	80,605	79,972	76,652	79,829	76,495	73,107	75,217	75,136	77,238	70,602	68,020	67,848	66,694	60,079	57,896	59,397	52,724	52,067	54,539	57,632	52,209	50,682	50,974	50,985	46,557	44,486	44,167	44,416	43,383	41,504	41,876	40,985	169,956	41,527	44,214	44,001	151,882	37,757	36,747	35,582	115,882	29,051	28,679	26,938	101,990	24,303	25,848	25,070	85,710	21,132	20,679	20,983	71,846	18,222	17,198	16,323	57,087	13,449	15,983	14,874	0	13,449	15,983	14,874	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Selling General Administrative	87,021	89,034	89,669	70,101	83,047	83,764	81,488	77,949	83,466	82,098	73,326	70,770	69,721	105,031	60,268	65,812	74,664	66,337	59,955	60,361	58,972	63,955	61,080	60,931	55,318	57,186	55,460	52,914	50,778	52,627	54,317	49,295	48,793	46,198	44,920	42,599	45,257	45,698	41,846	41,089	38,147	38,651	38,858	41,631	31,849	35,307	34,275	36,178	31,170	32,483	33,140	32,596	29,931	30,704	33,076	32,808	29,393	28,185	30,794	29,068	67,488	71,232	74,095	73,822	68,733	65,100	64,437	61,731	52,848	50,041	48,718	46,372	44,096	40,663	41,694	40,168	36,263	33,830	32,262	33,225	36,459	27,428	27,033	26,678	23,427	25,121	23,470	25,563	22,226	24,018	26,857	25,252	21,014	22,689	25,628	26,302	24,000	23,200	25,500	27,300	25,500	26,900	29,400	29,300	28,000	29,300	30,300	28,500	26,900	24,600	23,100	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Tax Provision	45,147	55,660	61,693	53,634	41,008	53,245	39,104	47,526	29,112	43,772	49,125	35,801	2,478	17,633	34,826	24,917	17,962	23,960	30,421	22,083	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-
Total Operating Expenses	280,865	272,699	276,706	262,572	258,400	261,798	334,966	250,409	257,230	246,959	230,055	223,160	224,407	250,750	186,094	215,265	215,518	205,148	193,578	198,459	185,014	188,293	186,845	190,055	174,666	173,589	170,151	165,948	156,801	158,271	156,381	153,744	150,784	144,167	144,454	142,741	147,364	141,147	135,299	132,051	127,337	120,298	118,935	122,786	105,623	107,723	108,872	114,367	103,582	102,571	102,735	101,393	93,967	92,393	94,449	93,933	88,784	86,272	89,264	85,992	84,672	89,152	92,369	91,117	85,502	82,381	81,754	77,702	66,799	63,737	62,010	59,050	54,732	51,206	51,689	49,942	45,636	42,654	40,947	41,745	44,761	35,804	35,337	34,015	30,509	32,460	31,196	32,175	28,663	30,974	34,465	32,677	33,949	34,166	37,666	37,626	34,700	33,700	37,200	38,800	36,100	35,900	37,600	38,900	37,000	37,600	37,900	35,000	33,500	31,200	27,600	25,400	21,700	20,200	20,400	17,900	15,000	13,600	13,600	12,800	11,000	11,800	11,700	9,700	8,200	8,100	8,100	6,500	4,900	3,900	3,900	-
Total Other Income Expense Net	-5,634	-7,392	-10,215	-12,711	-13,312	-10,645	-7,983	-6,853	-7,477	-7,012	-7,522	-7,532	-7,659	-7,902	-9,426	-7,552	-7,125	-7,004	-8,153	-8,346	-8,302	-8,311	-8,285	-8,695	-8,122	-8,364	-7,979	-7,506	-6,698	-6,935	-7,276	-7,484	-7,126	-8,212	-6,700	-5,879	-4,939	-3,981	-2,477	-2,303	-1,369	-1,007	-735	-391	-343	-400	-446	-757	-603	-478	-363	-359	-338	-551	-551	-312	-243	-388	-403	-396	-581	-560	-643	-485	-19	-515	-834	28	845	609	39	113	849	918	110	101	753	830	73	133	679	734	764	690	828	614	943	701	487	517	524	701	1,085	1,199	1,366	1,346	1,600	1,600	1,300	1,300	-35,600	2,000	1,700	1,600	-4,900	-26,400	1,700	1,800	2,000	1,800	2,300	2,300	2,500	400	600	600	-900	400	400	300	300	300	300	200	200	300	300	100	-1,700	1,300	100	-
Total Revenue	901,601	915,527	943,630	900,195	828,568	841,661	860,546	836,549	801,090	810,421	826,142	777,707	720,938	721,789	637,592	626,336	605,446	605,303	620,103	576,056	549,386	545,448	580,752	537,656	506,121	491,976	508,940	462,021	442,996	448,308	466,569	417,550	399,685	406,387	413,343	382,477	351,959	383,523	390,122	360,203	354,073	338,297	352,583	332,106	319,538	315,475	335,649	322,676	307,201	300,954	317,862	292,672	283,757	269,628	281,482	268,525	270,335	259,120	265,723	236,455	243,293	251,093	280,570	249,074	244,969	229,385	237,046	211,155	192,209	187,380	191,364	168,164	166,970	158,069	160,630	152,426	144,274	134,111	137,379	133,417	124,838	120,061	121,846	109,247	105,895	104,534	105,690	96,551	95,132	97,522	102,001	91,426	92,619	90,384	93,552	90,878	88,600	86,400	91,500	89,600	82,700	78,500	80,900	77,800	71,800	71,700	58,900	60,500	74,600	69,800	65,900	57,400	54,200	48,700	46,500	39,200	36,000	31,900	31,100	27,400	26,800	23,800	23,100	19,500	16,400	14,700	14,800	11,800	9,300	7,500	7,400	6,300

Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue	3,660,953
Cost of Revenue	-1,470,983
Gross Profit	2,189,970	2,189,970

Operating Income (+$)
Gross Profit	2,189,970
Operating Expense	-1,092,842
Operating Income	1,097,128	1,097,128

Operating Expense (+$)
Research Development	190,951
Selling General Administrative	335,825
Selling And Marketing Expenses	566,066
Operating Expense	1,092,842	1,092,842

Net Interest Income (+$)
Interest Income	2,233
Interest Expense	-35,952
Other Finance Cost	-9,911
Net Interest Income	-43,630

Pretax Income (+$)
Operating Income	1,097,128
Net Interest Income	-43,630
Other Non-Operating Income Expenses	0
Income Before Tax (EBT)	1,061,176	1,133,080 EBIT - interestExpense = 1,061,176 1,061,176 880,994
Interest Expense	35,952
Earnings Before Interest and Taxes (EBIT)	1,097,128	1,097,128
Earnings Before Interest and Taxes (EBITDA)	1,097,128

After tax Income (+$)
Income Before Tax	1,061,176
Tax Provision	-211,995
Net Income From Continuing Ops	822,728	849,181
Net Income	845,042
Net Income Applicable To Common Shares	0

Non-recurring Events
Discontinued Operations	0
Extraordinary Items	0
Effect of Accounting Charges	0
Other Items	0
Non Recurring	0
Other Operating Expenses	2,563,825
Total Other Income/Expenses Net	-35,952	43,630

Technical Analysis of Idexx
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Idexx. The general trend of Idexx is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Idexx's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitions	Bullish trend (-42.9%)		Bearish trend (42.9%)
Overbought to neutral	Bullish pullback	=	Bearish reversal
Upper to lower neutral	Bullish correction	=	Bearish continuation
Nuetral to oversold	Oversold	=	Oversold
Oversold to neutral	Bullish reversal	=	Bearish correction
Lower to upper neutral	Bullish continuation	=	Bearish pullback
Nuetral to overbought	Overbought	=	Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.

Score

Let's take a look at the Support & Resistance of IDEXX Laboratories Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 507.61 < 510.02 < 543.33.

The bearish price targets are: 458.97 > 456.78 > 435.83.

Tweet this

IDEXX Laboratories Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

Moving averages are lagging trend indicators.
There are many types of moving averages.
Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of IDEXX Laboratories Inc. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

MA 20 trending down: The MA 20 is trending down. -1
Close < MA 20: The price is below the MA 20. -1
MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
MA 50 trending down: The MA 50 is trending down. -1
Close < MA 50: The price is below the MA 50. -1
MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
MA 100 trending up: The MA 100 is trending up. +1
Close < MA 100: The price is below the MA 100. -1
MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
MA 200 trending down: The MA 200 is trending down. -1
Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving Average	Amount of candles	vs. MA 50	vs. MA 100	vs. MA 200
MA 20	20
MA 50	50	-
MA 100	100	-	-
MA 200	200	-	-	-

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Shows the moving average of the selected period.

There are four types of indicators:

Trend indicators
Momentum indicators
Volatility indicators
Volume indicators

There are various kinds of moving averages:

Simple moving average (SMA);
Exponential moving average (EMA);
Smoothed moving average (SMMA);
Linear weighted moving average (LWMA).

The moving average looks at a certain period of time and it calculates the price average. The various types of averages are using various formulas. Don’t worry, you don’t have to memorize any formula. All moving averages are calculated automatically by basically every charting software you use. But it’s good to know how moving averages are actually calculated.

Simple moving average

SMA is calculated by summing up the price closures of the selected period. The price is then divided by the selected period. For example, when using the 21 day moving average you sum up all the closing prices for each day and divide that by 21. The result is a line on the chart representing the average. Because it’s an average in the selected timeframe, the trend is always lagging. An moving average looks like this on the chart:

Source: Tradingview.com

In this case, the blue line represents a 21 day moving average. Because the average is based on results from the past, the indicator will always lag behind. For example, when price would suddenly go up, the moving average won't immediately follow.

All other moving averages discussed below look the same on the chart. The only difference is that the line will move in different directions based on the maths behind the used indicators and the amount of days used to determine the average.

Exponential moving average

The EMA gives more weight to the latest closing prices by giving them more value in the equation. EMA is calculated by adding a certain percentage to the latest closing prices:

EMA = (CLOSE (i) * P) + (EMA (i - 1) * (1 - P))

Where:

CLOSE (i) = current period close price.
EMA (i - 1) = value of the Moving Average of a preceding period.
P = the percentage of using the price value.

Smoothed moving average

A smoothed moving average is an exponential moving average with a long lookback period. Older prices are reduced in weight but are never left out in the calculation. Unlike SMA and EMA where prices are removed when they are beyond the selected period. SMMA is a combination of the SMA and EMA. The main advantage is that it smooths out fluctuations in price.

Linear weighted moving average

The LWMA gives the latest price the highest weight and then lineary scales down with each price before that. The result is that the LWMA reacts quicker to changes in price than the SMA or EMA. The formula:

LWMA = ((Pn∗W1)+(Pn−1∗W2)+(Pn−2∗W3)...) / ∑W

Where:

P = Price for the period.
n = The most recent period, n-1 is the prior period, and n-2 is two periods prior.
W = The assigned weight to each period, with the highest weight going first and then descending linearly based on the number of periods being used.

Moving averages are widely used by many traders. Which moving average you need depends on your trading strategy. Common practise is using a combination of multiple periods. For example, the EMA21, EMA50, EMA100 and EMA200. How does that look on a chart:

Source: Tradingview.com

The lowest (purple) line on the chart represents the EMA200 then following up the EMA100, EMA50 and EMA21.

You can use moving averages to determine a trend. The 200 moving average is mostly used as a baseline for determining the current trend:

When the 200 moving average is moving up it is considered a bullish trend.
When the 200 moving average is down it is considered a bearish trend.
When moving averages are flatlined, there is no clear trend so you should look for market structure, consolidation or trend reversals. Depending on how you want to trade.

This is not set in stone. Most trading strategies use multiple moving averages each with different settings. While one strategy might use the EMA20, the other uses the SMA21. There can be hundreds of different variations. Moving averages can also be used as support and resistance. More often than not, prices will bounce on moving averages.

IDEXX Laboratories Inc Daily Moving Averages Chart

2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

MACD is a lagging momentum indicator.
Uses two moving averages.
Can show buy or sell signals based on momentum.
Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of IDEXX Laboratories Inc. The current macd is -14.20728569.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Idexx price going down in the near term. -2
MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Idexx. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Idexx price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1

IDEXX Laboratories Inc Daily Moving Average Convergence/Divergence (MACD) Chart

2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.

Score

Let's take a look at the Directional Movement Index (DMI) of IDEXX Laboratories Inc. The current adx is 36.09.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Idexx shares, leading to potential downward momentum in its price. -1
PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2

IDEXX Laboratories Inc Daily Directional Movement Index (DMI) Chart

2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

Parabolic SAR (stop and reverse) is a lagging trend indicator.
Shows the current trend.
Shows potential entry signals.
Shows potential exit signals.
Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of IDEXX Laboratories Inc. The current sar is 471.88.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1

IDEXX Laboratories Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

Leading momentum indicator, meaning the signals are instant.
Ranges between 0 and 100.
Above 70 is considered overbought.
Below 30 is considered oversold.
Above or below 50 can also be used to determine price trend or support and resistance.
RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of IDEXX Laboratories Inc. The current rsi is 38.98. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
Trending up: The RSI is trending up. +1

Measures the speed and change of price movements.

There are four types of indicators:

Trend indicators
Momentum indicators
Volatility indicators
Volume indicators

The RSI measures the magnitude of recent price changes to determine if the asset is overbought or oversold.

Overbought (RSI above 70) means that the trading price is above its intrinsic value. This might indicate a sell or short signal.
Oversold (RSI below 30) means that the trading price is below its intrinsic value. This might indicate a buy or long signal.
RSI levels above or below 50 can also be used to determine a trend.
RSI divergence looks at a deviation between RSI and price movement.
Can be used in many different ways.

Original usage

Keep in mind that almost every indicator can be used in different ways. Even beyond the orginal settings. The relative strength index was developed by J. Welles Wilder. Wilder recommended a smoothing period of 14 days. That means a 14 day moving average (read more about this setting below). Another quote from the wikipedia page:

Wilders also considers the RSI 50 line as both support and resistance. I recommend to always read the original settings first before using an indicator. Many traders and websites are using their own version of the indicator which might be confusing.

How you can use RSI (Divergence)

First and foremost, there is no real right or wrong usage of the RSI indicator. You can use it in any way you want. Wilder recommends using a 14 day average but you can make it 50 or 100 if you like. Just keep in mind that using an indicator is just part of a larger trading plan. In other words, it’s not recommended to do any trading or investing based on a single indicator like the RSI.

The RSI is measured on a scale between 0 and 100. From 30 till 0 is considered oversold. and from 70 -100 is overbought. The RSI is a leading indicator, meaning the signals are instant.

I like to use the RSI as a trend\momentum indicator and not as an overbought or oversold indicator. I use the middle (50) as the baseline. When prices go above RSI 50 the trend is bullish and can indicate long positions. When below 50 it is considered bearish and can indicate short positions. Other traders use the 70 and 30 levels as overbought/oversold depending on the used strategy. The RSI indicator looks like this:

Source: Tradingview.com

The general concensus is that an RSI above 70 indicates that the security is overbought. In other words, the price this security is trading for is to high and should come down. So if RSI hits 70 or above this might indicate a sell signal or taking a short position (expecting the price will go down). Although RSI above 70 indicates the security is trading above it's fair value, that does not mean the price will go down.

Use tradingview to add indicators

I highly recommend using tradingview to add indicators to a chart. It has all the indicators you can think off and can add them for free (up to three indicators) to any chart you want. You can see that the levels 30 and 70 are marked with a dotted line. If you want you can remove these lines or give it another colour using Tradingview. You can also adjust the moving average used. You can also find RSI indicators made by the community that include other settings like RSI divergences.

Tradingview

Use Tradingview to (back)test your strategies and add hundreds of indicators created by the community.

View tool on Tradingview.com

RSI divergence

RSI is not only used to determine momentum but can also spot reversals or continuations of the trend. A reversal means that the trend is going in the opposite direction. From bullish to bearish or from bearish to bullish. These reversals can be spotted by looking at the price and the direction of the RSI. When the price is going up but the RSI is going down that means there is a divergence. This is also the case when RSI goes up but price is going down.

There are four types of divergences:

Regular bullish divergence
Regular bearish divergence
Hidden bullish divergence
Hidden bearish divergence

Regular bullish divergence

With a regular bullish divergence, the price is making lower highs but the oscillator (in this case the RSI) is making higher lows. A regular bullish divergence might indicate the end of the current trend. You’ll see regular bullish divergences mostly at the end of a downtrend. But that does not mean that every regular bullish divergence is a trend reversal.

Price is making lower highs
RSI is making higher lows
Indicating bullish reversal (price might go up)

Source: Tradingview.com

Regular bearish divergence

With a regular bearish divergence the price is making higher highs but the oscillator (in this case the RSI) is making lower highs. This might indicate the end of an uptrend.

Price is making higher highs
RSI is making lower highs
Indicating bearish reversal

Source: Tradingview.com

Hidden bullish divergence

With a hidden bullish divergence, the price is making a higher low while the RSI is making a lower low. This might indicate bullish trend continuation.

Price is making higher lows
RSI is making lower lows
Indicating bullish continuation

Source: Tradingview.com

As you have noticed, you can have multiple divergences in a row.

Hidden bearish divergence

With a hidden bearish divergence, price is making lower highs but RSI is making higher highs. This might indicate bearish trend continuation.

Price is making lower highs
RSI making higher highs
Indicating bearish continuation

Source: Tradingview.com

You can find many cheatsheets of RSI divergences online. Search for "RSI divergence overview" and you'll find a lot of examples. You can print these to learn the various types of divergences.

IDEXX Laboratories Inc Daily Relative Strength Index (RSI) Chart

3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

Leading momentum indicator, meaning the signals are instant.
Used to determine overbought and oversold areas much like the RSI.
Ranges between 0 and 100.
Above 80 is considered overbought.
Below 20 is considered oversold.
Consists of two lines named K and D.
K compares the highest high and lowest low on the selected price range.
The D line is a moving average of the K line.
Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of IDEXX Laboratories Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Idexx price going up in the near term. +2
Trending up: The STOCH %K is trending up. +1

IDEXX Laboratories Inc Daily Stochastic Oscillator Chart

3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

Lagging or leading Momentum indicator
When the CCI is above zero, the price is above the historical average
When the CCI is below zero, the price is below the historical average
Used for spotting trends
- If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
- If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of IDEXX Laboratories Inc. The current cci is -50.20757067.

IDEXX Laboratories Inc Daily Commodity Channel Index (CCI) Chart

3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

Lagging momentum indicator
Ranges between +100 and -100
Considered overbought above +50
Considered oversold below -50
It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of IDEXX Laboratories Inc. The current cmo is -12.72440508.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1

IDEXX Laboratories Inc Daily Chande Momentum Oscillator (CMO) Chart

3.5 Williams %R

Shows the current price relative to the highest high over the last 14 days.

Lagging momentum indicator
Ranging between 0 and -100
Above -20 is considered overbought
Below -80 is considered oversold
Is prone to give false signals

Score

Let's take a look at the Williams %R of IDEXX Laboratories Inc. The current willr is -56.60556558.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Idexx is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.

IDEXX Laboratories Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

Lagging volatility indicator
Uses 3 bands: one upper, one lower and one in the middle
Works best when the middle band reflects an intermediate trend (MA20).
When the price is moving closer to the upper band, the market might be overbought
When the price is moving closer to the lower band, the market might be oversold

Score

Let's take a look at the Bollinger Bands of IDEXX Laboratories Inc.

IDEXX Laboratories Inc Daily Bollinger Bands Chart

4.2 Average True Range (ATR)

Measures market volatility

Leading volatility indicator
Can be used to determine stop-loss positions
Calculated by:
- Current high minus the current low
- Current high minus the previous close
- Current low minus the previous close
The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of IDEXX Laboratories Inc. The current atr is 11.09.

IDEXX Laboratories Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Measures market volatility

Leading momentum indicator
Calculation:
- If the closing price is above the previous closing price: OBV = previous OBV + current volume
- If the closing price is below the previous closing price: OBV = previous OBV - current volume
- If the closing price is the same as the previous closing price than the OBV is the same.
Can be used to confirm price trends
Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of IDEXX Laboratories Inc. The current obv is -1,016,704.

IDEXX Laboratories Inc Daily On-Balance Volume (OBV) Chart

5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

Lagging momentum indicator
Looks like RSI but uses volume as an extra metric (RSI only considers price)
Above 80 is considered overbought
Below 20 is considered oversold
Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of IDEXX Laboratories Inc. The current mfi is 27.82.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

MFI < 50: -1

IDEXX Laboratories Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

Type	Notification	Date
Currently no notifications for IDEXX Laboratories Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

Date	Indicator	Signal
2023-12-01	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2023-12-04	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2023-12-06	STOCH	LONG EXIT		The %K line crosses below the %D line.
2023-12-08	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2023-12-11	STOCH	LONG EXIT		The %K line crosses below the %D line.
2023-12-12	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2023-12-13	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
2023-12-14	STOCH	LONG EXIT		The %K line crosses below the %D line.
2023-12-19	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2023-12-20	RSI	SHORT ENTRY	LONG CLOSE	70 crossover to downside
	STOCH	LONG EXIT		The %K line crosses below the %D line.
2023-12-21	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2023-12-26	STOCH	LONG EXIT		The %K line crosses below the %D line.
2023-12-27	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2023-12-29	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-01-02	RSI	SHORT ENTRY	LONG CLOSE	70 crossover to downside
2024-01-03	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-01-05	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-01-08	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-01-11	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2024-01-12	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-01-16	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
	BB	LONG ENTRY	SHORT CLOSE	Price closed below the lower band.
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-01-17	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-01-22	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-23	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-24	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-01-26	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-01-29	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-01-30	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-01-31	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-02-01	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-02-05	MACD	LONG ENTRY	SHORT CLOSE	The MACD line crosses above the signal line.
	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2024-02-07	STOCH	LONG EXIT		The %K line crosses below the %D line.
	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
2024-02-08	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-02-09	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-02-15	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2024-02-16	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-02-20	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-02-21	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-02-22	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2024-02-23	MACD	LONG ENTRY	SHORT CLOSE	The MACD line crosses above the signal line.
2024-02-26	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-02-27	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2024-02-28	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-02-29	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2024-03-01	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-03-05	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-03-07	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-03-11	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-03-13	BB	LONG ENTRY	SHORT CLOSE	Price closed below the lower band.
2024-03-14	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-03-15	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-03-19	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-03-20	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-03-21	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-03-25	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-03-26	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-03-28	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
2024-04-01	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-04-02	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-04-03	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-04-04	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-04-09	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-04-10	STOCH	LONG EXIT		The %K line crosses below the %D line.
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
	BB	LONG ENTRY	SHORT CLOSE	Price closed below the lower band.
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-04-12	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-04-15	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-04-17	MFI	SHORT ENTRY	LONG CLOSE	20 crossover to downside
2024-04-18	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-04-23	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
	RSI	LONG ENTRY	SHORT CLOSE	30 crossover to upside
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
	MFI	LONG ENTRY	SHORT CLOSE	20 crossover to upside

6.3. Candlestick Patterns

IDEXX Laboratories Inc Daily Candlestick Chart

Date	Candlestick Pattern

6.4. Technical Score

Let's check the technical score of IDEXX Laboratories Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

Indicator	Condition		Value
Rsi	Greater than	50	38.979
Ma 20	Greater than	Ma 50	505.784
Ma 50	Greater than	Ma 100	534.156
Ma 100	Greater than	Ma 200	536.235
Open	Greater than	Close	489.240
Total			1/5 (20.0%)

Create your own Symbol Scanner

Get notifications about IDEXX Laboratories Inc

I send you an email if I find something interesting about IDEXX Laboratories Inc.

IDEXX Laboratories Inc Buy, Hold or Sell?

Let's analyse Idexx together

Get notifications about IDEXX Laboratories Inc

Quick analysis of Idexx (30 sec.)

What can you expect buying and holding a share of Idexx? (30 sec.)

How much money do you get?

What is your share worth?

+ What do you gain per year?

For what price can you sell your share?

1. Valuation of Idexx (5 min.)

$494.26

$17.69

$43.59 - $96.76

$61.28 - $114.44

2. Growth of Idexx (5 min.)

Is Idexx growing?

How much money is Idexx making?

How much money comes from the company's main activities?

3. Financial Health of Idexx (5 min.)

4. Comparing to competitors in the Diagnostics & Research industry (5 min.)

Industry Rankings (Diagnostics & Research)

What can you expect buying and holding a share of Idexx? (5 min.)

What can you expect buying and holding a share of Idexx?

Speculation

Investing

How much money are you going to get?

When do you get the money?

How sure are you?

Linear %

Fundamentals of Idexx

About IDEXX Laboratories Inc

Financial Health

Valuation

1.1. Profitability of IDEXX Laboratories Inc.

1.1. Profitability

1.1.1. Net Profit Margin

Trends

Compared to industry (Diagnostics & Research)

1.1.2. Return on Assets

Trends

Compared to industry (Diagnostics & Research)

1.1.3. Return on Equity

Trends

Compared to industry (Diagnostics & Research)

1.2. Operating Efficiency of IDEXX Laboratories Inc.

1.2. Operating Efficiency

1.2.1. Operating Margin

Trends

Compared to industry (Diagnostics & Research)

1.2.2. Operating Ratio

Trends

Compared to industry (Diagnostics & Research)

1.3. Liquidity of IDEXX Laboratories Inc.

1.3. Liquidity

1.3.1. Current Ratio

Trends

Compared to industry (Diagnostics & Research)

1.3.2. Quick Ratio

Trends

Compared to industry (Diagnostics & Research)

1.4. Solvency of IDEXX Laboratories Inc.

1.3. Liquidity

1.4.1. Debt to Asset Ratio

Trends

Compared to industry (Diagnostics & Research)

1.4.2. Debt to Equity Ratio

Trends

Compared to industry (Diagnostics & Research)

2. Market Valuation of IDEXX Laboratories Inc

2.1. Earnings Per Share

2.1. Price to Earnings Ratio

Trends

Compared to industry (Diagnostics & Research)

IDEXX Laboratories Inc
Buy, Hold or Sell?